How long did these symptoms last?
All pain points should be treated this way, especially at your age.
And with them is fever.
You also need to get your cholesterol tested.
Are you feverish now?
Do you have a pain thumb right now?
Do you also have breathing problems?
And can you tell me what other symptoms you have with this?
How was your fever?
I have a cough, too.
I have data on colds and coughs.
And actually today I have a bit of a bad sore throat.
It's the perfect time for your camp.
And he had a stroke.
I think I have a little bit of candy.
I want you to define the area where the fingers hurt.
They also have the fever data.
and your sexual history
You know, I feel like my chest is aching.
You know, people cough on me all the time.
Do you have a sore throat?
You told us there was pressure in your chest.
any member of the family who has a heart attack, a heart disease, a heart attack, a high cholesterol, high blood pressure
any other symptoms or problems with the muscle pain?
Are there any other people in your household who are sick like you and have symptoms like yours?
Do you have any of these symptoms?
Do you have shortness of breath?
Do you still have the pain in your fingernails?
Because it's winter.
But we also shouldn't ignore chest pain and heart disease.
But a much more important problem right now is the root of this disease.
But I have trouble breathing.
But I know that many people have been upset with me.
But we need to treat every ailment with the utmost honesty.
But you're breathing fine right now, right?
And because of this pain in my foot, I completely forgot.
Does it feel like someone is holding your chest?
You still feel like you're breathing too short.
Do they think they have the same symptoms?
Do you have any chronic conditions like high blood pressure or anything like that?
Do you have any other chronic medical conditions, such as sclerosis?
Do you have any shortness of breath with this hip pain?
Do you have high blood pressure?
Do you have shortness of breath that goes along with it?
Do you know what the symptoms are?
Do you see the video?
Too much liquid today.
I'm going to take the diabetes test anyway.
Anyway, it has the same markings as my data.
How high is your fever?
How's your blood pressure?
if you continue to have high fever
if you have a fever of 102 or higher
if you think that your symptoms or problems deserve special attention
I had a fever yesterday.
The little bit of data was also there.
I had a fever yesterday.
I have a scar here on my chest.
I also have some breathing problems.
I'll send you the video.
I have a really painful data today.
I have a little bit of headache data and a little bit of cough data today.
In my opinion, this is a cold.
In my opinion, this is a mild cold.
It's like someone is sitting on my chest, really, really heavy.
It started with a headache and a fever at the same time.
It hurts in the middle of my chest.
It's like a painful, painful, painful painful, painful, painful, painful, painful painful, painful, painful, painful, painful, painful, painful, painful, painful, painful, painful, painful, painful, painful, painful.
It's in my heart.
It's in the middle of my chest.
It's in the middle of the chest.
I had a pain in my chest.
I'm very concerned about this heel pain.
I want you to go ahead and describe the symptoms of this.
as high blood pressure or diabetes.
It's like the right side of the middle of my chest.
Now you can treat fever as a sugary tachipirin.
Now, how many days have you had the symptoms?
Now you said you had a sore leg.
Sometimes I have a sore leg.
Okay, do you have any other symptoms of the disease besides pain?
Or is someone sitting on your chest?
Well, more like fever and cough, headaches and muscle pain.
Right in the middle of my chest.
Show me where you feel pain on the video.
until you have a fever.
So do you think that some of these symptoms might be related to your pregnancy?
So do your children have a portion of these symptoms?
Tell me about your leg pain.
The night fever is getting worse.
I've had a fever for the last two days.
The fever started to get worse.
This is Dr. Porter in the emergency room at the ICU.
Well, can you tell me a little bit more about your pain in the thigh?
Okay, I have a pain in my upper body, here, in my chest.
Well, I had a really bad leg pain.
Well, when I have that pain in my chest.
So what kind of pain do you have in your chest?
When did the pain in the thigh begin?
Where's your pain point?
And you feel this pain in your thigh, and it's in your chest.
You feel your feet twitching.
You know, I had diabetes and stuff.
You said, "You have this heel pain".
Rapid spread of the overall incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, from 1 January to 15 March 2020
The overall incidence of coronavirus (COVID-19) cases shows similar trends in the European Union/European Economic Area and the United Kingdom, which confirmed the same, while at different stages depending on the country, the global COVID-19 pandemic is spreading rapidly in all countries.
In view of the experience gained in Italy, countries, hospitals and emergency departments should increase their readiness to follow up with COVID-19 patients who require medical care, especially emergency care.
On 31 December 2020, a group of cases of unknown origin were reported in Wuhan, Hubei Province, China.
On 9 January 2020, the Chinese Center for Disease Control and Prevention reported the cause of the new coronavirus now called acute respiratory syndrome with coronavirus symptoms 2 ((SARS-CoV-2).
Until recently, the disease that causes the infection with SARSA-CoV-2 was called coronavirus disease (COVID-19).
Evidence suggests that up to 80% of people with COVID-19 have mild symptoms, such as respiratory tract infections with or without bronchitis, and often recover.
In 14% of cases, COVID-19 develops into a severe illness requiring treatment and in the remaining 6% cases, a severe illness requiring urgent care.
The mortality rate of COVID-19 patients under treatment is about 4%.
In this study, we assessed changes in all COVID-19 cases in each EU/EEA country and the United Kingdom (UK) compared to Hubei Province, China.
We also compare the current number of COVID-19 cases in the EU/European Economic Area EU/EEA and UK with Italy between 31 January and 15 March 2020.
COVID-19 cases in the EU/EEA and UK
After China, COVID-19 has spread to many geographic areas at the same rate as the COVID-19 pandemic in the rest of the world is now similar to this country.
11 March 2020, the Director-General of the World Health Organization (WHO) has declared COVID-19 a global pandemic.
On 5 March 2020, in the issue of Eurosurveilance, Spiteri et al. reported the first case of COVID-19 in Europe as defined by the World Health Organization (WHO).
Within the European Union/European Economic Area (EU/EEA), the first three confirmed cases were reported on 24 January 2020 in a person returning from Wuhan, Hubei Province, China.
On 15 March 2020, the first cases of COVID-19 were detected in all 30 EU/EEA countries and the United Kingdom (UK), while between 31 December 2019 and the date of the same, 39,768 cases and 1,727 deaths were reported, with 17,750 cases and 1,441 deaths in Italy alone.
Total number and incidence of COVID-19 cases
The European Centre for Disease Prevention and Control (ECDC) announces the number of reported COVID-19 cases in every country in the world from official sources such as the country's health ministries, national and regional health authorities and the World Health Organization (WHO) every day at 8:00 am.
This data was used to assess the COVID-19 trends in the EU/EEA and UK and to compare with those in Italy.
As the lead COVID-19 case reporting agency, we have calculated a 14-day delay in the total COVID-19 cases, thus taking into account the natural course of COVID-19 in each EU/EEA country and UK during the period 1 January-15 March 2020.
We have presented the total number of confirmed cases in each country on 15 March 2020 at 8:00 a.m. compared to Italy for the period 31 January-15 March 2020.
COVID-19 trends in the EU/EEA and UK
The 14 day trends in the overall abbreviated COVID-19 cases in EU/EEA countries and UK are generally the same as in Hubei Province (China) (Figure 1).
Across the EU/EEA and UK, the total incidence of COVID-19 cases began to increase around 21 February and then increased rapidly around 28 February 2020 (China assisted).
This is due to the rapid spread of reported cases in Italy, but all other EU/EEA countries and the UK are showing a rising trend in the total number of COVID-19 cases (China assisted).
Figure 2 shows the total number of COVID-19 cases in EU/EEA countries and UK compared to Italy from 31 January-15 March 2020.
It shows that, at 8:00 a.m. on March 15, 15 other EU/EEA countries and the UK had already reported a total number of cases comparable to that of Italy just two weeks ago or less.
Our results show that the number of detected COVID-19 cases is increasing rapidly in the EU/EEA and UK.
The observed changes in overall COVID-19 incidence suggest that the global epidemic is spreading at a comparable rate in all countries.
This comes as countries differ in standards, national public health responses vary, and the possibility of defining different cases in countries and different protocols for selecting which patients must be tested for COVID-19, including integration testing.
In early March 2020, doctors in the affected regions of Italy reported a situation where 10% of COVID-19 patients needed emergency care while media sources reported that hospitals and care facilities in these regions had reached the highest level of capacity.
Data on COVID-19 cases in hospitals and/or emergency departments are currently available at EU/EEU level for only 6% and 1% of cases, respectively.
It should, however, be collected in a systematic manner to replace existing surveillance data that focuses on the number of reported cases and the number of deaths.
A 2010-11 study showed widespread disparities in access to emergency care and central care beds in Europe, ranging from 29.2 in Germany to 4.2 beds per 100,000 people in the Portuguese population.
This means that countries may have more or less income than Italy (12.5 urgent care and nursing care beds per 100,000 people in 2010-11)
The design phases related to the integration of healthcare capacity with estimates for each EU/EEA country and UK prioritizing hospitalized COVID-19 cases associated with a > 90% risk of exceeding the emergency care bed capacity were reflected in the sixth update of the ECDC COVID-19 emergency risk assessment.
As cases are increasing in some regions of the EU/EEA and the UK, and hospitals and emergency departments usually serve specific regional integration, information on cases and emergency care beds should be made available primarily in the NUTS-2 area.
The experience of Italy and current trends in other countries show that the global COVID-19 pandemic is progressing rapidly in the EU/EEA and the UK.
Countries, hospitals and emergency departments should prepare for the continuing community transmission of SARS-CoV-2 and the rising number of COVID-19 patients requiring medical care, especially emergency care, as is happening in the affected regions of Italy.
According to the recent rapid risk assessment, a rapid, effective and comprehensive response is fundamental to delaying the spread of SARS-COV-2, moving from containment to mitigation, with the expected rapid increase in the number of cases likely to fail to provide decision makers and hospitals with timely time to understand, accept and adapt their response accordingly if it is not implemented in a timely manner.
The rapid risk assessment also lists public health measures to mitigate the impact of the pandemic.
There is little chance that the countries with the potential can further increase their containment efforts to reduce the spread of SARS-COV-2 and reduce the pressure on health care.
Failing this, it is likely that healthcare systems in other EU/EEA countries will face a significant increase in patients requiring urgent care in the coming days or weeks.
The outbreak of Coronavirus Disease 2019 (COVID-19), caused by the acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has so far killed more than 3,000 people and affected more than 80,000 in China and other parts of the world, causing a humanitarian catastrophe.
Similar to its similar virus, SARS-CoV, which caused SARS in thousands of people in 2003, SARS-CoV-2 can also pass through the sensor causing similar symptoms through a similar mechanism.
However, COVID-19 has a lower mortality and morbidity than SARS but is more transmissible and affects more adults than young people and more men than women.
In response to the rapidly increasing number of publications on emerging diseases, this article attempts to provide a comprehensive and timely view of the research topic as it is evolving.
We cover the basics of epidemiology, the origin of disease, virology, diagnosis, treatment, diagnosis of the causes of disease, and prevention of disease.
While many questions still need answers, we hope this insight will help us understand and eradicate the threat of disease.
The Spring Festival on January 25, 2020 became an unprecedented and unforgettable memory for all Chinese who were told to stay home on holiday for weeks after the outbreak of the new virus.
The virus is very similar to coronavirus (CoV) which caused an outbreak of acute respiratory syndrome during 2003; therefore, it was named SARS-CoV-2 by the World Health Organization on 11 February 2020, and the related disease was named CoV Disease-19 (COVID-19).
The pandemic began in Wuhan, China, and quickly spread throughout the country and to nearly 50 other parts of the world.
As of 2 March 2020, the virus has caused more than 80,000 confirmed cases of COVID-19, with more than 40,000 patients recovering and more than 3,000 patients dying.
The World Health Organization warns that COVID-19 is "social disease No. 1" and may be more powerful than terrorism.
According to PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), in less than two months, more than 200 papers have been published on COVID-19 including its virus study, epidemiology study, origin study, diagnosis, and treatment since its first report on January 7, 2020 which showed the sequence of how the virus was transmitted to several patients.
This edition attempts to summarize the research progress in the newly developing subject area.
Whenever possible, we try to compare COVID-19 with SARS and another disease caused by the coronavirus, Middle East Respiratory Syndrome (MERS, outbreak 2012).
We'll also talk about what we've learned so far in terms of predicting and predicting the causes of pain, as well as other remaining and urgent questions.
CoVs have traditionally been known as non-lethal infections, usually causing about 15% of influenza 4.
However, in this century, we have experienced two major human-caused epidemics of CoVs, such as SARS-CoV and MERS-CoV, which caused outbreaks that began in China in 2003 and Saudi Arabia in 2012, respectively, and quickly spread to many other countries with poor health and mortality.
Therefore, COVID-19 is now the third recorded CoV outbreak in human history.
As shown in Figure 1.1, the unidentified colubriotic groups were first reported in Wuhan on December 31, 2019 by the National Health Commission of China.
Seven days later the coronavirus was released.
On January 15, 2020, the first death was reported in Wuhan.
At the same time, the plague spread rapidly to neighboring cities, provinces and municipalities.
On January 20, health care workers reported a case of infection, suggesting that human transmission is possible.
On January 23, a curfew was imposed in Wuhan as all public transportation was suspended.
On January 24, the first clinical study reported that of the 41 confirmed cases, only 21 had direct contact with the Wuhan seafood market which is believed to be the site of the outbreak from unknown sources of livestock.
On January 30, the World Health Organization declared the pandemic a global health emergency.
At the time of this report, the disease had spread to China and nearly 50 countries around the world.
As the situation is changing rapidly, the ultimate extent and severity of the outbreak is present.
On 11 February 2020, a multi-centre study of 8,866 patients including 4,021 patients who tested positive for COVID-19 presented a widely updated picture of the pandemic as follows (https://mp.weixin.qq.com/s/UIBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 infection in people of any age, but not more than 30-65 years of age.
Nearly half (47.7%) of the affected individuals were over 50 years of age, a very small number were under 20, and only 14 of the affected individuals were under the age of 10.
SARS-CoV-2 was more prevalent in men (0.31/100,000) compared to women (0.27/100,000).
COVID-19 has spread to groups mostly in and around Hubei.
COVID-19 took an average of 5 (2-9) days from onset to diagnosis.
The average period of detention was 4.8 (3.0-7.2) days.
The average time to death was 9.5 (4.8-13) days.
The basal reproduction rate (RO) was 3.77 (95% Cl: 3.51-4.05), and the modified RO was 2.23-4.82.
The number of cases increased rapidly before 23 January 2020, during the Chinese Spring Festival traffic rush.
The mortality rate for patients with confirmed cases was 1.44% (95% CI: 1.10-1.86%), and the modified mortality rate for patients was 3.06% (95% CI: 202-4.59%).
The three major risk factors for COVID-19 were sex (sex), age (>=60), and poor collagen.
CoVs are a subfamily of large, coated viruses that contain one RNA receptor strand.
It can be divided into four categories, namely, alpha, beta, gamma and delta, which are known to occur in humans.
The upper membrane (S) glycoprotein binds to the nerve cells of angiotensin-converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) for SARS-CoV and MERS-CoV, respectively, and then membrane aggregation occurs.
The viral RNA genome is released into the cytoplasm; after the viral genome is replicated, the genomic RNA is released along with the membrane.
The first genome sequence of SARS-CoV-2 was reported on January 10, 2020.
SARS-CoV-2 was identified as a new beta-CoV variant with more than 99.98% genetic identification in 10 consecutive tests collected at the site of the first outbreak, Huanan Seafood Market in Wuhan.
SARS-CoV-2 is genetically similar to SARS-CoV compared to MERS-CoV.
Through electron microscopy transmission, SARS-CoV-2 traces were detected in a very thin region of the human respiratory membrane.
Human ACE2 has been identified as an infectious agent of SARS-CoV-2 as well as SARS-CoV.
However, the S protein of SARS-CoV-2 responds to human ACE2 much less strongly than SARS-CoV, which is compounded by the fact that SARS-CoV-2 causes less risk of infection in patients than SARS-CoV.
SARS-CoV-2 can also form abnormally short protein with orf3b and a highly expressed protein with orf8.
SARS-CoV-2 orf3b may play a role in virus infection and inhibit IFNB expression; however, orf8 has no known active site or expression.
On February 18, 2020, Zhou, et al., reported a fully extended cryo-EM version of human ACE2 at the 2.9 A site of the disrupted amino acid transporter B0AT1.
They found that the compound, which opens and then closes the detectors, binds to the compound as a weak one and ADCE2-B0AT1 can bind to two S proteins, which indicate the identification of CoVs and infection.
B0AT1 may be a therapeutic target in drug studies to prevent SARS-CoV-2 infection.
The initial and intermediate vector pain.
It was found that both SARS-CoV and MERS-CoV were derived from mosquitoes and transmitted to humans via cats and camels respectively.
Through comparison of the biological ancestry of SARS-CoV-2 with other CoVs, the coronavirus was identified as the original carrier of SARS-CoV-2 as the new virus is 96% identical to two SARS-CoVs identified in the virus, named SARS-CoV-SLZX45 and the virus-SL-CoVZX21.
However, the primary vector that helped the virus cross the biological barrier to infect humans is still unknown, and the route of transmission is still unclear.
Ji et al. have suggested that the mosquitoes are the carriers of the virus that transmits the virus to humans, which contains a homologous gene within the S protein.
In a study, researchers in Gangzhou, China, suggested that the larvae, milky throat-tips - often used in traditional Chinese medicine - are the most likely mediator of SARS-CoV-2 infections with 99% of the CoV genes detected in the larvae and SARS-CoV-2 being transmitted.
However, the 1% difference spread across both genetic information is still a large difference, so the combined results of the hard evidence are awaited (Figure 33)
The chemical mechanisms of SARS-CoV-2 are still largely unknown.
SARS-CoV and MERS-CoV can survive in vitro for 48 hours in a dry environment and up to 5 days below 20°C and 40%-50% humidity.
SARS-CoV-2 may have similar mechanisms.
It has been reported that SARS-CoV-2 is sensitive to sunlight and heat at 56C within 30 minutes, ether, 75% ethanol, an inflammatory agent containing chlorine, paracetic acid, chloroform, and other fatty compounds, but not chlorhexidine, can effectively remove the virus.
Almost all human populations are immune to SARS-CoV-2 and are therefore vulnerable to the new virus.
At present, there are no detailed studies reported on the basis of the body's immune response to SARS-CoV-2.
Therefore, we can only refer to earlier studies of other CoVs, specifically SARS-CoV and MERS-CoV (Fig. (Fig.4) 4).
Generally, after the virus attacks the infected person, it is first recognized by the body's natural immune system through a form of sensory recognition (PRR) that includes C-type lectin retinal sensors, Toll-like sensors (TLR), NOD-like sensors (NLR), and RIG-l-like sensors (RLR).
Through various pathways, the virus causes inflammation, deneritic neuron growth, and the production of type I interferons (IFN yo) that inhibit the spread of the virus and the acceleration of macrophage phagocoytosis of viral antigens.
However, the N protein of SARS-CoV can help the virus escape the immune response.
Recently, the adaptive immune response is joining the fight against the virus.
The white blood cells T, which include CD4+ and CD8+ T cells, play an important role in the immune system.
CD4+ cells stimulate B cells to produce specific antibodies to the virus, and CD8+ T cells that directly kill the infected virus cells.
T cell helpers produce cytokines that are inflammatory messengers to help the cells fight off infection.
However, CoVs can inhibit the functions of T cells that make T cells die.
Human immunity including antibodies such as C3a and C5a and anti-fungal agents are also fundamental to fighting viral infection.
For example, anti-powder derived from cured patients mediated MERS-CoV.
On the other hand, excessive interaction with the immune system produces more cells that interact locally which can cause serious damage to the heart and other organs, and, in the worst case, multiple organ failure and even death.
SARS-CoV-2 infection, which is characterized by a variable group, is more likely to be transmitted to older adults with pre-existing conditions and to pregnant women.
It is common for people who are susceptible to large numbers of viruses or whose immune system is weak to transmit the infection to others.
The estimated average incubation period for SARS-CoV-2 is 1-14 days, most often 3-7 days according to the study of 425 cases in Wuhan.
However, a study of 1,099 cases indicates that the period of daycare was 3 days on average, ranging from 0 to 24 days.
A more recent study, as described above, indicates that the duration of the daycare was 4.8 (3.0-7.2) days according to the 8,866 case statistics.
It is very important for health authorities to establish effective quarantine for the most part of the preschool period, which prevents people without symptoms from transmitting the virus to others.
As a rule, susceptible individuals, or those who have the virus, usually need to be quarantined for 14 days.
Can the quarantine period be extended to 24 days?
Fever is often the first and most important symptom of COVID-19, which may be accompanied by no symptoms or other symptoms such as dry cough, shortness of breath, muscle pain, nausea, headache, sore throat, multiple ulcers, pain in the thigh, diarrhea, dizziness, and headache.
Some patients had shortness of breath and low oxygen in their bodies just one week after the onset of the disease.
In severe cases, patients quickly progress to the stage where the disease begins to manifest as severe respiratory symptoms, inflammation of the lungs, acid retention and bleeding.
Patients with fever and/or respiratory and acute fever symptoms, even without symptoms of cardiovascular disease, should be tested for the virus immediately.
A statistical study conducted in late December 2019 showed that the symptoms of constipation were 98% cough, 78% coughing, 55% shortness of breath, and 3% diarrhea; 8% of patients required respiratory support.
Similar results were reported in two recent studies of a family group and the group caused transmission of the disease in a person who did not show symptoms.
In comparison, a 2012 statistical study shows that MERS-CoV patients also had fever (98%), dry cough (47%), and shortness of breath (55%) as the main symptoms.
However, 80% of them require respiratory support, in addition to COVID-19 patients and the risk of dying from MERS is constant compared to COVID-19.
We also saw patients with MERS with diarrhea (26%) and hives (21%)
In SARS patients, fever (99%-100%), dry cough (29%-75%), shortness of breath (40%-2%), diarrhea (20%-25%) and diarrhoea (13%-25%) were the main symptoms and respiratory support was estimated at 14%-20% of patients.
On 14 February, the death rate from COVID-19 was 2% when the confirmed cases reached 66,576 worldwide.
In comparison, the deaths from SARS in November 2002 were 10% of the 8,096 confirmed cases.
As for MERS, based on study statistics from June 2012, mortality was 37% of the 2,494 confirmed cases.
A previous study reported that the R0 of SARS-CoV was above 6.47 with a 95% confidence point (CI) of 5.71-7.23, while the R0 of SARS-CoV was only scaled from 2 to 4.
A comparison of SARS-CoV-2 with MERS-CoV-2 and SARA-CoV in terms of their symptoms, mortality, and R0 is presented in Table1.1.
High data suggests that SARS-CoV-2 has a higher transmission rate compared to MERS-CoV and SARS-CoV, but a lower mortality rate than the latter.
Therefore, it is very difficult to control the SARS-CoV-2 pandemic compared to other pandemics such as MERS-CoV and SARS-CoV.
Currently, groupings are usually held in the same family or in the same place or in the same vehicle, such as a cruise ship.
Patients with a history of travel or residence in Wuhan or other affected areas or who have had contact with infected people or patients in the two weeks prior to the current outbreak.
However, it has been reported that people can contract the virus without showing symptoms for more than two weeks and patients who have been treated and discharged from hospital may contract the virus again, which raises concerns about extending the quarantine period.
Patients have a normal or decreased number of red blood cells (especially red blood cells) at an early stage.
For example, decreases in serum <4x109/L including serum 1x109/L and elevated levels of aspartate aminotransferase and verimia were found in 1,099 COVID-19 patients.
The level of liver and muscle fluid and myoglobin increased in the blood of some patients, and the high reactive protein C and red blood cell counts increased in the blood of most patients.
In high-risk patients, the D-dimmer level, the decrease in the production of fibrin in the blood, was elevated, and the leukocyte count was progressively reduced.
Faulty forehead imaging has been found in many COVID-19 patients with a small male subclavian or a lack of cardiac luminescence.
Patients often develop bronchitis, severe heart damage, and severe respiratory distress syndrome (ARDS).
When ARDS occurs, uncontrollable inflammation, fluid accumulation, and growing tumors can seriously impair respiration.
Disorders of organ function in type-I and type-II pneumocytes decrease the rate of contraction and increase area tension, which decreases the ability of the heart to expand, indicating a risk of cardiac death.
So the worst result of taking a picture of d
On 18 February 2020, a laboratory trial of COVID-19 showed the elimination of pneumocytes, formation of hyaline membranes, and synthesis of red blood cells, and multi-membrane syncytial cells in the heart of patients who died from the disease. The frequency of laboratory tests for viral infections and ARDS was similar to that of SARS and MERS patients.
Detection of SARS-CoV-2 RNA by reverse-transcriptase polymerase (RT-PCR) was used as the main criterion for COVID-19 testing.
However, due to the high false price, which can accelerate the pandemic, clinical indicators that are not particularly reliable for RT-PCR testing began to be used in China on February 13, 2020.
A similar situation occurred with SARS.
Therefore, the combination of background, clinical evidence, laboratory tests and imaging results are fundamental and indispensable to making the diagnosis effective.
On February 14, 2020, Feng Zhang's team described a protocol using CRISPR-based SHERLOCK technology to detect SARS-CoV-2, from the SARS-CoV-2 RNA fragmentation of 20 x 10- 18 mol/L to 200 x 10- 18 mol/L (10-100 copies per microliter of questionnaire) using a long rod in less than one hour and without the need for large equipment.
Hopefully, the new technology could suddenly improve sensitivity and fitness if it's confirmed in clinical trials.
Due to the lack of experience with new CoVs, doctors can often only provide follow-up care to COVID-19 patients while trying different treatments that have been used or recommended before for treatment of other CoVs such as SARS-CoV and MERS-CoV and viral diseases (Table20.2).
The treatment includes the possibility of now treating with antiviral drugs, immune system inhibitors, steroids, plasma and cured patients, Chinese medicine and psychological support.
Even plasma from cured patients has been suggested for use as medicine.
Pharmaceutical companies are competing to develop antibiotics and vaccines against the virus.
SARS-CoV-2 is most commonly found in the early stage of heart disease and also occurs in the weak, other ACE2 specific organs, the gastrointestinal tract and the kidney.
However, respiratory failure and death are the biggest fears of patients as one of the biggest causes of death.
Therefore, respiratory support is potentially dangerous to alleviate symptoms and save lives, including general oxygen therapy, high oxygen flow, without breathing equipment, and with mechanical inhalation of breathing equipment depending on the risk of infection.
Patients with severe respiratory symptoms should be supplemented with extracorporeal membrane oxygenation (ECMO), which is an updated technique of short-acting vascular surgery used to treat life-threatening coronary artery disease or respiratory tract disease.
In addition, maintaining electrolyte balance, preventing and treating advanced infections and inflammatory cell activation, and inhibiting the function of vital receptors are also fundamental for SARS-CoV-2 patients.
It has been found that cytokine storm is caused by an overreaction of the immune system in SARS and MERS patients.
Cytokine storm is a type of systemic inflammatory reaction that follows the release of a cytokine sequence including TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, and MCP-1.
These cytokines cause my immune cells to release a large number of radical antibodies, which are the primary cause of ARDS and multiple cell death.
Lowering the immune system is fundamental to the treatment of cytokine storms, especially in debilitated patients.
Corticosteroid and tocilizumb, an anti-IL6 monoclonal antibody, were used to treat cytokine activation.
Other cytokine-reducing immunotherapy treatments include direct T cell inhibition of immune reactions; inhibition of IFN-y, IL-1, and TNF; inhibition of JAK; blinatumomab; inhibition of cytokine-indicating 4; and inhibition of HDAC.
Steroids, as an immunosuppressant, have been widely used in the treatment of SARS to reduce the severity of the disease.
However, high doses of steroids were not useful for severe lung injury in SARS and COVID-19 patients.
Instead, they can cause serious side effects, particularly avascular osteonecrosis, which can significantly affect the prognosis of the cause of the disease.
Similarly, short-term corticosteroids in low to moderate doses are recommended for use with caution in patients who are severely susceptible to COVID-19.
At the time of writing, there are no proven effective antiviral treatments.
However, intravenous administration with remdesivir, a nucleotide analog, has been found to be successful in US patients with COVID-19.
Remdesivir is a new antiviral drug developed by Gilead that was originally developed for the treatment of diseases caused by Ebola and Marlburg viruses.
Later, remdesivir also showed potential control of other RNA-binding viruses including MERS and SARS viruses.
Based on these, Gilead brought the site to China to conduct several tests on people infected with SARS-CoV-2, and the results are highly desirable.
In addition, baricitinb, interferon-α, lopinavir/ritonavir, and ribavirin have been suggested as potential treatments for patients with symptoms of acute respiratory distress.
Diarrhoea, dizziness, vomiting, heart damage, and severe reactions may occur with treatment with lopinavir/ritonavir.
Interactions of this treatment with other medicines used for patients should be carefully monitored.
Plasma from cured patients and antibody generation
The collection of blood from patients who have recovered from a communicable disease to treat other patients with the same disease or to prevent healthy people from contracting the disease has a long history.
In fact, recovered patients often have high levels of antibodies that they protect against infection in their blood.
Antibodies are immunoglobulins (Ig) produced by the white blood cell B that fight infections and other foreign substances and identify specific gravity on the infection and kill it directly.
Based on this, plasma was collected from the blood of a group of patients who had recovered from COVID-19 and injected into 10 critically ill patients.
Their symptoms were gone within 24 hours, with decreased inflammation and increased potency of the virus and oxygen in the blood.
However, validation and definition are important to suggest a method that is widely used before a specific treatment is developed.
In addition, the effects of the treatment, some problems with plasma absorption, should be considered carefully.
For example, antibodies can over-stimulate the immune response and cause cytokine release symptoms, which can potentially cause toxicity.
The body's antibody count is low, and the need for plasma is large to treat sick patients.
It is difficult to develop and produce specific anti-powder drugs quickly enough to fight the global pandemic.
As a result, it is difficult to directly remove B cells from cured patients and determine the genetic code of the disease by inserting effective antibodies or a screen with effective antibodies that can fight the underlying virus protein.
So, we can imagine the production of anti-fouling.
TCM has been used to treat various diseases in China for thousands of years.
However, its effectiveness is largely dependent on the combination of the mutation patterns with the diagnosis based on the TCM concepts.
The most effective drugs are often unknown or subtle and it is difficult to produce and verify such a formula or the best combination.
Currently, due to the lack of effective treatment specifically for COVID-19, TCM has become the primary treatment option for patients with mild to moderate symptoms or those who have recovered from severe cases.
For example, Shu Feng Jie Du capsules and Lian Hua Qing Wen capsules have been found to be effective in treating COVID-19.
The highest drug-response rate for COVID-19 treatment was observed in several Chinese provinces that used TCM in 87% of their patients, including Gansu (63.7%), Ningxia (50%), and Hunan (50%), while Hubei Province, which used TCM in only 30% of its COVID-19 patients, received the lowest drug-response rate (13%).
However, this is a very small comparison as other factors such as the number and risk of patients should be included in the evaluation.
On February 18, 2020, Boli Zhang and colleagues published a study comparing Western medicine (WM) therapy alone with the combination of WM and TCM therapy.
They saw that the time it took for your body to get a fever relief, the symptoms were subtle, and the treatment was less effective in the WM+TCM group than in the WM alone.
Interestingly, the rate of worsening in people with symptoms (mild to severe) was significantly lower in the WM+TCM group than in the WM group alone (7.4% versus 46%) and mortality was lower in the WM+TCM group than in the MW alone (8.8% versus 39%).
However, the efficacy and safety of TCM still awaits highly controlled trials in many ways and in many centers.
It will also be interesting to characterize the mechanical actions and prove the effectiveness of TCM treatments or a combination of them if possible.
Patients suspected or who have COVID-19 often face a great fear of the pandemic and death from the disease, and people in quarantine face boredom, loneliness, and anger.
In addition, inflammatory symptoms such as fever, oxygen deprivation, and cough as well as the serious side effects of treatment such as insomnia caused by corticosteroids can cause increased anxiety and depression.
In the early stages of the SARS outbreak, a number of psychiatric disorders including obsessive-compulsive disorder, anxiety, fear, underlying psychiatric disorders, parental symptoms, neurodegenerative disorders and suicide have been reported.
Mandatory contact training and quarantine, as part of the public health response to the COVID-19 pandemic, can make people more anxious and guilty about the impact of the pandemic, and critical of their families and peers.
Therefore, mental health care should be provided to COVID-19 patients, suspected persons, and persons who have been in contact with such persons, as well as to the elderly who need it.
Lab testing curricula should include the formation of mixed mental health teams, clear communication on outbreak monitoring and ongoing and effective SARS-CoV-2 treatment plans and the use of professional electronic tools and the implementation of close proximity precautions.
Effective vaccines are the basis for fighting the chain of infection from infectious animals and humans to susceptible carriers and often increasing the treatment of the virus while controlling the epidemic disease caused by emerging viruses.
Efforts have been made to develop vaccines based on protein S to produce long-term and potent mediators of antibodies and/or immunity against SARS-CoV.
Anti-virus vaccine is being tested for animal variant of SARS
However, the efficacy of the vaccine in vaccinated elderly and low-risk groups and protection from transmission of the animal virus infection is yet to be determined before clinical studies are initiated.
This is because SARS has been in decline for 17 years and no new cases have been reported to me.
In comparison, chronic cases and subtypes of MERS are occurring in the Middle East and spreading to other regions with a steady recovery in these areas.
Vaccine strategies for MERS have been developed using non-functional viruses, DNA plasmids, genetic transducers, nanoparticles, viral-like substances and mixtures of small protein molecules, some of which have been tested in animal molecules.
The development of safe vaccines and anti-SARS-CoV-2 vaccines for people without adequate immunity is urgent and a difficult task to control the ongoing pandemic.
However, it is difficult to overcome the difficulties due to the long period (average 18 months) needed for vaccine development and the existing variants of the CoV.
Like the new disease, COVID-19 is just beginning to show up in the open with comprehensive clinical screenings of thousands of patients.
In most cases, patients gradually recover from the absence of the previous symptoms.
However, like SARS and MERS, COVID-19 is also a disease associated with increased infection and death in patients with severe cases.
Therefore, building a mental model of health care for disease is the basis for health care institutions to give priority to their services, especially in areas with limited resources.
Based on the clinical studies reported so far, the following factors may affect or be related to the concept of healthcare for COVID-19 patients (Table 33):
Age: Age was the most important factor in causing SARS, which is also true for COVID-19.
COVID-19 is most commonly diagnosed in the 30-65 age group with 47.7% of patients being over 50 years old and 8,866 cases were studied as mentioned above.
Patients who needed emergency care were more likely to have previously dealt with other illnesses and acute conditions and were significantly heavier than those without (average age 66 versus 51), suggesting age was a factor in the outcome of COVID-19 patients.
Sexual: SARS-CoV-2 was more prevalent in males than females (0./100,000 compared to 0.27/100,000) as mentioned above.
In the emergency department, there is a higher risk of severe heart damage and abnormal heart attacks.
Heart attacks were also the leading cause of death in SARS patients.
It has been reported that SARS-CoV-2 can also bind to ACE2-positive cholangiocytes, which can cause cardiac arrest in COVID-19 patients.
It is important to note that age and chronic illness are strongly linked and can interact.
Abnormal laboratory results: The level of CRP in the blood reflects the severity of the cell disease or injury and has been suggested as a factor in possible pain causation, treatment reaction, and ultimately recovery.
The relationship of CRP level to severity and cause of COVID-19 has also been suggested.
In addition, increased lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatine kinase (CK) may also help predict outcomes.
These enzymes are highly expressed in several tissues, especially the heart and liver, and are released during cell injury.
Therefore, it is a traditional sign of cardiac or hepatic retirement.
The major medical symptoms: chest pain and timing of the onset of medical symptoms should be considered along with other factors to predict the outcome and adverse events of COVID-19.
Use of steroids: As mentioned above, steroids are immunosuppressants that are commonly used as an auxiliary therapy for infectious diseases to reduce the severity of painful injuries.
As heavy corticosteroid medication was widely used in SARS patients, many of those who recovered developed avascular osteonecrosis with longevity disability and decreased quality of life.
Therefore, if necessary, steroids should be used in low doses and for a short period of time for COVID-19 patients.
Brain Injury: As mentioned above, during the COVID-19 pandemic many patients suffered from the same excessive speech as they often endure long periods of quarantine and excessive inactivity and saw the death of close family members and patients' friends.
It is important to provide long-term psychological counselling and support to help these patients recover from their speech and return to a normal life.
According to the population census studies so far, COVID-19 appears to have different pathological conditions than SARS.
In addition to multiplying in the lower respiratory tract, SARS-CoV-2 also effectively multiplies in the upper respiratory tract causing asymptomatic or mild early-stage infection, similar to other CoVs that cause influenza.
Therefore, patients with frontal or endogenous disease can release large amounts of the virus during daily activities, causing a great deal of strain in controlling infection.
However, transmission of SARS-CoV has been found to occur when patients are severely ill, whereas transmission is usually not at the initial stage.
Therefore, the current COVID-19 outbreak is more severe and difficult to control than the SARS outbreak.
Major efforts are currently underway in China including lockdowns in Wuhan and nearby cities and ongoing quarantine for almost all communities in an effort to disrupt the transmission of SARS-CoV-2.
While these actions are seriously damaging the economy and other parts of the country, the number of new cases is declining, indicating a decline in infections.
The most optimistic estimate is that the kill will end by the end of March and that the recession will last for 3-4 months.
However, other experts do not go so far.
Paul Hunter, et al., estimated that COVID-19, which appears to be more infectious than SARS, will not end by 2020.
The pandemic and suggests that SARS-CoV-2 could infect one-third of the world's population.
A Canadian team reported that SARS-CoV-2 was detected in both nasal and nasal fluids of recovered patients who left the hospital 2 weeks ago, suggesting that the newly identified virus may be a circulating event similar to influenza.
However, promising signs have emerged in Shinaha in light of the decline in the number of new cases, which suggests current strategies may have worked.
Ebola was originally predicted to cause a million cases and another half million deaths.
However, through strict quarantine and quarantine, the disease was eventually contained.
It is possible, like SARS-CoV, that SARS-CoV-2 could weaken in transmission and eventually die or become a mildly infectious virus that can coexist with humans.
The comparison of COVID-19 infections with SARS and MERS is shown below (Figure 55).
SARS-CoV-2 can be transmitted extensively through cough and diarrhea, and possibly also by direct contact with objects that have been infected by the virus.
The virus was also found in feces, which brings a new possibility that it could pass through feces into the mouth.
A recent study of 138 cases showed that 41% of cases may have been nosocomial infection, including 17 patients with other pre-existing conditions and 40 health care providers.
Therefore, extreme care must be taken to protect the human being, especially health care providers, social workers, family members, friends, and those who come into contact with the infected person.
The first defensive step to reduce the risk of infection is to wear face masks; both the use of surgical masks and N95 respiratory masks (series #1860) helps to control the spread of the virus.
Egyptian surgical masks prevent fluid droplets from people who may have had the infection from air travel or touching a place where it would not have been transmitted to anyone else.
However, only N95 (series # 1860 yo) oral coating can protect against the absorption of very small viruses as small as 10 to 80 nm during respiration, with a capacity of only 5% of the virus able to pass through completely; SARS-CoV-2 is similar to SARS-CoV in terms of both dimensions being approximately 85 nm.
Since particulate matter can pass through even five surgical masks that are balanced, healthcare providers who deal directly with patients are required to wear N95 (series # 1860 yady) masks but not surgical masks.
In addition to mouthguards, healthcare providers must wear protective clothing to further reduce exposure to the virus.
Viruses can get into a person's eyes.
On January 22, 2020, a doctor contracted SARS-CoV-2 despite wearing an N95 mask, possibly getting the virus into his body through his eyes.
Therefore, healthcare providers must wear a face shield or glasses when working with patients.
The public in affected or potentially affected areas are strongly advised to wash their hands with disinfectant soap more often than before, to stay home to self-quarantine suspiciously and to reduce contact with people who may have been infected.
Three feet was identified as the appropriate distance for people to stay away from patients.
These measures are effective ways to reduce the risk of infection and prevent the spread of the virus.
Although SARS-CoV-2 has arrived as a new virus to the human world, it is very similar to SARS-CoV as reported on 7 January 2020 and has caused high alertness in China based on the deep memory of the SARS 2003 outbreak.
However, as of 19 January 2020, the director of Wuhan's disease control center has not released the information to the public as he says the new virus has a low potential for spread and reproduction control among humans and that is not a problem to prevent and stop the disease.
The message dramatically eased public concerns, especially as the entire country was preparing for the Spring Festival, and a crucial time was canceled to halt the outbreak at the nearest point in Wuhan.
China's disease control agencies may learn from this difficult lesson and make major advances in the future.
For example, these agencies should (1) be extra cautious when making public announcements as any word said to the public can change their sentiment and position; (2) more sentiment and reaction from the abnormal information coming from health facilities while they wait for official reports from doctors and officials; (3) more restrictions to stop the possibility of long-range transmission at an early stage than attempts to calm the public; and (4) distribute targeted materials to increase public awareness about the pandemic and to test and promote a long-term response process.
The COVID-19 outbreak caused by the novel virus SARS-CoV-2 began in late December 2019.
In less than two months, it has spread throughout China and to more than 50 countries around the world as of this writing.
As the virus is very similar to SARS-CoV and the symptoms are similar to COVID-19 and SARS, the COVID-19 outbreak has created a sense of a resurgence of SARS.
However, there are some notable differences between COVID-19 and SARS, which are the basis for stopping the tour and treating patients.
COVID-19 affects older people more than younger people and men more than women, and the risk and mortality rates are also higher among older people than younger children.
SARS has a much higher mortality rate than COVID-19 (10.91% versus 1.44%).
COVID-19 patients transmit the virus even without any symptoms whereas SARS patients were the same when they were very ill, which causes a greater problem in stopping the spread of COVID-19 than SARS.
This partly explains why SARS-CoV-2 is more rapidly spreading and spreading than SARS-CoV.
The standard SARS-CoV-2 RNA test may be non-infectious in some COVID-19 patients.
On the other hand, patients who have been treated may be re-infected.
The results suddenly increase the risk of the virus spreading.
Given the rapid progress in COVID-19 testing, many complex issues will be addressed, such as:
Where did SARS-CoV-2 come from?
Although 96% of the genes of the SARS-CoV-2 and two SARS-CoVs have been identified, we cannot conclude that SARS-CoV-2 originated from a mouse.
Which animal was the intermediate organism in the spread of the virus that spread the disease, say, to the mouse, to humans?
Without knowing answers #1 and 2, we can't effectively cut the transmission and the infection can get worse at any time.
Although model and chemical studies have shown that SARS-CoV-2 is ACE2-bound, how exactly does the virus enter the cell membrane and cause the mutation in the emergency tests?
Does the virus respond to ACE2 signaling in other host cells?
Without clear answers to these questions, we cannot achieve prompt and accurate diagnosis and effective treatment.
How long will the outbreak last?
How does the virus genetically advance during human-to-human transmission?
Will it be a global pandemic, a slowdown like SARS or a temporary deterioration like influenza?
It is important, but it may take time to find answers to the above questions and others.
However, whatever the cost, we have no choice but to stop this global pandemic as soon as possible and bring life back to normal.
The origin of the human-animal coronavirus
Genetic mutation and adaptation have led to the co-evaluation of coronavirus (CoV) and disease carriers, including humans, for thousands of years.
Before 2003, two human-infected CoVs (HCoVs) were known to cause mild illnesses, such as the common cold.
The outbreak of severe acute respiratory syndrome (SARS) and the symptoms of Middle East influenza (MERS) have changed the timeline to reveal how dangerous and dangerous HCoV infection is.
The outbreak of SARS-CoV-2 in central China in late 2019 has again lowered the chances of CoVs and has surprised us with its extremely high transmission capacity but has slowed the spread compared to its sister SARS-CoV.
Human coronavirus infection (HCoV) is a disease that is transmitted from animals to humans. Understanding the origin of human viral infections (HCoVs)
Most HCoVs are derived from fungi but are not infectious.
The central carrier disease that stores some HCoVs is also known as the central carrier disease.
Identification of the host animals has a direct impact on the prevention of human diseases.
Learning about animal-based CoV carriers can also provide important insights into the development of CoV in humans.
In this review, we present an overview of what is known about seven HCoVs, with an overview of their discovery history as well as their origin and transmission across organisms.
Importantly, we compare and differentiate between HCoVs from the concepts of virus evaluation and genetic mixing.
The current pandemic of CoV 2019 (COVID-19) is being discussed in this context.
In addition, the criteria needed for successful epidemiological evolution and the final decisions for virus risk assessment were also stated.
Coronaviruses (CoVs) belong to the family Coronaviridae, which consists of a cluster of genes that show, in turn, single-stranded RNA viruses.
These viruses house a large host gene of 26 to 32 kilobases of RNA viruses called "CoV" because of the complexity of the biological structure when viewed under a microscope.
Structurally, these CoVs have genes that do not divide to share with one organism.
Approximately two-thirds of the human genome consists of two major message-reading cells (ORF1a and ORF1b), which are translated into pp1a and pp1b replicase polyprotein.
The polyprotein was then activated to produce 16 non-structural proteins, formulated as nsp1~16.
The remaining portion of the gene contains ORFs that are used to construct proteins, including spikes (s), envelopes (E), membranes (M), and nucleoproteins (N).
A number of specific sequence proteins were introduced into the infected sites of different CoVs.
Based on the variation in protein sequence, CoVs are classified into four categories (alpha-CoV, bet-CoV, gamma-CoV and delta-CoV), of which the bet-CoV category comprises most HCoVs and is further divided into four subtypes (A, B, C and D).
Evidence from genetic studies has shown that mice and rats are the genetic source of most alpha-CoVs and beta-CoVs, while birds are the largest reservoir of gamma-CoVs and delta-CoVs.
For thousands of years, CoVs have been crossing the species boundary and emerging as vital pathogens for humanity.
To date, seven human CoVs (HCVs) are known.
These include HCoV-229E and HCoV-NL63, which are alpha-CoVs.
The other five beta-CoVs include HCoV-OC43, HCoV-HKU1, coronavirus from severe acute respiratory syndrome (SARS-CoV), coronavirus from Middle East respiratory syndrome (MERS-CoV) and SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 and HCoV-NL63 often cause mild symptoms, such as a common cold and/or diarrhea.
In contrast, the newly identified SARS-CoV, MERS-CoV and SARS-CoV-2 are highly pathogenic, causing severe lower respiratory infections in many patients with a high risk of developing symptoms of acute respiratory distress syndrome (ARDS) and symptoms of pulmonary hypertension.
The first HCoV-229E virus, B814, was isolated from nasal fluid of influenza patients in the 1960s.
Since then, much knowledge has been gained through extensive studies on HCoV-229E and HCoV-OC43, both of which cause autoimmune symptoms.
In fact, the topic has been widely accepted that HCoV infections are generally harmless until the SARS outbreak.
The SARS outbreak occurred in 2003 and is one of the worst in recent history, with more than 8,000 people killed and the death toll at nearly 10%.
A decade later, the outbreak of the Middle East respiratory syndrome (MERS) led to a persistent epidemic in the Arabian Peninsula and a pandemic that spread to the rest of the world.
HCoV (2019-nCOV) 2019 variant, which was successively named SARS-CoV-2, is the causative agent of the pandemic of the novel coronavirus disease 2019 (COVID-19), which has killed more than 3,120 people and infected more than 91,000 people as of March 3, 2020.
The bell is ringing and the world must prepare for the next SARS-CoV-2 pandemic.
All seven HCoVs have a zoonotic transmission from mice, rats or domestic animals.
Several lines of evidence support a mutated lineage of all HCoVs from the feeder, where the viruses are well adapted and not infectious but show significant genetic variation.
The COVID-19 pandemic has brought major health, scientific, social and ethical challenges to China and the world.
Investigation of the origin of animal-transmitted HCoVs provides a way to understand the natural history, driving force and barrier factors of the transition of the species.
This can also guide or facilitate the search for SARS-CoV-2 stocks, intermediates and breeding stock, which has important implications for preventing its spread to other areas in the future.
In this review we present a summary of the animal-borne pathogenesis, transmission to other organisms and the development of HCoV disease.
In particular, we shed light on and discuss the general theme of the origin of HCoVs: they are normally sterile in the biology of their host organism but become pathogenic after crossing over from one organism to another.
We are also reviewing the direction of HCoV transmission as the increased transmission often occurs when the germination rate drops.
The outcome of the ongoing SARS-CoV-2 outbreak was also discussed at the forum.
Animal CoVs have been known since the late 1930s.
Before the first detection of HCoV-229E B814 in the nasal secretions of influenza patients, several CoV variants were quarantined in infected animals, including beans, mice, cows, pigs, cats and dogs.
In the last decade, seven HCoVs have been identified.
A brief summary of the history of HCoV detection and sequencing (Table 1) will be informative and informative.
The HCoV-229E virus was first detected in the respiratory tract of patients with upper respiratory infection in 1966, and was subsequently induced to grow in the lung cell regions of WI-38.
Patients infected with HCoV-229E have shown flu symptoms, including headache, diarrhea, dyspnea and eating disorders, with fever and cough seen in 10-20% of cases.
In late 1967, HCoV-OC43 was discovered in cell culture and sequence pathway in mouse brains.
The symptoms of HCoV-OC43 infection appear to be similar to those caused by HCoV-229E, which is not symptomatically detectable from infection with other respiratory viruses such as influenza A virus and rhino virus.
Both HCoV-229E and HCoV-OC43 have spread globally, making them more likely to be transmitted during the winter season of global warming.
In general, the time period of exposure to the two viruses is less than one week, followed by approximately two weeks of illness.
According to the human voluntary study, healthcare individuals who were infected with HCoV-229E had moderate flu.
Only a few immunocompromised patients showed severe inflammation of the lower respiratory tract.
SARS, also known as "common cold", was first successfully documented as a global pandemic caused by HCoV in human history and the original cause was SARS-CoV, the third HCoV to be identified.
The first case of SARS can be traced back to late 2002 in the Guangdong province of China.
The SARS outbreak has resulted in 8,096 reported cases with 774 deaths, and is spreading across many countries and continents.
Except for the major vectors, it is estimated that each case can cause approximately two additional cases, during the symptom-free period of 4 to 7 days and the peak viral strength on the 10th day of illness.
Patients with SARS-CoV first experience muscle pain, headache, fever, nausea and fever, followed by shortness of breath, cough and respiratory problems.
Anemia, low liver function tests, and elevated creatine kinase are common laboratory complications of SARS.
Alveolar drug excretion, body cavity membrane proliferation and increased macrophages were also observed in SARS patients.
About 20-30% eventually require emergency medical care and mechanical ventilation.
In addition to the lower respiratory tract being constricted, many organs including the intestinal tract, heart and spleen can also be infected in these severe cases, often accompanied by the release of cytokines, which can be dangerous to the brain in patients with low immunity.
The virus was first quarantined through open lung tests of nearby patients who traveled to Hong Kong from Guangzhou.
Since then, a number of efforts have been made to conduct scientific research on HCoVs.
HCoV-NL63 was quarantined in a 7-month-old baby from the Netherlands during late 2004.
It was first found to be more prevalent in young children, elderly people and immunocompromised patients with respiratory diseases.
The manifestation of nasal mucosal inflammation, sinusitis, fever, and respiratory tract inflammation is common in HCoV-NL63 infection.
Another independent study described the quarantine of the same disease with nasal sprays from an 8-month-old boy with burkyitis in the Netherlands.
Although it was discovered in the Netherlands, it has actually spread around the world.
It is estimated that HCoV-NL63 accounts for approximately 4.7% of common respiratory illnesses, with peak incidences occurring in early summer, spring and winter.
HCoV-NL63 is inhibited by laryngitis, also known as laryngitis.
In the same year, HCoV-HKU1 was detected in a 71-year-old man who was being treated for bronchitis and respiratory tract inflammation in Hong Kong.
In addition to community-acquired burkyitis and inflammation of the respiratory tract, HCoV-HKU1 is reported to be associated with a worsening of toxicity.
Similar to HCoV-NL63, HCoV-229E and HCoV-OC43, HCoV-HKU1 has been detected worldwide, causing mild respiratory diseases.
All four of the community-acquired HCoVs have been positively adaptive to humans and are generally less likely to grow and cause a more serious pandemic, although cases have occurred for unknown but rare reasons, most commonly the HCoV-NK63 strain, which is now reported to be causing severe infections in the lower respiratory tract in China.
In general, when HCoVs require effective transmission capabilities and to continue to persist in the human body, they become less toxic or more virulent and transmissible.
MERS-CoV was first detected in 2012 in the heart of a 60-year-old patient who had severe burnout and kidney failure in Saudi Arabia.
While most cases were confirmed by laboratory tests originating in the Middle East, exported cases with additional human transmission were reported in various European countries and Tunisia.
Another outbreak occurred in South Korea in 2015 with 186 confirmed cases.
The clinical symptoms of MERS are similar to those of SARS, which is characterized by severe, highly progressive bronchitis.
Unlike MERS, many patients with MERS have been diagnosed with renal failure, which is significantly different from MERS caused by HCoV infections.
More than 30% of patients have gastrointestinal symptoms, such as diarrhea and nausea.
As of February 14, 2020, more than 2500 laboratories with confirmed cases have reported a high mortality rate of 34.4%, making MERS-CoV one of the most destructive viruses known to mankind.
During mid to late December 2019, groups of patients with burkyitis who were estimated to be neglected by SARS-CoV-2 infection were detected in Wuhan, Hubei Province, China.
The World Health Organization has declared the ongoing outbreak of lower respiratory tract infection caused by SARS-CoV-2 as a Public Health Emergency of Global Concern and also designated as a COVID-19 disease.
As of March 3, 2020, 90,053 cases have been confirmed worldwide, with a mortality rate of 3.4%.
Notably, the mortality rate in Hubei, China is 4.2%, while the mortality outside is 1.2%.
SARS-CoV-2 causes severe respiratory infections such as SARS-CoV and MERS-CoV, expressed as fever, cough and oxygen deficiency.
Epilepsy was also seen in some patients.
Burnout is one of the most severe symptoms and can quickly lead to acute respiratory distress.
Although SARS-CoV and SARS-CoV-2 have a large number of similarities in terms of nucleotide sequence similarity of 82%, they are divided into different subtypes of the classification tree of biological mutations.
SARS-CoV-2 is obviously less virulent but more transmissible compared to SARS-CoV and MERS-CoV.
Substances that do not show symptoms of SARS-CoV-2 infection have been reported and may contribute to its rapid spread worldwide.
Comparison and classification of SARS-CoV-2 with six other HCoVs has revealed similarities and differences of high priority.
First of all, the duration of the absence and the duration of the illness are very similar.
Therefore, SARS-CoV-2 follows the general mutations of the other six HCoVs.
Second, the risk of COVID-19 symptoms is between SARS-CoV and the four HCoVs that are community-specific (e.g. HCoV-2229E, HCoV-OC43, HCoV-HKU1 and HCoV-NL63).
On the other hand, it has been observed during community-acquired infections of HCoVs, including non-specific, mild or even asymptomatic exposure.
On the other hand, small fractions of severe COVID-19 cases can also be seen as SARS-CoV infections, although the proportion is low.
Third, transmission of SARS-CoV-2 also shows interesting characteristics common to both HCoVs and SARS-CoVs-receiving communities.
On the other hand, the transmission capacity of SARS-CoV-2 is at least as high as that of HCoVs as the community considers.
On the other hand, it remains to be confirmed whether the transmission capacity of SARS-CoV-2 decreases after transmission to humans as in the case of SARS-CoV and MERS-CoV.
Finally, another HCoV-like variant, SARS-CoV-2, was found in mouse samples.
Whether transmission of SARS-CoV-2 by oral parasites has played as significant a role as SARS-CoV cases, at least in some circumstances, has yet to be confirmed by future studies.
It is also particularly important to consider that SARS-CoV-2 may show temporal variation in how community cases acquire HCoVs.
However, the characteristics of SARS-CoV-2 including its transmissibility, virulence and sustained transmission after transmission to humans will be the ultimate impact of the ongoing COVID-19 pandemic.
All four HCoVs identified by the community that cause mild symptoms have been well adapted by humans.
On the other hand, it may be true that humans have adapted well to 40 HCoVs.
In other words, both could be survivors of the classical HCoV pandemic.
The HCoV that causes human malignancy and the human with malignant HCoV have been eliminated.
For this to happen, it must reproduce in humans to a level that allows for adaptation to the general growth patterns that combat the inhibitory factors of pathology.
In this sense, prolonging the resilience of the SARS-CoV-2 outbreak and the increasing number of people infected, are the greatest opportunities for better human adaptation.
If it adapts well, its transmission to humans will be difficult to stop quarantine or other infection control measures.
For years, the four community-acquired CoVs have been circulating in the human environment, triggering flu in people with healthy immune systems.
And viruses don't need to be stored by animals.
In comparison, many SARS-CoV and MERS-CoV viruses have not adapted to humans and their transmission to humans cannot be stopped.
They want to contain and spread their stockpiles of human-borne animal diseases and seek opportunities to spread them to vulnerable human targets, using one or two intermediate routes and increasing pathogenicity.
SARS-CoV-2 has similar symptoms to both SARS-CoV/MERS-CoV and the four HCoVs that have been identified by the community.
It is highly transmissible in the same way that HCoVs are transmitted in the community, at least for the time being.
However, it is more virulent than HCoVs found in the general population and less virulent than SARS-CoV or MERS-CoV.
It is yet to be seen whether it will fully adapt to humans and circulate among humans without stocks or moderate pathogenic animals.
Before we talk about the animal origin of HCoV, it would be good to talk about the definitions and characteristics of mutation, biology, stock, enhancer carrier and mediator of HCoV.
An animal acts as a mutant host for HCoVs if it provides a home to closely related ancestors by sharing high nucleotide sequence similarity.
The previous virus was normally infected and had no infectious disease.
Also, the host host hosts HCoVs on a permanent and long-term basis.
In both cases, the infection occurred naturally and was caused by the natural HCoV or its derivative virus.
Conversely, if HCoVs are newly transmitted to a moderate vector shortly before the end of the human transmission, the new vector is not well-infected and is usually pathogenic.
Mediated infectious disease can be a source of animal-to-human infectious disease and can play a role in the spread of infectious disease by allowing the virus to multiply in a short time and then spread to humans to intensify the spread of infection to humans.
HCoVs can pass through post-concussion infection if they cannot survive moderate infection.
In contrast, HCoVs can also adapt to moderate disease and establish long-term isolation.
In this case, the central pain receptor becomes a natural pain receptor.
Data from epidemiological studies have shown in a review that the first case of SARS had a historical link to livestock.
Subsequent germ level tests showed that livestock traders had a higher prevalence of SARS-CoV igG resistance compared to the general population.
Covered wildcat (Paguma larvata) and wild dog in live animal markets were first identified as carrying SARS-CoV-like viruses that are mostly similar to SARS-CoV.
This was publicly supported by the fact that more SARS was not reported after the killing of all the stray cats in the market.
However, there have been reports of covered wild cats in pastures or farms that are not exposed to live animal markets largely missing from SARS-CoV, suggesting that covered wild cats may be only a moderate enhancer carrier but not a natural reservoir of SARS-CoV.
Significantly, since 80% of the livestock variety in Guangzhou markets have antibodies against SARS-CoV, the possibility that several micro-mammals could also be moderate enhancer vectors of SARS-CoV cannot be ruled out.
All of these appear to be the end of the SARS-CoV infection.
A series of searches for a natural animal vector SARS-CoV has revealed a highly related detector CoV, known as SARS-related Phinolophus Cov detector HKU3 (SARSr-Rh-BatCoV HKU3), which is present in the shoe of Chinese detector horses.
These viruses have antibodies to SARS-CoV and the genome sequence of SARSr-Rh-BatCoV HKU3.
Other virus-like CoVs share 88-92% of the same nucleotide sequence as SARS-CoV.
This study laid the groundwork for the new idea that the silk is a storehouse for emerging human pathogens.
Several SARS-like CoVs (SL-CoVs) have also been identified in the virus, but none but one WIV1 mutated virus can be identified as a live virus.
Human angiotensin-converting receptor 2 (ACE2) has been identified as a receptor for SARS-CoV.
WIV1 from fecal swabs was found to be used by feces, wild cats and human ACE2 as a sensor for cell entry.
Interestingly, the cells of patients recovering from SARS were able to get rid of WIV1.
To some extent, WIV1 represents the closely related early SARS-CoV strains found in the fungus, sharing 95% of their nucleotide sequence of self-binding.
Despite the great similarities between these two viruses, it is generally believed that WIV1 is not the immediate ancestor of SARS-CoV and the virus is not the immediate vector of SARS-CoV.
Analysis of biological origin studies place MERS-CoV in the same group as CoV-HKU4 and CoV-HKU5 receptors.
CoV-HKU4 and MERS-CoV viruses use a single-nerve pathogen, dipeptidyl peptisase 4 (DPP4), for the transmission of the virus.
MERS-CoV RNA-dependent polymerase is a closely related group of beta-CoVs that have been detected in Europe and Africa.
To date, no live MERS-CoV has been found in wild eider ducks.
MES-CoV and the closest-related strain CoV-HKU25 share only 87% of the nucleotide sequence.
Therefore, the virus may not be the closest pathogen to MERS-CoV.
In addition, studies in the Middle East show that one-horned camels have been found to have a specific body tumor mediating MERS-CoV, camels originating in the Middle East are similar to those in many African countries.
MERS-CoV, a direct human-derived virus, was found in camel studies, and camels have been shown to be immune to MERS-CoV-like vectors.
It is also worth noting that generally mild but high release of the virus has been observed in camels tested for MERS-CoV infection.
It is noteworthy that infected camels not only released the virus through the respiratory tract but also through the fecal tract, which is the main route of transmission of the virus.
However, questions remain as many confirmed cases of MERS do not have a history of contact with camels before the onset of symptoms, it is possible that it was caused by human-to-human transmission or unknown transmission routes involving an unknown animal that hosted MERS-CoV.
SARS-CoV-2 shares 96.2% nucleotide origin similarity with the isolated CoV RaTG13 from the Rhinolophuw affinis vector.
As with SARS-CoV and MERS-CoV cases, the sequence variation of SARS-CoV-2 and RaTG13 is also highly suspected to be caused by parental relationship.
That is to say, the virus is not a reservoir for the SARS-CoV-2 virus (s) until similar viruses are found in the future.
It is possible that the SARS-CoV-2 infected animals were among the wildlife that was purchased and sold in the Huanan SeaFood Market, where the first COVID-19 cases were forgotten, suggesting the exact case of transmission from animals to humans.
Several recent studies of sequential genetic studies suggest that a small group of dangerous mammals known as pangolins (Manis Javanica) may also be the origin of the SARS-CoV-2 related beta-CoV lineage.
The new CoV gene from pangolines shares 85-92% of the nucleotide sequence similarity with SARS-CoV-2.
However, they are equally and very closely related to RatG13 in approximately 90% of the nucleotide level recognition.
They divide SARS-CoV-2 into two subgenera as the respiratory system viruses, one sharing the relapsing-remitting-deficiency (RBD) SARS-CoV-2, with 97.4% of the amino acid sequence identification.
The comparison of the molecular structure of SARS-CoV-2 in RBD and RaTG13 is very different, although there is a high degree of similarity in the broad genetic table.
An earlier study on sick pangolins also reported the detection of a multi-disease virus in a sample taken from the heart, which turned out to be related to SARS-CoV-2.
This study, based on combined methods and manual therapy to generate the partial sequence of the virus gene, comprises approximately 86.3% of the total length of the virus gene.
We cannot rule out the possibility that it is a carrier of SARS-CoV-2.
However, at this time there is no further evidence to directly trace the origin of SARS-CoV-2 in pangolins due to the sequential variation of SARS-CoV-2 and SARS-CoV-2 in pangolins that are related to beta-CoVs.
Furthermore, the distance between SARS-CoV-2 and RaTG13 is even much shorter than that between SARS-CoV-2 and SARS-CoV-2 pangolins related to beta-CoVs.
The pathway of SARS-CoV-2 mutation in bats, pangolins, and other mammals is still being investigated.
While high genetic similarity has been found for RBD between SARS-CoV-2 and the genome, SARS-CoV-2 related beta-CoV and RaTG13 share broad genetic similarities.
There is a high probability of similarity in the RBD of the pangolin-associated SARS-CoV-2 to the beta-CoV and SARS-CoV-2 from the mediated selection of similar values.
Another proposal prefers recombination of SARS-CoV-2 with beta-CoV-associated pangolins and RaTG13 with wild animals in a third-generation.
With the intensification of evaluation, recombination is becoming more widespread in the beta-CoVs.
The decision-making team is still missing the source of the animal-to-human SARS-CoV-2 disease.
Apart from the multi-virus HCoVs, the origin of diseases transmitted by animals to humans HCoV-229E, HCoV-OC43, HCoV-NL63 and HCoV-HkU1 have also been studied.
Evidence from biogeochemical studies shows that HCoV-NL63 and HCoV-229E are both derived from the fungus CoV, while the original HCoV-OC43 and HCoV-HKU1 viruses were found in mice.
A variant of the coronavirus known as ARCoV.2 (Appalachian Ridge CoV) detected in North America has been reported in a tricolored variant that has shown a very close relationship to HCoV-Nl63.
On the other hand, HCoV-229E is genetically related to another venereal CoV, known as Hipposideros/GhanaKwam/19/2008, which was detected in Ghana, while a camel variant was suspected to be a moderate pathogen.
As a proof, the current knowledge of the animal origin of the detected HCoV is summarized in Figure 1 and Table 2.
A study of bioseparation has provided evidence that historical events of HCoVs' inter-biological transmission have been observed.
When HcOV-OC43 was transmitted to humans via a virus that was introduced from a flammable animal in the late 1890s, a global respiratory infection was registered.
The history of HCoV-229E transmission in the organism is well-defined.
It has been found that the alpha-CoV virus is very closely related to HCoV-229E.
Among them is the alpha-CoV alpaca.
More evidence supports the possibility that the virus can be transmitted directly to humans.
First of all, humans, not alpacas, are the ones most likely to interact with the ape on the planet with which they share a habitat.
Instead, humans are closely interacting with alpacas.
Second, the HCoV-229E associated with alpha-CoV or alpaca is different from the non-alpha-CoV associated with alpaca, which caused the death of respiratory disease in infected animals.
Finally, alpaca alpha-CoV has not been found in wild animals.
Therefore, the possibility of alpacas acquiring HCoV-229E-associated alpha-CoV in humans cannot be ruled out.
In fact, the virus is the direct source of human viruses including rabies, Ebola, Nipah and Hendra.
It is therefore not surprising that parasites can transmit HCoV-229E directly to humans.
Similarly, while alpha-CoVs are the genetic pool of HCoV-229E, alpacas and camels while mosquitoes can be a mediator of human transmission of the virus, just as in the case of MERS-CoV.
MERS-CoV is a high-level example of transmission from the feces to camels and from camels to humans.
The origin of the MERS-CoV mutation from the detector was known through its early identification and also confirmed by the test results.
It is normal for the fibroids to produce a large area of rich virus in the inter-organism synthesis of genetic components and transmission to the inter-organism.
Longevity, widespread groups, close social interaction and strong flight ability are all conditions that make the virus a viable 'virus'.
On the other hand, MERS-CoV has been present in camels with a fever for decades.
They have adapted well to these camels that have been transformed from moderate to natural, stable carriers.
MERS-CoV causes very mild disease and maintains very few mutations in these animals.
Transmission to humans is accidental and humans are terminal carriers of MERS-CoV as transmission cannot survive.
Unlike the role of camels in MERS-CoV transmission, the role of natives, if any, in SARS-CoV-2 transmission is different.
In particular, the beta-CoVs of the genus are highly pathogenic to natives.
They may be a non-infectious vector of the SARS-CoV-2 related beta-CoV, similar to wild cats of the SARS-CoV.
Several possible transmission of SARS-CoV-2 from mammals to humans is being tested or eliminated in future studies.
First, sensors can be a repository of SARS-CoV-2 related virus-like pathogens that often resemble SARS-CoV-2.
Humans can share the filter with the host by cutting meat or cooking coal.
Second, pangolins may be one of the enablers of the recently discovered SARS-CoV-2 related virus.
The virus is transmitted to humans through the access to and consumption of prey meat.
It is possible that many mammals, including permanent domestic animals, are susceptible to SARS-CoV-2.
A comprehensive test of domestic and wild animals for antibodies has been guaranteed.
Third, as mentioned above, the recombination and adaptation of SARS-CoV-2 may have occurred in a third species that was associated with both the parasite and the natives.
The animal origin of SARS-CoV-2 is still being investigated.
Apart from the different types of pathogens, the three main factors in the virus are also important to make it easier for CoVs to cross the biological barrier.
First, there is a large scale of RNA mutation.
Compared to other single-stranded RNA viruses, the estimated range of mutation of CoVs can be identified as "medium" to "high" with an average range of ~10-4 mutations per year at 2 positions, in the CoV adaptation phase of non-communicable disease.
CoVs have exoribonuclease reading confirmation, which is the elimination of a highly variable and decreasing or non-reproducing strain.
Interestingly, the nucleotide analogue of Remdesivir is known to slow down CoV reproduction by blocking exoribonuclease and RNA-dependent RNA polymerase.
Remdesivir is one of the most effective anti-SARS-CoV-2 drugs to be tested in clinical trials.
However, the limit of mutation of these CoVs is almost a million times higher than that of their carriers.
In addition, the margin of change is often higher when the new CoV does not adapt well to infectious disease.
Compared to SARS-CoV with a high margin of change, the margin of change of SARS-CoV-2 is clearly low, suggesting a high degree of human adaptation.
It's possible that he was infected with another human carrier.
In addition to SARS-CoV-2, this also applies to MERS-CoV, which has adapted well to camels rather than to rats.
In theory, it is unlikely that genetic extinction will lead to vaccines and antibodies against SARS-CoV-2 not working quickly.
Second, the enlarged RNA genome in CoVs provides additional modeling latitude for the genome design for mutation and assembly, thus increasing the chance of mutation in species, which is better for the emergence of rare CoVs when the solution becomes suitable.
This is supported by the available open reading specifications and protein functions inserted into the end 3 of the genome.
Third, these CoVs often change the design indefinitely during RNA replication through the special "copy-by-will" process.
In a disease in which the disease is recurrent, mutations in the genome occur mostly during the process of replication of CoV RNA.
Full-length, highly similar and subgenome RNAs can reassemble to form new CoVs.
Evidence of bioaccumulation in biomodulation studies has identified both HCoV-HKU1 and HCoV-OC43, as well as animal CoVs such as SL-CoV and CoV-HKU9 receptors.
Viral disease interaction in relation to transmission
In addition to the three factors mentioned above, the interaction of the virus with the neurotransmitter is another important factor affecting the transmission of the virus to different organisms.
Here, the recombination of SARS-CoV is being taken as a typical example, which has also shown to be a good selection during the transition to a different species.
Based on comparative analysis between human quarantines and civet SARS-CoVs, SARS-CoV is thought to undergo rapid adaptation to various carriers of disease, especially when accompanied by RBD mutations in protein S.
In general, RBD in the S-protein of CoV penetrates the cell's neurons and is strongly selective in antibody reaction to infection.
SARS-CoV, RBD gu is located at the 318th to 510th amino acid subunit S1, which binds to human ACE2 and similarly on the surface of the neurons of the virus entry.
The SARS-CoV RBD is able to identify ACE2 receptors in various animals, including mice, civets, mice and wild dogs, allowing the virus to pass through a variety of organisms.
In fact, only six amino acid residues were found to be different from the human and wild cat virus classification. Four of the RBDs are in the auditory nerve architecture to bind to the ACE2 receptor.
SARS-CoV in wild cats has mutations K479N and S457T in RBD genes, which may increase the tendency to bind to the spike protein associated with human ACE2 neurons.
In other words, the mutation of these two amino acids is a threat to the adaptation of the virus to humans.
It is worth mentioning that SARS-CoV-2 shares neuronal similarities with SARS-CoV.
A 30% difference between SARS-CoV-2 and SARS-CoV in the S1 subunit of protein S suggests that involvement of the S ACE2 protein in the human response may be altered.
In fact, a cryo-Em study shows that there is a 10 - to 20-fold greater affinity for this substance than between human ACE2 and the S protein of SARS-CoV.
It will also be of interest to know whether other cell surface sensors may be needed for transmission of SARS-CoV-2.
Interestingly, HCoV-NL63 also responds to ACE2 but to the other S subtype.
There are other HCoV receptors, such as aminopeptidase N for HCoV-229E, and 9-O-acetylated sialic acid for HCoV-OC43.
It may be caused by successful adaptation of CoVs to humans after animal-to-animal transmission of the disease.
In addition to cellular sensors, the resulting transmission of HCoVs between organisms is also controlled by the absence of reliance on other pathogens and inhibitory factors.
The differences in these pathogenic proteins between human and natural HCoV pathogenic carriers such as mice, camels and mice may contribute to preventing the transmission of the same organism.
HCoVs must migrate between non-pathogenic and low-pathogenic sources to successfully combust with the same organism.
In other words, molecular determinants within this critical site of viral pathology interaction must be defined and characterized.
A large-scale non-polluting genetic test that relies on pathogenic and inhibitory factors for SARS-CoV-2 using the state-of-the-art CRISPR technology is likely to bear fruit.
New HCoV outbreak: returning to where it started.
The variation of the coronavirus provides sufficient opportunities for the emergence of new HCoVs.
In this sense, the virulent CoVs serve as the genetic carriers of all HCoVs.
In addition, rapid growth mutation and re-synthesis of the gene also provide for HCoV evaluation and serve as two important steps in this process.
For example, finding or missing a gene that defines a protein may significantly restore the similarity of the viral gene.
Among the additional proteins of SARS-CoV, ORF8 is thought to be important for human adaptation, as SARS-CoV is related to the virus that has been quarantined but has been found to produce different ORF8 proteins.
The elimination of the 29-nucleotide characteristics of SARS-CoV-2 was found in groups that were quarantined at the onset of the human pandemic.
The loss of ORF8 cells in ORF8a and ORF8b is thought to be due to the adaptation of growth changes that promote mutation of pathogens.
In particular, SARS-CoV has a potential gene sequence history of alpha and beta-CoVs, where a large number of subregions of the gene sequence have been observed in RNA-dependent RNA polymerase.
Genetic reassortment sites were also reported in nsp9, mostly nsp10, and parts of nsp14.
Also, the MERS-CoV pandemic was observed in the genetic mutation events in several breeds of camels in Saudi Arabia.
Aside from SARS-CoV and MERS-CoV, re-combination events have also been observed in other HCoVs, where HCoVs combine the genetic material of non-structural carriers of CoVs with other animals.
It should also be noted that selection in humans may contribute to unintended mutations in the virus's genetic makeup, often those that cause the virus to recover from selective stress, such as the immune system's anti-inflammatory response.
An example of this effect is the loss of normal length of the same ORF4 strain of HCoV-229E, which has a loss of two-nucleotides.
While the inactivity of ORF4 can be seen in the fungus and camel-related HCoV-229E viruses, alpha-CoV alpaca exhibits a nucleotide entry site, which results from a genetic growth spurt.
Last but not least, evaluation of new HCoVs has also been provided from genetic mutation of pathogen-preserving agents.
No signs or only mild symptoms were observed when the cameras picked up the new CoV infection, indicating a two-way interaction between the new CoV and the virus.
It appeared that the guards had not adapted well to the CoV in both physical and functional terms.
For example, the defects in the inflammatory response of the fungus effectively reduce the viruses that trigger the CoV.
In addition, natural killer of stem cell activity has been stressed due to increased activation of natural killer inhibitor NKG2/CD94 receptors and low definition level of Class I molecule binding.
In addition, the high level of biological oxygen stimulation (ROS) that results from the chemical metabolism activity of the feces both suppresses CoV reproduction and the re-reading effect of exoribonuclease, which provides the selective pressure for the emergence of multi-species germ-resistant viruses when new pathogens are introduced.
Many strains of the virus that cause CoVs may slowly grow by recombining, resulting in the discovery of new proteins or proteins with pathological adaptation characteristics.
So it's not a coincidence that the three new HCovs have emerged in the last two decades.
CoVs are either sterile or do not cause mild symptoms in carriers of disease such as ticks and camels.
They multiply aggressively without disrupting the body's strong immune response.
Here's the secret to why people with HIV are seen as asymptomatic and what causes the most severe cases of human infection.
Severe symptoms are often caused by an over-activation of the immune response and cytokine deficiency while severe immune response is more likely to result in severe heart damage.
Instead, patients who do not show symptoms, the immune response is disrupted by the CoV replication.
Similar strategies for cutting out the immune response may have had a beneficial effect in the treatment of SARS-CoV-2.
The interferon reaction is particularly strong in the kidneys.
Therefore, taking type I interferon at least in the early stages of SARS-CoV-2 infection in humans is beneficial.
In addition, the NLRP3 inflammasome in the kidney is defective.
For this reason, the inhibitor of NLRP3 inflammasome with MCC950 is effective in the treatment of COVID-19.
The SARS-CoV-2 outbreak follows the general pattern from which SARS-CoV and MERS-CoV emerged.
While the beta-CoV virus shares 95% nucleotide similarity with SARS-CoV, there is also a virus CoV that shares 96% nucleotide similarity with SARS-CoV-2.
While wild cats and other market animals have been found to store SARS-CoV-like viruses, the closest known vector of SARS-CoV has not been identified.
Beta-CoVs of pangolins that are very similar to SARS-CoV-2 have been identified, suggesting that pangolins may be one of the intermediate carriers of the disease or that beta-CoVs of pangolins may provide a genetic component to the more recent variant of SARS-CoV-2.
Although questions remain, there is no evidence that SARS-CoV-2 is intentionally or accidentally human-made.
The CoVs have returned to the light due to the recent outbreak of SARS-CoV-2.
The study of the virus in mammals and other animals has significantly changed our understanding of the importance of the animal disease origin to human and the animal environment of the HCoV in human transmission.
Extensive evidence has shown that SARS-CoV, MERS-CoV and SARS-CoV-2 have a viral origin and are transmitted to humans through a mediated vector disease.
If SARS-CoV infection originated from human contact with civets in the market, closing wet markets and killing civets then it would effectively end the SARS pandemic.
For similar reasons, pangolins should be removed from wet markets to prevent transmission of animal diseases to humans, given the detection of several species of pangolin beta-CoVs closely related to SARS-CoV-2.
However, whether and how SARS-CoV-2 is transmitted to humans via pangolins and other mammals remains to be determined by future studies.
On the other hand, MERS-CoV has been present in camels and mice for a long time.
Camels are an important means of transportation and also the main source of meat, milk, leather and wool products for the local people.
It is widely distributed throughout the Middle East and Africa.
It is therefore possible to slaughter all camels to control MERS, as has been done in wildlife in China to prevent the spread of SARS-CoV and SARS-CoV-2.
To stop the recurrence of MERS infections, a comprehensive approach should be taken to develop effective vaccines against MERS-CoV in camels, along with other measures to control infection.
Since we are unable to eradicate these viruses, new genotypes may emerge to cause infections.
Different types of animal-to-human viruses are circulating in the environment.
In particular, the viruses that have the potential to transmit diseases from animals to humans are quite different.
There are many possibilities for human-to-human CoVs and animal-to-animal disease to evolve and recombine, causing the emergence of new CoVs that could be more transmissible and/or more lethal to humans in the future.
The practice of eating wild animals in some parts of China should be abandoned to reduce unnecessary contact between humans and animals.
In the face of the SARS, MERS and COVID-19 crises, good preparation and a response plan must be put in place.
In fact, many viruses have been around on Earth for a very long time.
They remain in their natural habitat until the opportunity arises to spread elsewhere.
Although fungi have many features that help spread viruses, the chance of humans coming into contact with fungi and wildlife could be reduced if people are taught to stay away from them.
Continuous monitoring of mammals is essential for better understanding of the environment of CoVs and their natural vectors, which prove their effectiveness in preventing transmission from animals to humans and future infections.
In conclusion, the most effective way to prevent animal disease viruses from passing to humans is for humans to avoid a natural habitat for animal disease viruses that pass to humans.
Several parts of the evidence for the origin of the animal-to-human disease SARS-CoV-2 are still missing.
First, if the caterpillars transmit the original SARS-CoV-2 virus to the pangolin, it will be interesting to see the circumstances that led the caterpillars and the caterpillars to share the same habitat.
Second, if video plays a more direct role in human transmission, how humans interact with video should be explored.
Third, if third-tier mammals are truly a mediator disease, how it enters into the various organisms including humans, vultures and pangolins must be clarified.
Finally, since many mammals including animals that are washed can carry SARS-CoV-2, both surveillance and infection testing should be done.
Whether it is a whale, pangolin or other mammal, it is expected that the SARS-CoV-2 variant from which the virus is derived, which is often self-replicating, will be detected in its natural pathogenesis in the larval stage.
Further studies at the site will clarify the pathway of SARS-CoV-2 mutation in animals, with important results in the prevention and control of COVID-19 in humans.
The updated COVID-19 testing pattern for "suspected case" and "confirmed case" is important.
On 6 February 2020, our team published an emergency warning guideline for the diagnosis and treatment of the new coronavirus infection 2019 (2019-nCoV). This guideline has increased our expertise and made a good reference in the fight against this pandemic worldwide.
However, the coronavirus disease 2019 (COVID-19) is a new disease, and our awareness and knowledge is gradually increasing based on the results of ongoing research and clinical discovery; therefore, diagnostic and treatment strategies are also being updated regularly.
In this letter, we have responded to one comment in the rulebook and provided the latest diagnostic form of "suspected case" and "confirmed case" in reference to the COVID-19 Testing and Treatment Regulations (Verification Week) issued by the National People's Health Commission of China.
In December 2019, the novel coronavirus 2019 (2019-nCoV) caused an outbreak, which is now officially known as the coronavirus disease 2019 (COVID-19) and the virus was named the acute respiratory virus coronavirus 2 (SARS-CoV-2).
On 11 March 2020, the World Health Organization has declared COVID-19 as a global pandemic.
To combat the SARS-CoV-2 infection, our team has developed an emergency warning policy and published it online in the Military Medical Research on 6 February 2020.
It attracted a lot of attention the day it was published.
Note that although COVID-19 is a new disease, our awareness and knowledge is gradually increasing based on research findings and clinical experience; therefore, research and treatment statistics are also regularly updated.
The COVID-19 diagnostic and treatment measures issued by the National People's Health Commission of China (http://www.nhc.gov.cn/), from 16 January 2020 to 3 March 2020, have produced a total of seven revised versions whose content has been effectively modified.
Now our guidelines are by Zhou et al., they've developed a simple suggestion based on medical expertise.
Their work has added to the legal evidence and has provided valuable references for the global spread of the disease.
We supported their important work and showed them our gratitude.
However, their work also needs to be updated in light of the latest COVID-19 Diagnostic and Treatment Guidelines (Test Week Version) and current studies.
With reference to the weekly update (3 March 2020), to confirm suspected cases it is necessary to combine one item of historical characteristics from the epidemiological study and two items of clinical characteristics to make a complete vaccination, or the need to obtain three items of clinical characteristics if there is no clear history of epidemiological diseases.
History of epidemiological studies: (1) history of travel or residence in Wuhan and its vicinity, or other communities where COVID-19 cases were reported within the last 14 days before the onset of symptoms; (2) history of lockdown of SARS_CoV-2 infection cases (determined by nucleic acid testing); (3) history of contact with patients with fever or respiratory symptoms from Wuhan or its vicinity, or other communities with COVID-19 reported within the last 14 days before the onset of symptoms; (4) history of contact with confirmed cases (>2 cases of fever/respiratory symptoms occurred within two weeks in local settings, such as offices, schools, schools, etc.).
Symptoms: (1) fever and/or respiratory symptoms; (2) with symptoms of COVID-19 infection; (3) total white blood cell count indicating normal, decreased, or decreased white blood cell count in the early stage of onset.
Confirmed case testing is based on suspected case with any of the following virulence or blood drain evidence: (1) real-time PCR detection of SARS-CoV-2; (2) whole virus genome sequence showing high similarity to known rare coronavirus; (3) specific IgM antibody and IgG antibody from SARS-CoV-2 in the test serum; or replacement of SARS-CoV-2 specific IgG antibody from missing antibody, or increased facial swelling >=4 times that of the critical facial swelling.
We can see that real-time PCR testing of respiratory nucleic acid or blood samples has been included in the second edition (18 January 2020) and the third edition (22 January 2020).
The germ detection of blood samples was included in the fourth edition (27 January 2020) and the fifth edition (8 February 2020), and after the confirmation of blood plasma was included in the seventh edition.
In addition to this, the ongoing work by researchers to find a better nucleic acid detection tool for rapid testing, as well as samples from the respiratory tract of patients undergoing blood testing, has increased the availability of more tests, and supported the delivery of specific antibodies from the results that have become the confirmed method.
In addition, there is ample evidence to remind us to be vigilant about abnormal and symptomatic symptoms in patients.
Therefore, the map of Zhou et al. should be updated, as it is categorized by the person without health symptoms as "low risk".
The scoring system also needs to be confirmed by additional clinical operations and studies.
To conclude, we hope that more and more direct testimonies will emerge and readers will be invited to comment.
For the investigation of "suspected cases" and "confirmed cases", we suggest that they follow and follow the latest guidelines in their home countries.
Our team will update our guide periodically to provide assistance.
Bangladesh reported five new deaths from COVID-19, the highest for a day.
Yesterday, Bangladesh confirmed five new deaths from COVID-19 on the same day.
This is the highest number of deaths in a single day from the virus.
As of yesterday, the Institute of Bangladesh Epidemiology, Disease Research and Control (IEDCR) reported the number of reported cases, including 114 standing cases and 33 recovered cases who were at home.
A total of 17 deaths were reported.
In a brief online report, the director of IEDCR, DR Meerjady Sabrina Flora, said the deaths were four males and one female.
According to DR Meerjady, two cases were over the age of 60, two between 51 and 60, and one between 41-50 years old.
She also said that two of the victims were from Dhaka.
The World Health Organization (WHO) declared COVID-19 as a global pandemic on the 11th of March.
A hospital official told Anadolu Agency, a local reporter, that one of the dead was Jalal Saifur Rahman, director of the Bengali Anti-Corruption Commission, who was being treated at Kuwait Maitree Hospital.
On Saturday, in a video announcement online, the Minister of Road Transport and Bridges of Bangladesh Obaidul Quader said that public transport will be suspended for longer than planned, until next Saturday.
The public transportation stop had already started on March 26 and was scheduled to end on Saturday, April 4.
The movement of basic goods -- health, fuel and food -- is still allowed.
The first reported case of COVID-19 infection in Bangladesh was on March 8, two people returned from Italy and the wife of one of them.
As of March 19, the three have already recovered.
SARS-CoV-2 has surpassed one million infections worldwide.
On Thursday, the total number of cases of SARS-CoV-2 coronavirus infections exceeded one million worldwide, data from Johns Hopkins University showed.
At least 52 thousand deaths have been linked to COVID-19, the disease caused by coronavirus.
The incident came on the same day Malawi confirmed its first coronavirus infection and Zambia had its first coronavirus-related death.
South Korea has claimed, as of Thursday, to be among the few countries that have survived coronavirus infections.
Yesterday, the World Health Organization reported 1,051,635 confirmed cases, including 79,332 cases in the twenty-four hours before 10 a.m. Central European Time (0800 UTC) on April 4.
In the United States, more than 244 thousand cases of coronavirus have been recorded, with at least 5,900 deaths associated.
CBC News reported, citing data from Johns Hopkins University, that there were more than 1,000 deaths in the United States on Wednesday due to coronavirus infection.
Globally, countries have announced strong measures to prevent the disease from spreading further.
On Thursday, Moscow Mayor Serei Sobyanin extended the curfew in the capital until May 1.
Nationally, President Vladimir Putin announced that Russians will continue to be paid without going to work until April 30.
The Portuguese parliament voted to extend the national state of emergency for 15 days, with 215 votes in favour, 10 against, and one abstention.
Saudi Arabia extended the curfews on the holy cities of Mecca and Medina throughout the day; earlier, the curfew was only in effect from 3 p.m. to 6 a.m.
Thailand plans to activate a bandaged area between 10 p.m. and 4 a.m.
Ohio Governor Mike DeWine announced that the state has extended the curfew until May 1.
Stores in Australia lower the limit of toilet paper per purchase.
On Sunday evening, the Australian chain stores Woolworths and Coles lowered their restrictions on the purchase of toilet paper to two and one pack per purchase at all stores nationwide, respectively.
ALDI has imposed a one-pack limit, on Monday.
These restrictions were posted as a message on the exit points, and on the Facebook series.
Shoppers were reportedly buying more because of fears of COVID-19 in case people needed to quarantine.
On Wednesday, Woolworths also limited the purchase of household toilet paper to one package per order.
These changes followed the previous ban of four packages per purchase issued by Woolworths and Coles on March 4 and 5 respectively.
Coles, in a March press release, said the restrictions on four-pack spaces "are being bought by many stores at the drop-off", calling the demand "unprecedented", while ALDI, in a Facebook post, called it unexpected.
The purchases rose in a "sudden surge" last week, according to a spokesperson for Woolworths.
The Costo store in Canberra also limited the amount of two packages allowed last week.
To further reduce the shortage, Coles ordered larger vessels from suppliers to expedite deliveries, Woolworths ordered more goods, while ALDI made the planned shipments on Wednesday early.
Russell Zimmerman, executive director of the Australian Retailers Association, said retailers should increase their products, but local council restrictions on shipping time have put a strain on them.
He expects production costs to rise, and the distribution of the public goods to try to meet demand, among other special needs.
On Tuesday, Aldi announced that the next pre-order delivery in some stores will not continue on Wednesday, in particular.
According to News.com.au, Dr Gary Mortimer, retail expert at Queensland University of Technology, said that stores will be filled with goods every night.
He said that toilet paper is a heavy commodity, which leads to a low quantity of products, and, when sold, leaves the shelves empty, reinforcing the feeling of scarcity.
Colos and Woolworths have the view [that] if they filled the closets with stuff, if things like toilet paper and disinfectants [were bought] and they were full, then the fear would be lowered", Russell Zimmerman said according to ABC News.
Manufacturers of recycled toilet paper who produce high-quality toilet paper said last Wednesday that they will be out of stock.
Kimberly-Clark, which makes Kleenex toilet paper, and Solaris Paper, which makes Sorbent, emphasized that they were working 24/7 to maintain the distribution of goods, according to News.com.au.
Domain.com, a real estate site, reported that some home sellers were offering free toilet paper to the first bidder at the Melbourne auction, when a small auction was held because buyers were away for the long holiday weekend of International Labor Day.
Thursday editionee NT News, published a simultaneous Darwin, which contained eight pages of text intended to be cut and used as toilet paper.
The stores were initially reluctant to lift the restrictions, according to ABC Australia's report on 3 March, when they said they had no plans to impose any restrictions on purchases.
Russell Zimmerman added that other products are in high demand, including mouthwash, disinfectant, dry goods, hand washing soap and flour.
Similarly, outside Australia, the British online supermarket Ocado on Sunday evening restricted the sale of Andress toilet paper to two 12-pack sets.
The World Health Organization has declared COVID-19 a global pandemic.
On Wednesday, the World Health Organization announced that the ongoing COVID-19 outbreak caused by the coronavirus SARS-CoV-2 is a global pandemic.
Although the term "global epidemic" refers to a disease that spreads globally, but is not as serious as some cases are, the World Health Organization noted the need for governments to take action.
All countries can still change the course of this pandemic. https://en.wikinews.org/wiki/World_Health_Organization_declares_COVID-19_pandemic CC_BY-SA_2.5 en if countries detect, test, treat, follow up and organize their own response populations, said Tedros Adhanom Ghebreyesus, Director General of the World Health Organization.
I'm deeply concerned about the appalling levels of waste and the appalling levels of risk and inaction.
According to Dr. Tom Frieden, former director of the U.S. Centers for Disease Control and Prevention, the global pandemic is "unprecedented".
He said, in comments published by CNN in mid-February, "Apart from influenza, no other respiratory virus has been tracked from the outbreak to the ongoing spread around the world.
Ghebreyesus also expressed a similar view, saying "We have never seen a global pandemic spreading coronavirus before".
He continued, "And we've never seen a global epidemic that could be controlled at the same time".
The new situation as the global pandemic continues is prompted by the World Health Organization's decision in January to declare the outbreak a public health emergency of international concern.
Director of the US National Institute of Allergy and Epidemiology, Dr. Anthony Fauci, said the outbreak, "under the foundations, will be worse".
As of Thursday, Associated Press reported that there were at least 126,000 COVID-19 cases worldwide, resulting in more than 4,600 deaths.
The 2019-20 global coronavirus pandemic is a global pandemic of the ongoing coronavirus 2019 (COVID-19), caused by severe respiratory symptoms of the coronavirus 2 (SARS-CoV-2).
The outbreak was detected in Wuhan, China, in December 2019, and was declared a State of Emergency of Global Concern on 30 January 2020, and a global pandemic on 11 March 2020.
As of 10 April 2020, an estimated 1.6 million cases of COVID-9 have been reported in 210 countries and territories, resulting in an estimated 97,000 deaths.
Nearly 364,000 people have recovered.
The death rate is estimated at 4% in China, while the global average is 13.04% in Algeria and .08% in New Zealand.
Common symptoms include fever, cough and shortness of breath.
The most serious cases include burnout and symptoms of severe respiratory problems.
The time from exposure to onset of symptoms is approximately five days, but it can range from two days to fourteen days.
There is no recognized vaccine or specific anti-virus treatment.
Basic treatment is the treatment of symptoms of a chronic illness. Recommended preventive measures include hand washing, covering the mouth when coughing, maintaining social distancing, and monitoring and self-quarantine of people suspected of infection.
World leaders from all over responded by implementing travel restrictions, quarantines, bandaging, workplace hazard control and closures.
The global pandemic has caused severe socioeconomic distress around the world, with postponement or cancellation of sporting, religious, political and cultural events and widespread supply shortages exacerbating fear of shopping.
Schools and universities were closed nationally or locally in 193 countries, affecting an estimated 99.4 percent of the world's students.
Misrepresentation of the virus has spread online, and there are incidents of xenophobia and discrimination against Chinese, other ethnic groups or people of East and Southeast Asian descent, and others from areas with high cases of the virus.
Due to the reduction of travel and the closure of major industries, there is a reduction in air pollution and carbon emissions.
Health authorities in Wuhan, Shinaha (capital of Hubei Province) were reported to have reported cases of unknown burnout on 31 December 2029, and an investigation was initiated in early January 2020.
The cases are mostly related to the Huanan Seafood Wholesale Market and therefore the virus has a genetic basis for animal-to-human infections.
The virus causing the outbreak is known as SARS-CoV-2, a newly discovered virus that is related to the influenza virus, the influenza virus, and SARS-CoV. The first person with symptoms was later diagnosed as ill on 1 December 2019, and the person appears to have no relation to the latter group of people.
Of the first batch of cases reported in December 2019, two-thirds were found to be related to the market.
On 13 March 2020, an unconfirmed report by the South China Morning Post suggested that the case was followed on 17 November 2019, with a 55-year-old man from Hubei Province, the first case.On 26 February 2020, the World Health Organization reported that new cases reported in China had decreased but increased while in Italy, Iran, South Korea, the number of new cases of measles in China exceeded the number of new cases in China for the first time.
There may be some cases that are not reported, especially those with mild symptoms.
As of 26 February, the proportion of cases reported among young people was relatively low, with those aged 19 and under accounting for 2.4% of the global total.The UK's Scientific Advisory Chairman, Patrick Vallance, estimated that 60% of the British population will contract the infection before a resilient and effective immune system is achieved.
Cases refer to the number of people tested positive for COVID-19, who were tested for the disease according to official protocols.
As of March 23, a country that tested more than 3% of its total population many countries had official regulations requiring people with mild symptoms to be tested, such as Italy, the Netherlands, Spain, and Switzerland.
A study published on 16 March found that in China, as of 23 January, approximately 86% of COVID-19 infections were undetected, and the unregistered infection was the source of infection in 76% of the cases registered.
A statistical estimate published on 30 March suggests that the estimated number of infections in Italy may be significantly higher than the reported cases.
The original estimate of the baseline reproduction rate (R0) for COVID-19 was 1.4 to 2.4.
A study published by the U.S. Centers for Disease Control and Prevention concluded that it could be 5.7.
Most people with COVID-19 recover.
For those without HIV, the time from the onset of symptoms to death is between 6 and 41 days, with a maximum of 14 days.
As of 10 April 2020, approximately 97,000 deaths have been caused by COVID-19.
In China, as of 5 February, nearly 80% of the deaths were in people over 60, and 75% of them had pre-existing medical conditions including heart disease and diabetes. The official death toll from the global COVID-19 pandemic is generally referred to as people who tested positive for COVID and died according to official protocols.
The actual death toll from COVID-19 is likely to be much higher, not including those who die without being tested - for example, those who die at home, those in home care, etc.
Partial data from Italy shows that the additional death toll during the global pandemic has exceeded the official total number of COVID-19 by 4-5 times.
A spokeswoman for the U.S. Centers for Disease Control and Prevention (CDC) admitted, "We know that [the reported death toll] is relatively low", citing unofficial reports of lower numbers in the United States.
The first death outside mainland China occurred in the Philippines on February 1, and the first death outside Asia occurred in France on February 1.
By the end of February 28, outside mainland China, more than a dozen deaths were being recorded in each of Iran, South Korea, and Italy.
By the end of March 13, more than four countries and territories had reported deaths, on every continent except Antarctica. Several measures were commonly used to reduce deaths.
This number varies from state to state, and is facilitated by multiple tests, quality of health care, treatment options, time since the outbreak began, and social factors such as age, gender, and general health.The death ratio versus case ratio shows the number of deaths divided by the number of cases tested.
Based on Johns Hopkins University statistics, the overall case mortality ratio is 6.0% (97,039/1,617,204) as of 1 April 2020.
The numbers change when you look at the world.
China estimated the death rate relative to the case rate to have decreased from 17.3% (those with symptoms beginning on 1-10 January 2020) to 0.7% (those without symptoms starting after 1 February 2020). Other measures include the mortality rate (CFR), which translates to the percentage of people tested who die from the disease, and the infection mortality rate (IFR), which translates to the percentage of people who have the infection (tested and untested) who die from the disease.
This statistic is not time-bound and follows a particular community from the time of infection through the resolution of cases.
A number of academics have tried to calculate this number for a specific population.
The Exford University Research-Based Health Research Centre estimates the global infectious mortality rate to be between 0.1% and 0.39%.
The above estimate is consistent with the results of the first non-classified COVID-19 test in Germany, and the statistical validation of the study's impact on CFR estimates.
The World Health Organization says the global pandemic can be controlled.
The peak period of the outbreak is uncertain and varies by location.
Macieji Boni of Penn State University says she was left uncertain about the outbreak of pandemics in most highlands.
But it's impossible to make any reasonable prediction about when that will be".
Senior health adviser Zhong Nanshan of the Chinese government argued that "it will be over by the end of June" if all governments are organized to follow the World Health Organization's measures to stop the spread of the virus.
On 17 March, Adam Kucharski of the London School of Hygiene & Tropical Health Sciences said that SARSCoV-2 "will be circulating, in a stable state for one to two years".
According to the Imperial College study led by Neil Fergusin, physical distancing and other measures are needed "until vaccination is achieved (possibly 18 months and more).
"I think it's unlikely that it's a coronavirus - the virus can be transmitted quickly - it's going to disappear completely" and "it's possible that it could become a seasonal disease, which could come back every year", said William Schaffner of Vanderbilt University.
The risk of relapse depends on the strength of the immune system and the limitations of the growth pattern.
COVID-19 symptoms are usually non-specific and carriers may not show symptoms.
The two most common symptoms are fever (88%) and coughing (68%).
Rare symptoms include fatigue, loss of breathing in the jaw, loss of sense of smell, shortness of breath, muscle and limb pain, diarrhea, headache, cough, vomiting, blood clots, diarrhea or a blue discoloration.The World Health Organization says that approximately one person with six symptoms can be very sick and have difficulty breathing.
The U.S. Centers for Disease Control and Prevention (CDC) has listed emergency symptoms such as difficulty breathing, persistent pain in the thigh without pressure, sudden wheezing, trouble-making, and blue-turned faces or moles; immediate medical attention is recommended for anyone experiencing symptoms. Further progression of the disease can lead to severe burnout, severe respiratory symptoms, a critical condition, low blood pressure and death.
Those who have been infected may be asymptomatic, who have no clinical symptoms but whose test results confirm infection, so researchers recommend that anyone who has had close contact with a confirmed infected person be monitored closely and screened to rule out infection.
China estimated the proportion of people without symptoms to be as low as 44%.
The incubation period (the time between infection and onset of symptoms) ranges from one to 14 days; usually it is as long as five days. For example, without certainty, the estimated fraction of COVID-19 patients who lost their sense of smell was initially 30% and then dropped to 15%.
Some information about how the disease spreads is still unknown.
The disease is believed to spread most strongly through close contact and coughing spots that appear when someone coughs, sneezes, or talks; these are spots that are close to a person from 1 to 2 meters (3 to 6 feet).
Studies have found that uncovered cough can cause cough droplets that fly up to 4.5 meters (15 feet) to 8.2 meters (27 feet).
Some suggested that the virus could also be transmitted through tiny droplets that remain in the air for long periods of time, which can emerge when speaking. Respiratory droplets can also emerge in the breathing process, including when speaking, although the virus does not transmit through the air.
The stains can be on the tongue and nose of people nearby or it is possible to breathe through the lungs.
Medical procedures such as cardiopulmonary resuscitation (CPR) can cause the respiratory system to be blown out and spread through the air.
It can also spread when a person touches a sensitive area, including the skin, and then touches his or her eyes, nose, or mouth.
While there are concerns that it may spread through feces, the risk is believed to be low.
The Chinese government denied the possibility of oral transmission of SARS-CoV-2. The virus spreads rapidly during the first three days of the onset of symptoms, although it may spread before symptoms and later stages of the disease appear.
People were diagnosed three days before they showed symptoms, suggesting that transmission may be possible before more symptoms appeared.
There are only a few reports of laboratory-confirmed symptomatic cases, but symptomatic transmission has been detected in some countries during the screening of patients.
The European Centre for Disease Control and Prevention (ECDC) says that since it is not generally clear how easily the disease is spread, one person generally infects two to three others, and the virus can survive on the surface of objects for hours to days.
In particular, the virus was found to be detectable in polypropylene bags for up to three days and 304 stainless steel, in wood for one day, and in copper for up to four days.
This, however, varies depending on humidity and temperature. Cats and other animals are tested for COVID-19.
There is no evidence that animals can transmit the virus to humans, although British authorities advise people to wash their hands when touching animals, as well as when touching other areas that may have been touched by infected people.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rare virus, first identified in three people with burkyitis in cases of acute respiratory syndrome in Wuhan.
All the symptoms of the new SARS-CoV-2 virus are caused by a naturally related coronavirus. Outside the human body, the virus is killed by household soap, which is mixed in its solid membrane. SARS-CoV-2 is closely related to the original SARS-CoV.
It is thought to have a zoonotic origin and is transmitted to humans.
Genetic analysis has revealed that the coronavirus is genetically grouped with the Betacoronavirus subgenus, Sarbecovirus (Grade B) with two strains from the virus.
96% is the same as the total genome of other coronavirus detector samples (BatCov RaTG13).
In February 2020, Chinese researchers found that there is only one amino acid difference in specific parts of the genome sequence between the human and the mouse viruses.
A comparison of the entire genome so far has identified at most 92% of the genetic elements shared by the coronavirus and SARS-CoV-2, which is not enough to prove that the natives are moderate-to-severe.
The presence of the virus can be tested professionally based on the symptoms, although confirmation is ultimately by replication of the polymerase reaction series (rRT-PCR) from the excavations or CT scans.
A study comparing PCR and CT in Wuhan suggests that CT is significantly more sensitive than PCR, although it is particularly small, with many of its imaging symptoms masking other burnout and pathological processes.
In March 2020, the American College of Radiology recommended that "CT should not be used for primary diagnostic testing for COVID-19".
WHO published several methods of RNA testing for SARS-CoV-2 which were first announced on 17 January.
The test uses real-time replication of the polymerase reaction series (rRT-PCR).
The test can be done with a respirator or a blood sample.
The results are usually available within a few hours to a few days.
The test is usually done in the nasal fluid, although throat fluid can be used.A number of laboratories and companies are doing blood fluid tests, which detect antibodies.
As of 6 April 2020, none have been confirmed to be valid for widespread use.
In the United States, the blood flow test by Cellex was approved for emergency use only in authorized laboratories.
Characteristics of radiography and computed tomography (CT) of people with symptoms include empty vessels on the surface and lack of fluid between the lungs and chest.
The Italian Association of Research is collecting an international online database of photographic results of confirmed cases.
Due to the prevalence of other infections such as adenovirus, imaging without PCR confirmation has limited scope for COVID-19 identification.
A large study in China compared CT and chest CT scans and PCR results and showed that while imaging is not specific to infection, it is faster and more sensitive, suggesting it should be considered as a diagnostic tool for infection sites.
A hand-made scan based on neural network imaging has been developed to detect viral imaging symptoms in both radiography and CT.
Strategies to prevent transmission include maintaining good general personal hygiene, washing hands, avoiding eye contact or mouth contact with unwashed hands, and coughing or sneezing in a toilet and putting it in a garbage disposal.
Those who have already been infected are advised to wear surgical masks in public.
Significant distancing measures are also recommended to prevent transmission.Many governments have restricted or warned against all non-essential travel to and from countries and areas affected by the virus.
However, the virus has reached the point of social spread in many parts of the world.
This means that the virus can spread between communities, and some parts of the community do not know where or how it has spread. Healthcare providers caring for someone who may have been infected are advised to use up-to-date precautions, contact precautions, and eye protection. Contact tracking is an important way for health authorities to detect the source of the infection and prevent further transmission.
The use of location data from government-operated mobile phones for this purpose has raised privacy concerns, with Amnesty International and more than 100 other organizations issuing articles calling for restrictions on protection.
Several mobile apps have been activated or suggested for optional use, and as of April 7, 2020, more than a dozen expert teams were working on encryption solutions, such as using Bluetooth to see the proximity of the user to other mobile phones.
Users will then receive a message if they have been in close contact with someone who has been tested positive for COVID-19. There are rumors circulating about how to prevent infection; for example, washing the nose and mouth with a mouthwash is not the best option.
There is no vaccine for COVID-19, although many agencies are working to develop one.
Hand washing is recommended to prevent the spread of the disease.
The CDC recommends that people wash their hands frequently with soap and water for at least twenty seconds, especially after going to the bathroom or when hands are dirty, before eating; and after blowing a towel, coughing, or sneezing.
This is because outside the human body, the virus is killed by household soap, which protects the body from infection.
The CDC further recommended the use of alcohol-based hand sanitizer with at least 60% alcohol content when soap and water are not readily available.
WHO advises people to avoid touching their eyes, nose, or mouth with unwashed hands.
The surface can be sterilized with a number of solutions (a minute of sterilization on stainless steel surface), including 62-71% ethanol, 50-100% isoproponal, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, and 0.2-7.5% povidone-iodine.
Other solutions, such as benzalkonium chloride and chrohexidine gluconate, are less effective.
CDC advises that if a COVID-19 case is suspected or confirmed in a day care facility such as an office or day care center, all facilities such as offices, bathrooms, public places, shared electronic devices such as tablets, touch screens, keyboards, remote controls, and ATM machines used by sick people, should be disinfected.
Health authorities advised people to cover their mouths and noses when coughing or sneezing at the corners of their noses or nipples, and to add garbage to each nostril as soon as possible.
Surgical masks are recommended for those who are affected, as wearing masks may limit the distance and distance traveled by the falling spots when speaking, sneezing, or coughing.
WHO has issued recommendations on when and how to use masks.
According to Stephen Griffin, a virologist at the University of Leeds, "wearing masks can reduce the incidence [of] people touching their faces, which is a big eye that can be removed if there is no proper hand hygiene". Masks are also recommended for use by people caring for someone with the disease.
WHO advised wearing masks for healthy people if they are at high risk, such as those caring for someone with COVID-19, although it also acknowledges that wearing masks can help people avoid contact with their faces.
Several countries have begun to encourage the use of face masks among members of the public.
In the United States, the CDC recommends wearing non-medical face masks made of cloth.China has specifically recommended the use of disposable medical masks for public health personnel, especially when they are within 1 meter (3 feet or less) of others.
Hong Kong recommends wearing surgical masks when travelling in public transport or in crowded areas.
Health authorities in Thailand are encouraging people to make cloth face masks at home and wash them daily.
The Czech Republic and Slovakia have banned going outdoors without wearing masks or covering one's nose and mouth.
On 16 March, Vietnam urged everyone to wear face masks when going out in public places to protect themselves and others.
Austria has made it legal for anyone entering a store to wear a face mask.
Israel has asked all residents to wear face masks when in public.
Taiwan, which has been producing ten million masks a day since mid-March, requires passengers on trains and buses in outlying cities to wear face masks from April 1.
Panama made it mandatory to wear face masks when going outdoors, while also recommending the production of home-made face masks for use by those who cannot afford face masks.
Face masks have also been widely used in Japan, South Korea, Malaysia, and Singapore.
Social distancing (also known as physical distancing) is an infection control measure designed to reduce the spread of disease by reducing close contact between people.
These measures include quarantines, travel restrictions, and closure of schools, workplaces, playgrounds, theatres, or shopping centres.
People can implement social distancing by staying at home, limiting travel, avoiding crowded places, using non-contact greetings, and avoiding other people visually.
Many states are now legalizing or recommending social distancing in the affected states.
The maximum gathering recommended by US government officials and health agencies was simply reduced from 2500 people (if no COVID-19 outbreak was known in the state) to 50 people, and at most 10 people.
On 22 March 2020, Germany suspended social gatherings of more than two people. Older people and those with underlying health conditions such as diabetes, heart disease, respiratory disease, blood pressure and low immune system are at high risk of serious illness and disability and the CDC advised them to stay at home as much as possible in the social areas where the outbreak has occurred. In late March 2020, the WHO and other health agencies began to replace the use of the term "social distancing" with "visible distancing", to clarify that the goal is to reduce visible disruption by maintaining social contact, whether direct or indirect.
The use of the term "social distancing" has led to people entering complete social isolation, rather than being advised to contact others in similar ways. Some authorities have issued sexual health advice to be used during the pandemic.
These include the recommendation to have sex only with a cohabitant who is not infected with the virus or has no symptoms of the virus.
Home quarantine was advised for those who tested positive for COVID-19 and those who suspected it.
Health authorities have issued clear guidelines for appropriate quarantine.Many governments have legalized or recommended quarantine for all communities in affected areas.
The strongest quarantine recommendations were given to high-risk groups.
Those who may have been in contact with someone with COVID-19 and those who have recently traveled to a country or region with widespread transmission are advised to quarantine for 14 days from the last time they were in possible contact.
Strategies to control the spread are to stop or reduce, and to reduce.
The lockdown is being taken in the early stages of the outbreak and they want to find and quarantine those infected and similarly introduce other measures to control infection and vaccination to stop the disease from spreading to the rest of the community.
When it is not possible to stop the spread of the disease, efforts then go to the mitigation stage, steps are taken to slow the spread and reduce its impact on the health system and society.
The combination of the two measures of stopping and reducing can be taken at the same time.
Mitigation requires more robust measures to reverse the global epidemic by reducing the baseline reproduction rate to less than 1. The infectious disease management unit is trying to mitigate the rise in influenza, known as the enlargement of the saffron curve.
This reduces the risk of health services being lost and gives more time to develop vaccines and medicines.
Medically appropriate interventions to manage the outbreak include personal protective measures, such as hygiene, wearing face masks, and quarantine; humanitarian measures to prevent visible distancing such as closing schools and cancelling large gatherings; community involvement to encourage acceptance and participation in such interventions; and similarly environmental measures such as surface cleanliness. Many strict measures to stop the outbreak have been taken in China as the epidemic has become more severe, such as urban quarantines and the introduction of strict curfews.
Other countries have also implemented several measures aimed at limiting the spread of the virus.
South Korea has implemented widespread investigations and local quarantines, and issued warnings about the movement of affected people.
Singapore provided financial support to those who quarantined themselves and imposed heavy fines on those who did not.
Taiwan has increased the production of face masks and banned the increase in the price of medical supplies.British and US designs show that mitigation (reducing but not stopping the spread of influenza) and suppression (reversing the growth of influenza) have many challenges.
The best mitigation techniques could reduce the need for health care at the top two-thirds of these deaths by half, but still result in hundreds of thousands of deaths and the destruction of health systems.
The pressure can be elevated but must be maintained until the virus spreads through human populations (or until a vaccine is found, if that is not possible), otherwise transmission will double rapidly when measures are relaxed.
Long-term intervention in the global pandemic repression has social and economic costs.
There is no specific antiviral treatment approved for COVID-19, but efforts to develop it are underway, including ongoing drug trials.
Taking available cold medicines, drinking juice, and resting can help alleviate the symptoms.
Depending on the severity, oxygen therapy, intravenous fluid, and respiratory support may be needed.
Steroid use can also affect the results.
Several combinations that have already been approved for the treatment of other viral diseases are being investigated for use in the treatment of COVID-19.
WHO also states that some "traditional and home remedies" can somewhat relieve the symptoms caused by SARS-CoV-2.
WHO has identified increasing the scope and adapting healthcare to the needs of COVID-19 patients as a fundamental response to the outbreak.
ECDC and the European Regional Office of WHO issued guidelines for hospitals and basic health care services to transfer resources at several levels, including focusing on laboratory services for COVID-19 testing, halting screening procedures whenever possible, quarantining and quarantining COVID-19 patients, and emergency care capabilities by training staff and increasing the number of respirators and available beds.
There are several claims about where the first case (called the "epileptic patient") originated.
The first known case of the new coronavirus may have been in December 2019 in Wuhan, Hubei, China.
In a month, the number of coronavirus cases in Hubai has increased gradually.
These have long been associated with the Huanan Seafood Wholesale Market, which also sold live animals, and one theory is that the virus originated from one of these animal species; or, in other words, it has a zoonotic origin that is transmitted to humans.The known burkit group of the cause was detected on 26 December and was treated by Dr. Zhang Jixian at Hubei Provincial Hospital, which reported Wuhan Jianghan CDC on 27 December.
On 30 December, a team of doctors at Wuhan Central Hospital warned their colleagues about the "SARS-like coronavirus".
Eight of these doctors, including Li Wenliang, warned the police about the spread of false news, among other things, Ai Fen, was reprimanded by her supervisor for fomenting fear.
The Wuhan Municipal Health Commission finally issued a public notice on 31 March and informed the World Health Organization.
A sufficient number of unidentified burkits were reported to Wuhan medical authorities which initiated an investigation in early January. During the early stages of the outbreak, the number of cases doubled by approximately seven per day.
In early and mid-January 2020, the virus spread to other provinces in China, which was delayed by the Chinese New Year parade with Wuhan being the transportation hub and the largest train hub.
On January 20, China reported nearly 140 new cases in one day, including two in Beijing and one in Shenzhen.
Official data later revealed that 6,174 people had pre-symptomatic cases by the end of 20 January 2020, and on 26 March, the United States overtook China and Italy with the highest number of confirmed cases worldwide. As of 9 April 202o, more than 1.61 million cases have been reported worldwide; more than 97,000 people have died and 364 have recovered.
Nearly 200 countries and territories have detected at least one case.
Due to the global pandemic within Europe, many countries in the Schengen Area have restricted free movement and established border controls.
The strict response includes containment measures such as quarantines (also known as stay-at-home orders, stay-at-home orders, or general lockdowns) and curfews.As of April 2, nearly 300 million people, or nearly 90% of the population, are under some form of lockdown in the United States.More than 50 million people are under lockdown in the Philippines, nearly 59 million people are under lockdown in South Africa, and 130 billion people are under lockdown in India.
On 26 March, 1.7 billion people worldwide were under some form of lockdown, rising to 2.6 billion people two days later - nearly one-third of the world's population.
The first confirmed case of COVID-19 was traced back to 1 December 2019 in Wuhan; one unconfirmed report suggests the first case was on 17 November.
Dr. Zhang Jixian observed a group of cases of unknown cause of burnout on December 26, where her hospital notified Wuhan Jianghan CDC on December 27.
Genetic testing of previous patient samples on 27 December 2019 showed SARS detected in the coronavirus.
A medical notice was issued by the Wuhan Municipal Health Board on December 31.
The World Health Organization was informed on the same day.
As the news spread, Wuhan doctors warned the police against "spreading false information" about the outbreak.
China's National Health Commission has previously said there is no "clear evidence" of human-to-human transmission.
In late January, the Chinese government launched a reform campaign that later described Communist Party of China Secretary General Xi Jinping as "fighting the people" to stop the spread of the virus.
In what has been described as "the greatest quarantine in human history", a lockdown was announced on 23 January, halting travel in and out of Wuhan, and expanded to a total of 15 Hubei capitals, affecting a total population of nearly 57 million.
The use of private vehicles is prohibited in the capital.
Chinese New Year celebrations (25 January) have been cancelled in many places.
The authorities also announced the construction of a temporary hospital, Houshenshan Hospital, which was completed in 10 days.
Another hospital was built after that, Leishenshan Hospital, to receive new patients.
In addition to the newly built hospital, China has converted 14 other sites in Wuhan into temporary hospitals, such as conference centers and stadiums.On 26 January, the government introduced additional measures to contain the spread of COVID-19, including providing medical certificates to travelers and extending the Spring Festival holiday.
Colleges and schools were closed across the country.
Hong Kong and Macau have issued several measures, especially regarding schools and universities.
Measures for off-site work have been introduced in neighboring provinces of China.
Travel restrictions were imposed in and out of Hubei.
Public transportation has been altered, and all theaters in China have been temporarily closed.
Controls on social mobility have been implemented in many capitals, and an estimated 760 million people (more than half of the population) are facing some form of restrictions.After the outbreak entered its global phase in mid-March, Chinese authorities have taken strict measures to prevent "exportation" from other countries.
For example, Beijing has made mandatory 14-day quarantine for all international travellers entering the capital.On 23 March, mainland China reported only one domestic case five days earlier, in the same case, through a traveller returning to Guanzzhou from Istanbul.
On 24 March 2020, Chinese Premier Li Keqiang said that the domestic spread of the contagious disease has been controlled and that the outbreak is being controlled within China.
On the same day that travel restrictions were eased in Hubei, except for Wuhan, two months after the imposition of the general lockdown.China's Foreign Ministry announced on 26 March 2020 that entry visa and residence permit holders will be suspended from 28 March onwards, with no specific information on when the restrictions will end.
Those who wish to enter China must apply for visas at the Chinese embassy or consulate.
The Chinese government encourages businesses and industries to reopen from March 30, and provides incentives to enterprises.The State Council has declared a day of national mourning which will begin with a three-minute national mourning at 10:00 am on April 4, coinciding with the Qinming Festival, although the central government has asked families to pay their respects online while maintaining physical distancing to avoid the renewed spread of COVID-19.
COVID-19 has been confirmed to have spread in South Korea from China.
The National Health Agency reported a significant increase in confirmed cases on February 20, largely due to the Daegu gathering of activists of the new religious movement known as Shincheonji Church of Jesus.
Shincheonji worshipers visiting Daegu from Wuhan are suspected to be the source of the outbreak.
As of February 22, 9,336 parishioners, 1,261 or nearly 13% reported symptoms. South Korea declared maximum alert on February 23, 2020.
On 28 February, more than 2,000 confirmed cases were reported in Korea, which rose to 3,150 on 29 February.
All military installations in South Korea were quarantined after three of the soldiers tested positive for the virus.
The flight schedule was also affected and so was changed. South Korea launched what was considered the largest and best organized program in the world to screen the population for the virus, quarantine anyone infected and track and quarantine those who have been exposed.
Testing methods include compulsory diagnostic reporting of symptoms for people arriving from around the world through a phone app, going for a virus test and getting the results the next day, and increasing the testing capacity to be able to test 20,000 people per day.
The South Korean program was seen as a failure in controlling the outbreak despite the quarantine not being implemented in all capitals.The South Korean community has previously blocked President Moon Jae's response to the crisis.
Many Koreans signed a lawsuit alleging that Moon's removal was a misrepresentation of the government's handling of the outbreak, or praising his response.
On 23 March, South Korea reported the lowest daily case count in a total of four weeks.
On 29 March it was announced that from 1 April all travellers arriving from abroad will be quarantined for two weeks.
According to media reports on April 1, South Korea received requests to delay testing of the virus from 121 different countries.
Iran said its first confirmed case of SARS-CoV-2 infection was on 19 February in Qom, while, according to the Ministry of Health and Medical Education, two people died later that day.
The government announced emergency measures including cancellation of concerts and other cultural events, sports events, and Friday prayers, and closure of universities, higher education institutions, and schools.
Iran allocated five trillion riyals to fight the virus.
President Hassan Rouhani said on 26 February 2020 that there is no plan for quarantine facilities affected by the outbreak, only people will be quarantined.
Plans to restrict travel between the capitals were announced in March, despite the large traffic jams that continued between the capitals ahead of the Persian New Year Nowrus.
Chinese holy sites remain open to visitors as of 16 March 2020, Iran became the epicenter of the virus outbreak after China in February.
The moderate reporting of the spread of the virus within Iran, followed by more than ten countries to Iran by the end of February 28, indicating that the spread of the virus is much worse than the 388 cases reported by the Iranian government that day.
Iran's parliament was shut down, with 23 of 290 members of parliament reportedly tested positive for the virus on March 3.
On 12 March, Human Rights Watch urged Iranian prison authorities to release unconditionally human rights defenders detained for dissent, as well as to release all deserving detainees on a temporary basis.
She said there is a greater risk of spreading the virus in closed institutions such as prisons, which lack adequate health care.
On March 5, the Iranian government reported 100 deaths in one day, the highest recorded in the country since the outbreak began.
At least 12 current or former Iranian politicians and government leaders have died of the disease since late March 17.
As of the end of March 23, Iran was experiencing 50 cases per hour and one death per 10 minutes due to the coronavirus.
According to World Health Organization officials, there may be more cases of coronavirus in Iran than reported.
It was also suggested that the US sanctions on Iran could affect the country's economic ability to respond to the virus outbreak.
The UN High Commissioner for Human Rights has called for easing economic sanctions on countries hardest hit by the global pandemic, including Iran.
The outbreak was confirmed in Italy on January 31, when two Chinese tourists were tested positive for SARS-CoV-2 in Rome.
Cases began to rise rapidly, which prompted the Iranian government to suspend all flights to and from China and declare a state of emergency.
A group of COVID-19-related cases were recently identified, starting with 16 confirmed cases in Lombardy on 21 February.On 22 February, the Cabinet announced a new decree to stop the outbreak, which included quarantining more than 50,000 people from 11 districts in northern Italy.
Prime Minister Giuseppe Conte said, "The areas where the infection has spread, entry and exit will not be available.
A halt to work activities and sports forums was ordered in these areas.4 In March, the Italian government ordered the complete closure of all schools and colleges across the country as Italy reached 100.
All sporting events, including Serie A football matches, must be held in closed spaces, but on 9 March, all sports are suspended for at least a month.
On 11 March, President Conte ordered the suspension of almost all business activities except supermarkets and pharmacies.6 On 6 March, the College of Addiction, Anesthesia, Rehabilitation and Emergency Care (SIAARTI) published medical recommendations with reference to a separate protocol that may be implemented.
On 19 March, Italy overtook China as the country with the highest number of coronavirus deaths globally when it reported 3,405 deaths from the global pandemic.
On 22 March, it was reported that Russia had sent nine military aircraft to Italy as medical supplies.
As of 5 April, there were 128,98 confirmed cases, 15,887 deaths, and 21,815 recoveries in Italy, with the majority of these cases occurring in the Lombardy region.
A report released by CNN shows the combination of the high number of elderly people in Italy and the inability to test for the virus may contribute to the high mortality rate.
The UK's response to the virus initially appeared to be the most flexible and most flexible among the affected countries, and as of 18 March 2020, the UK government has not implemented any social distancing or any form of mass quarantine measures in its network.
As a result, the government has been criticized for its lack of action and lack of response to the concerns faced by the public.On 16 March, Prime Minister Boris Johnson issued a message warning people against non-essential travel and social distancing, suggesting that people work from home when possible and avoid places such as bars, hotels, and theatres.
On 20 March, the government announced that all leisure gatherings such as bars and gyms would be closed as soon as possible, and pledged to pay up to 80% of the salaries of employees above £2,500 per month to prevent unemployment during the crisis. On 23 March, the Prime Minister announced strict measures of social distancing, banning gatherings of more than two people and restrictions on movement and staying at home which were seen as important.
Unlike previous measures, these restrictions were enforced by the police through fines and the dismissal of meetings.
Most businesses were ordered to close, except for those considered "basic", including supermarkets, pharmacies, banks, hardware stores, battery stores, and grocery stores.
On January 20, the first known case of COVID-19 was confirmed in the Pacific Northwest in Washington State in a man who returned from Wuhan on January 15.
The White House Corona Virus Task Force was formed on January 29.
On January 31, the Trump administration declared a public health emergency and imposed entry restrictions on travelers from China.
On January 28, 2020, the Center for Disease Control - the premier public health institute in the United States - announced that it had developed its own diagnostic tool.
In doing so, the U.S. government's investigation is a low-key start, which hides the true extent of the outbreak in time.
The study was hampered by defective screening materials released by the federal government in February, the lack of federal approval of non-government screening materials (in academia, companies and hospitals) until the end of February, and a limited number of people eligible for screening until early March (after which a medical advice is required).
On February 27, The Washington Post reported that fewer than 4,000 tests had been conducted in the United States.
At the end of March 13, Atlantic reported less than 14,00 searches had been conducted.
On March 22, Associated Press reported: "Many people with symptoms and doctor's orders waited hours and days to be tested".Following the first death reported in the United States in Washington state on February 29, Governor Jay Inslee declared a state of emergency, a move that was later followed by other states.
Schools in the Seattle area canceled classes on March 3, and by mid-March, schools across the country were closed.On March 6, 2020, a team of epidemiologists from Imperial College London advised the United States on the prediction of the impact of the new coronavirus on the country.
On the same day that President Trump signed the Reasonable Supplemental Preparedness and Response Act, which provided $8.3 billion in immediate funding to federal agencies to respond to the spill.
Companies have imposed travel restrictions on their employees, cancelled meetings, and encouraged employees to work from home.
Events and sports seasons are cancelled.On 11 March, Trump announced travel restrictions in most of Europe, except the United Kingdom, for 30 days, effective 13 March.3
The next day, he extended the ban to include the United Kingdom and Ireland.
On 3 March, he declared a national state of emergency, which made federal funding available for disaster response.
Since March 15, many businesses have closed or reduced their hours of operation across the United States in an effort to slow the spread of the virus.
On March 17, the pandemic was confirmed in all 50 states and the District of Columbia.On March 23, it was reported that 10,700 coronavirus cases had been detected in New York City, more than the total number of cases in South Korea.
On 25 March, the inspector general said that social distancing appears to be working, as the estimated doubling of cases has dropped from 2.0 days to 4.7 days.
As of March 28, there were 32,308 confirmed cases in New York, and 672 people died from the virus.On March 26, the United States reported more confirmed cases of coronavirus infection than any other country in the world, including China and Italy.On April 8, 400,335 cases were confirmed in the United States, and 12,841 people died.
As reported by media on March 30, US President Trump decided to extend the social distancing advice until April 30.
On the same day, USNS Comfort, a hospital ship with nearly 1000 beds, docked in New York.
On April 3, the United States recorded 884 coronavirus deaths in 24 hours.
In New York State, cases surpassed 100,000 on April 3.The White House has been criticized for underestimating the risk and controlling messages by ordering health officials and scientists to isolate articles and publications related to the virus from the office of Vice President Mike Pence.
General approval of Trump's management of the disaster is opposed by partisan ranks.
Some U.S. officials and commentators have criticized the U.S.'s unwillingness to prioritize raw materials, including basic medical supplies, imported from China.
The air travel chart was used to chart and predict the pattern of outbreaks and was published in The Journal of Travel Medicine in mid-January 202o.
According to 2018 data from the International Aviation Association, Bangkok, Hong Kong, Tokyo, and Taipei had the highest number of arrivals from Wuhan.
Dubai, Sydney, and Melbourne are also reported to be the most popular destinations for travel from Wuhan.
Bali is reported to be one of the least prepared of the 20 popular tourist destinations, while the Australian capital is identified as the most prepared.Australia released an Emergency Response Plan for the New Corona Virus (COVID-19) on 7 February.
It was reported that while much is still unknown about COVID-19, Australia will focus on border control and communication in response to the global pandemic.
On 21 March, measures to protect humanity from emerging hazards were announced in Australia.
With effective quarantine on public transportation in Wuhan and Hubei, several countries have planned to evacuate their citizens and diplomatic personnel from the area, primarily using state-owned chartered flights, with official permission from Chinese authorities.
Canada, the United States, Japan, India, Sri Lanka, Australia, France, Argentina, Jatmalka, and Thailand were among the first to mock the evacuation of their populations.
Pakistan has said it will not evacuate any of its citizens from China.
On 7 February, Brazil is evacuating 34 Brazilians or family members in addition to four Poles, one Chinese, and one Indian.
Polish, Chinese, and Indian nationals were flown back to Poland, when a Brazilian plane stopped in the middle before it continued on to Brazil.
A Brazilian-born citizen who traveled to Wuhan was quarantined at a military base near Brasília.
On the same day, 215 miners who were en route to Canada (176 on the first plane, and 39 people on the second plane hired by the US government) were evacuated from Wuhan to CFB Trenton for two weeks of quarantine.
On February 11, another 185 Canadian-class aircraft from Wuhan landed at CFB Trenton.
Australian authorities released 277 citizens on February 3 and 4 to the Christmas Island Detention Centre, which was set up as a quarantine facility, where they remained for 14 days.
A New Zealand return flight arrived in Auckland on 5 February, and its passengers (including those from Australia and the Pacific) were quarantined at the naval base at Whanaparoa, north of Auckland.
On February 15, the United States announced that it would be sending American passengers aboard the Diamond Princess cruise ship.
On 21 February, a flight carrying 129 Canadian passengers from Diamond Princess landed in Trenton, Ontario.
In early March, the Government of India started the evacuation of its citizens from Iran.On 14 March, South African Airways, owned by the Government of South Africa, repatriated 112 South African citizens.
A medical screening was conducted prior to departure, and 4 South Africans who showed symptoms of coronavirus were left behind to reduce the risk.
Only missing South Africans were repatriated.
The results of the investigation confirmed all South Africans, including aircrew, pilots, hotel staff, police and military involved in the humanitarian operation who, as a precautionary measure, were all monitored and quarantined for 14 days at Ranch Resort.
On 20 March, the United States began withdrawing its troops from Iraq due to the pandemic.
On 5 February, the Chinese Foreign Ministry said that 21 countries (including Belarus, Pakistan, Trinidad and Tobago, Egypt, and Iran) had sent aid to China.
Some Chinese students at US universities have gathered to help send aid to areas affected by the virus in China, with a mixed team in the Greater Chicago area reportedly managing to send 50,000 N95 masks to Hubei Provincial Hospital on January 30.Direct Aid from the Humanitarian Aid Foundation, working with FEDEX, sent 200,000 face masks along with other personal protective equipment, including gloves and gloves, which were immediately airlifted to Wuhan Union Hospital on January 30.
On February 5, Bill and Melinda Gates announced a $100 million donation to WHO to fund vaccine research and treatment efforts while protecting "at-risk populations in Africa and Asia".
Interaksyon reported that the Chinese government donated 200,000 masks to the Philippines on February 6, after Richard Gordon donated 3.16 million masks to Wuhan.
On 9 February, the Red Crescent of Singapore announced that it would send $2.26 million in aid to China.
Japan donated one million face masks to Wuhan, Turkey took medical supplies, Russia sent more than 13 tons of medical supplies to Wuhan, Malaysia announced a donation of 18 million Chinese medical supplies, Germany donated various medical supplies including 10,000 Hazmat kits, and the United States donated 17.8 tons of medical supplies to China and pledged an additional $100 million in financial support to the affected countries. After cases in China appeared to be declining, the country was sending aid to various countries hit by the global pandemic.
In March, China, Cuba and Russia sent medical supplies and experts to help Italy deal with the coronavirus outbreak.
Jack Ma sent 1.1 million test kits, 6 million face masks, and 60,000 protective pads to Addis Ababa, Ethiopia to be distributed to the African Union.
He then sent 5,000 test kits, 100,000 face masks and 5 respirators to Panama.
Ma also donated medical supplies to Canada.Netherlands, Spain, Turkey, Georgia, and the Czech Republic have expressed concern about Chinese-made masks and testing equipment.
For example, Spain has exported 58,000 Chinese-made coronavirus test kits with a 30% accuracy rate, while the Netherlands has returned 600,000 Chinese face masks that were bad.
Belgium returned 100,000 unusable masks, thought to have come from China, but in fact from Colombia.
On the other hand, China's aid was well received in parts of Latin America and Africa.On April 2, the World Bank launched emergency operational support to developing countries.
WHO praised the efforts of Chinese authorities in managing and controlling the pandemic.
WHO said one was against the 2002-2004 SARS outbreak, where Chinese authorities were accused of hiding delays in prevention and control efforts, and the current pandemic while the federal government "is providing new guidance to prevent anxiety during the Lunar New Year holidays".
On 23 January, in response to the central authorities' decision to impose traffic restrictions on Wuhan, WHO spokesperson Gauden Galea noted that it was not "a recommendation by WHO", but a "very important step in the commitment to control the epidemic at its peak" and dubbed it "a lack of public health record". On 30 January, following confirmation of transmission to humans outside China and the increase in the number of cases in other countries, WHO announced that the pandemic is a Global Emergency Public Health Emergency (PHEIC), taking it to the sixth tier during the 2009 pandemic pandemic.
WHO Director-General Tedros Adhanom said PHEIC is "close to a global pandemic, especially in low and middle income countries that lack a robust healthcare system".
Reacting to the implementation of travel restrictions, Tedros said "there is no reason to take measures that do not adequately address international movement and trade" and that "WHO does not recommend restrictions on movement and trade".
On February 5, WHO requested a donation of $675 million from the international community to fund strategic preparations for low-income countries, expressing the urgency to support those countries "who do not have systems in place to detect people infected with the virus, even if it does emerge".
Tedros added in an article that "we are only as strong as our weakest link" and called on the international community to "invest today or spend more tomorrow".On February 11, WHO held a press conference and named the disease COVID-1.
On the same day, Tedros said that UN Secretary General Antonio Guterres had agreed to give "power to the general UN system to react".
The UN Disaster Management Group was activated in response to the outcome, allowing for a comprehensive collaboration in the UN response, which WHO says will allow it to "focus on the health response while other agencies can bring expertise to deal with the broader social, economic and progressive consequences of the outbreak".
On 14 February, a Joint Working Group led by WHO with China was engaged to engage international experts and those of WHO in China to help local management and assess "the risk and transmission of the disease" by holding seminars and meetings with key national-level academics and to conduct field visits to assess "the effectiveness of response activities at the provincial and autonomous level, including urban and rural areas". On 25 February, WHO announced that "the world is doing more to prepare for a possible global pandemic", despite the previously announced global pandemic, and that countries should always be "prepared".
In response to the ongoing killing spree in Iran, WHO sent a Joint Task Force to assess the situation. On 28 February, WHO officials said that the global coronavirus risk assessment would be raised from "high" to "extremely high", the highest level of warning and risk assessment.
Mike Ryan, executive director of the WHO's Emergency Health Program, warned in an article that "This is a fact check for every government on earth: Direct,
The virus could be in the way and you need to be prepared", he said, adding that the right response measures can help the world avoid "the worst".
Ryan further said that the current data does not guarantee that public health authorities will declare it a global pandemic, saying such a declaration means "we fundamentally accept that every human being on the planet is infected with the virus.
On 11 March, WHO declared the coronavirus a global pandemic.
The Director-General said that WHO was "deeply concerned both by the alarming levels of spread and severity, and the alarming levels of inaction". WHO faced heavy criticism for what appeared to be insufficient handling of the global pandemic, including the late declaration of a public health emergency and the recognition of the virus as a global pandemic.
The criticism included a petition to WHO Director-General Tedros Adhanom to submit his resignation, which was signed by 733,000 people on April 6.
On 26 March 2020, dozens of UN human rights experts reiterated the need to respect the rights of everyone during the global COVID-19 pandemic.
The expert group said that everyone has the right to save lives and the state is responsible for it.
One group emphasized that lack of income or health insurance should never be an evidence of discrimination against a particular group.
The experts emphasized that everyone has the right to health, including people with disabilities, people from minority groups, older people, internally displaced persons, homeless people, people living in extreme conditions, people in prisons, as well as refugees and other unnamed groups who need government support.
International government agencies report the economic and social impact of the COVID-19 pandemic.
The Organisation for Economic Co-operation and Development (OECD) has launched a platform to provide comprehensive and timely information on the reaction patterns of countries around the world, as well as insights and advice.
From ways to strengthen global health systems and economies to discussing the impact of the ban and travel restrictions, the state-of-the-art facility, including the Country Code Enforcement, aims to help countries learn from each other and facilitate a collaborative global response to the coronavirus challenge.
The Chinese government has been criticized by the United States, British Cabinet Minister Michael Gove, and the son of Brazilian President Jair Bolsonaro, for its handling of the global pandemic that began in China's Hubei province.
A number of provincial-level CPC administration officials were dismissed for their handling of quarantine efforts in Central China, a sign of dissatisfaction with the policies created by the outbreak in those provinces.
Analysts believe that the move was aimed at protecting Chinese Communist Party Secretary General Xi Jinping from the coronavirus pandemic.
Some Chinese officials, such as Zhao Lijian, denied earlier claims that the coronavirus outbreak began in Wuhan, and dismissed the conspiracy theory that COVID-19 originated in the United States or Italy.
US administration Donald Trump described the coronavirus as "Chinese virus" or "Wuhan virus" saying that Chinese tests had led to a virus that has now evolved into a global pandemic, which critics have condemned as racist and misleading as his administration has failed to control the disease.
Daily Beast received a cable from the US government showing a communications fraud with clear origins from the National Security Council, with a strategy that says "Everything is about China".
We were told to try and receive these messages in every possible way, including press conferences and television appearances".Publications such as Politico, Foreign Policy, and Bloomberg reported that China's efforts to send aid to the countries hit by the virus are part of a broader push to influence the world.
EU foreign policy commissioner Josep Borrell warned that there is "a geopolitical issue including the struggle to influence through aggression and 'political liberalism'.
Borrell also said, "China is aggressively pushing the message that, apart from the United States, it is a responsible and reliable partner".
China also called on the United States to lift its blockade of Syria, Venezuela and Iran, and send aid to the latter two countries.
Jack Ma's donation of 100,000 masks to Cuba was blocked by US sanctions on April 3.
US officials were also accused of diverting aid to other countries to their own country.
There were reported problems with masks between other countries, such as Germany, Austria, and Switzerland; and the Czech Republic and Italy.
In addition, Turkey seized hundreds of respirators that were being transported to Spain.
In early March, the Italian government condemned the European Union for its lack of attention to Italy's coronavirus outbreak.
Maurizio Massari, Italian ambassador to the EU, said "only China has responded in a two-pronged manner.
This is certainly not a good sign of European solidarity".
On 22 March, after a phone call with Italian Prime Minister Giuseppe Conte, Russian President Vladimir Putin arranged for the Russian military to send military doctors, special anti-inflammatory vehicles, and other medical equipment to Italy.
The Italian newspaper Stampa quoted an unknown "high-level political source" as saying that 80 percent of Russian aid was "ineffective or of little value to Italy".
Sources accused Russia of pursuing a "geopolitical and diplomatic" campaign to seek support.
Lombardy President Attilio Fontana and Italian Foreign Minister Luigi Di Maio rejected the media reports and expressed their gratitude.
Russia also sent a cargo plane carrying medical aid to the United States.
Kremlin spokesman Dmitry Peskov said "when giving aid to a friend of the United States, [Putin] assumes that when US manufacturers of medical equipment and other supplies gain power, they will also be able to reward if necessary".
The NATO military exercise "Defense 2020" planned to take place in Germany, Poland, and the Baltic States, the largest NATO war exercise since the end of the Cold War, will be held on a smaller scale.
Secretary General of the Organization for Nuclear Disarmament Kate Hudsan criticized the 2020 Defense Declaration: "The current public health crisis, endangers not only the lives of the US and many European countries involved but also the lives of the people of the countries where they are operating".The Iranian government has been severely affected by the virus, with nearly two dozen members of parliament as well as fifteen other current or former political officials.
Iranian President Hassan Rouhani wrote a general letter to world leaders requesting help on 14 March 2020, saying his country is struggling to fight the epidemic due to the lack of acceptance in international markets as a result of the sanctions imposed by the United States on Iran. The outbreak has led to calls for the United States to introduce social systems that are similar to other rich countries, including universal health care, universal childcare, paid family leave, and high levels of public health funding.
Political analysts predict that it will negatively affect the chances of Donald Trump's re-election in the 2020 presidential election.Diplomatic relations between Japan and South Korea have deteriorated due to the global pandemic.
The Republic of Korea has been criticizing "the ongoing unproven quarantine efforts" after Japan announced that anyone arriving from South Korea will be quarantined for two weeks at government-planned locations.
The South Korean public has previously shared President Moon Jae-in's reaction to the disaster.
Many Koreans signed a petition announcing Moon's removal from office for allegedly handling the government's mismanagement of the outbreak, or to praise his response.The global pandemic has allowed countries to pass emergency legislation to respond.
Some analysts expressed concern that it would allow governments to strengthen their hold on power.
Hungary's parliament voted to allow Prime Minister Viktor Orban to pass a law without discrimination, suspend parliament as well as elections and punish those deemed to have spread false information about the virus and how the government is handling the pandemic.
The coronavirus outbreak has been blamed on several cases of supply shortages, which have led to increased use of resources to combat the outbreak, panic buying, and troubled manufacturing and supply operations.
The US Food and Drug Administration issued a warning about shortages of medicines and medical supplies due to the increasing demand from consumers and the concerns of suppliers.
Several places also witnessed panic buying which led to the closure of retail stores such as food, toilet paper, and bottled water, resulting in shortages of supplies.
The technology industry was particularly warned about the delay in shipping of electronic products.
According to the Director-General of the World Health Organization Tedros Adhanom, the need for personal protective equipment has increased by 100 times.
This demand has caused the price to rise twenty times the normal price and also caused the delay of medical supplies for four to six weeks.
It has also led to a shortage of diagnostic personal protective equipment worldwide, with the World Health Organization warning that this will put healthcare workers at risk.
In Australia, the pandemic has given new opportunities whereby retailers sell Australian goods from China.
The process that led to the shortage of baby milk in some supermarkets which was later banned by the Australian government, as well as the spread of COVID-19 cases in Northern Italy and Wuhan Province, and the high demand for food supplies, both of which have survived severe food shortages.
The measures taken by China and Italy to combat the advertising and illegal trade of dangerous goods have been successful, avoiding the severe food shortage expected in Europe as well as North America.
In northern Italy, where agricultural production is high, there is no significant decline, but prices may rise according to industry representatives.
Empty food cans were temporarily met, even in Wuhan, while the Chinese government officially released pig stores to ensure nutrition supply to the community.
Similar regulations apply in Italy where food production is required to be stored and packaged for emergency use.
The economic impact of the global economy has been felt in China: According to media reports on 16 March, China's economy has been severely affected in the first two months of 2020 due to the measures taken by the government to contain the spread of the virus, retail purchases have fallen by 20.5%.
As mainland China is a major economic and manufacturing hub, the outbreak of the virus has been seen to bring about a major panic that is disrupting the global economy.
Agathe Demaris of Financial Advisors predicted that markets will rebound until clear visibility of productive results emerges.
In mid-January 2020, some analysts estimated that the economic recovery from the pandemic would surpass the global growth of 2002-2004 from the SARS outbreak.
One estimate by an expert at Washington University in St. Louis estimates the impact of the global supply chain to be more than $300 billion, which could last for up to two years.
OPEC is reportedly "confused" after a sharp drop in oil prices due to a shortage of demand from China.
The brand's stock market fell on 24 February due to the high increase in the number of COVID-19 cases outside mainland China.
On 27 February, amid growing concern over the coronavirus outbreak, commodity stock indices including the NASDAQ-100, S&P 500 index, and the Dow Jones Industrial Average posted their lowest decline since 2008, with the Dow dropping to 1,191 points, the biggest one-day drop since the 2007-08 financial crisis.
All three commodity indices ended the week with a fall of more than 10%.
As of 28 February, the rating firm SCope Ratings GmbH confirmed that its independent assessment of the risk of investing in China, however, remained negative.
In the re-offs of goods based on the fear of corona virus, the biggest drop was on 16 March.
Many people see a possible economic downturn.
The health minister Mohamed El-Erian praised the central bank and state banks for their immediate action.
Central banks reacted quickly to the 2008 financial crisis.
Tourism was the worst affected due to travel restrictions, closure of public places including tourist attractions, and government warnings against traveling anywhere in the world.
As a result, a number of airlines have cancelled their flights due to declining demand including British Airways, China Eastern Airlines, and Qantas, while British regional airline Flybe has flourished.
The impact on the cruise industry is unprecedented.
Several train stations and docks were also closed.
The coronavirus outbreak has improved in Chunyun, a major travel season associated with the Chinese New Year holidays.
A number of events involving mass gatherings were cancelled by local and national governments, including the annual New Sand festival, with private companies closing their shops and tourist attractions such as Hong Kong Disneyland and Shanghai Disneyland.
Most Lunar New Year events and tourist attractions were closed to prevent large gatherings, including Beijing's Forbidden City and the traditional temples in the temples.
In 24 of China's 31 provinces, municipalities and provinces, authorities extended the New Year's holiday until 10 February, ordering most workplaces not to reopen until that date.
These regions accounted for 80% of the country's GDP and 90% of its exports.
Hong Kong raised its pandemic response to the highest level by declaring a state of emergency, closing schools until March and canceling New Year's Eve celebrations.The retail sector was affected worldwide with reduced store opening hours and temporary closures.
Retail travel in Europe and Latin America declined by almost 40%.
Retailers in North America and the Middle East saw a decline of 50-60%.
This was also due to a 33-43% drop in the sales of shopping malls in March compared to February.
Additional measures were imposed on people operating in shopping malls around the world, such as increased sanitation, installation of temperature meters to check the temperature of shoppers, and cancellation of events.According to estimates by the United Nations Economic Commission for Latin America, the global pandemic has caused an economic downturn that has left between 14 and 22 million people in Latin America in much lower poverty than they would have been in the absence of the global pandemic.
In mid-January and February, during the surge of the flu epidemic in Wuhan, nearly 5 million miners in China lost their jobs.
Most of the nearly 300 Chinese migrant workers were confined to their homes in the inland or confined areas of Hubei Province. By mid-March 2020, more than 10 million Americans had lost their jobs and sought government assistance.
The coronavirus outbreak could cost 47 million jobs in the United States and the unemployment rate could reach 32%, according to estimates by the Federal Reserve Bank of St. Louis.The restrictions in India have made tens of millions of migrant workers (who are paid daily wages) unemployed.The Angus Reid Institute's overall survey found that 44% of Canadian-born households have experienced some form of unemployment.Almost 900,000 workers have lost their jobs in Spain since the restrictions went into effect in mid-March 2020.
During the second half of March, 4 million French workers applied for temporary unemployment benefits and 1 British worker applied for the old-age benefit scheme. Nearly half a million companies in Germany sent their employees the government-sponsored short-term work plan known as Kurzarbeit.
The German compensation scheme for short-term work was adopted by France and the UK.
The exhibition and cultural heritage sector has been severely affected by the global pandemic, affecting the activities of organizations as well as individuals - both workers and freelancers - across the globe.
Organizations in the art and culture sector have tried to support their mission (often funded by the community) to provide access to oral heritage, maintain the well-being of its staff and the community, and support artists where possible.
At the end of March 2020, all the world's museums, libraries, festival venues, and cultural institutions have unrestrictedly cancelled or postponed their exhibitions, events, and events.
In response, there has been a massive effort to provide alternative services through digital platforms.Other factors that are now rapidly adding to the pandemic are the cancellation of religious services, large sporting events, and other cultural events, such as music and concerts, technology conferences, and fashion shows.
The film industry also faced a crisis, with the Vatican announcing the Holy Week celebrations in Rome, which took place last week during the Christian Lent, were canceled.
Many financial leaders suggested that elderly Christians stay home while attending Sunday Mass; churches in the nude can access services via the trail, online or by telephone while others offer worship in their cars.
While the Chinese Roman Catholic Church leader closed its churches and temples and Christian pilgrims evacuated St. Peter's Square, other religious communities also canceled services and restricted public gatherings in churches, mosques, temples, churches and places of worship in Gurdwara.
Iran's Ministry of Health announced the cancellation of Friday prayers in the areas affected by the outbreak and the holy places were later closed, while Saudi Arabia banned the entry of foreign pilgrims as well as those from its own country to the holy places of Mecca and Medina.
The pandemic was the most disruptive sporting event until World War II.
Major sporting events have been cancelled or postponed, including the Euro 2020, the 2019-20 NBA season, and the 2019-20 NHL season. These include the 2019-20 EUFA Champions League, 2019-20 Premier League, UEFA Euro 2020.
The pandemic has disrupted the 2020 Summer Olympics, which were originally scheduled to begin in late July; the International Campaign Committee stated on 24 March that the event will be held "after 2020 but no later than summer 2021". Gambling and other international platforms have been closed throughout the season and international poker tournaments have been postponed or suspended.
This led to more gamblers switching to online gambling, which many gambling websites reported increased revenue due to new members joining.The entertainment sector was also affected, with various groups suspending or cancelling their concerts.
Major theaters like Broadway also canceled all performances.
Some artists are looking for ways to streamline production and how to put their product online which is another way to present live, like live broadcasts of performances or to do "live editing" of art online, distribute and then publish their product.
Online, many coronavirus programs have been circulated on the Internet that are joking about the uncertain.
Since the start of the COVID-19 pandemic, much hatred, discrimination and racism has been raised against Jains and those of East Asian origin, as well as people from Europe, the United States and other countries.
Incidents of fear, suspicion, and violence have been observed in many countries, including Europe, Western Asia, North America, and the Asia Pacific region.
The reports in February (when most cases were being confirmed in Jan) contained allegations of a conspiracy by various groups of Janis around the world who were doing what they claimed was right for them.
In some African countries, there is a hate for the Jains.
Many residents of Wuhan and Hubei reported being discriminated against because of their place of origin.
There's been support for the devil, online and offline, and in places where the virus has spread.
After the pandemic reached new countries, the people of Italy, the first country in Europe to see a severe COVID-19 outbreak, are also suspected of being viewed with suspicion and aloofness.Natives of Malaysia, New Zealand, Singapore, and South Korea have signed a campaign to ban Jains from entering their country and thus stop the spread of the disease.
In Japan, the hashtag #ChineseDontComeToJapan is going on on Twitter.
Jains as well as other Asians in Britain and the United States also reported an increase in incidents of racial discrimination, as well as abuse.
US President Donald Trump has been criticized for calling the coronavirus "the demonic virus", a term that some see as discriminatory and a metaphor for the demon.
Protesters in Ukraine attacked buses carrying Ukrainians and foreigners from Wuhan to Novi Sanzhary.
Students from North India, which is located in the Jaina region, and students in major cities of India have reportedly been given condolences in connection with the coronavirus pandemic.
Bharatiya Janata Party West Bengal State Chief Dilip Ghosh says that the demons have destroyed the unnatural life and "that is why God is avenging them".
The song was later criticized by the Jains' consulate in Kolkata, which called it "wrong". The song also sparked hatred and discrimination against non-Jains, which led to the pandemic, and foreigners were described as "coco garbage" and should be targeted "to be spilled".
The parts purchasing newsletters removed some or all of the coronavirus reports.
Some scientists have published a scientific report that is thus related to open access.
Some scientists have chosen to share their quick results from the first published research, BioRxiv.
Emergent diseases - Inflammatory diseases that arise from influenza, usually the novel form of the virus or the mode of transmission.
Hemorrhage and pain - A summary of hemorrhage and pain transmission
List of epidemics and diseases - List of deaths from infectious diseases
Wildlife trafficking and sinusitis - health risks associated with the trade in wildlife without training
Respiratory coronavirus disease 2019 (COVID-19) tests and its relationship to the SARS-CoV-2 virus including the method of diagnosing the presence of an antibody that is a response to infection.
Detection of the virus in the sample confirmed by RT-PCR, which is then followed by RNA from the coronavirus.
The test is specifically designed to detect the SARS-CoV-2 virus RNA.
It is used to detect a recent or existing infection.
The antibody detection (serogly) can be used for laboratory testing and monitoring of the population.
Antibody tests show the number of people who have the disease, including those with very few, no reported symptoms or those with symptoms.
The exact degree of mortality and the degree of interaction with the immune system can be determined by this test.
As laboratories are limited, as of March 2020 no country had reliable information on the virus in its population.
As of March 23, no country had tested 3% of its population, and there is a huge difference in the number of tests that countries have done.
This variation is likely reflected in the increasing cases and mortality rates, which are likely to be higher in some countries.
Using the polymerase chain reaction (rRT-PCR) in the laboratory to make respiratory samples obtained from various methods, including particle samples or fluid samples.
The results usually take from a few hours to 2 days.
RT-PCR tests are performed on a food sample that can only be detected during the first week of the illness.
When the virus is dead, it passes through the throat and then multiplies in the lungs.
For the second week of testing, other samples taken from the airways and then sucked into the catheter or urine may be used.
One of the first PCR labs conducted by Charite in Berlin in January 2020 using reverse transcriptase polymerase chain reaction (rRT-PCP), was sampled from 250,000 lungs and then distributed to the World Health Organization (WHO).
The UK also conducted a test on 23 January 2020. South Korean company Kogenebiotech developed a clinical, oral monitoring of SARS-CoV-2 based on PCR (PowerCheck Coronavirus) on 28 January 2020.
The "E" gene was detected in the then-common coronavirus, and the RdRp gene specific to SARS-CoV-2.BGI Group was among the first companies to receive emergency response approval from the National Heart Health Administration for lung monitoring of SARS-CoV-2 based on PCR.In the United States, the Centers for Disease Control and Prevention (CDC) distributed the RT-PCR 2019 laboratory data for the Novel Coronavirus (2019-nCoV) Global Response.
One of the three original lung samples from the lab produced an incomplete and therefore erroneous result, and a transnational test at the CDC in Atlanta yielded an average of less than 100 samples per day for full testing in February 2020.
The two-unit lab was found to be unreliable until 28 February 2020, when state and local labs were allowed to start testing.
The lab was approved by the Food and Drug Administration as an Emergency Use Authority. In the United States, commercial labs began testing in early March 2020.
As of 5 March 2020, LabCorp announced that COVID-19 tests based on RT-PCR will be conducted across the country.
A nationwide COVID-19 parallel test drive was launched on 9 March 2020.
No quantity is specified; the sample has been taken and must be processed according to the CDC's guidelines.
In Russia, a COVID-19 test was developed by the State Center for Virology and Biotechnology VECTOR.
On 11 February 2020, the lab was registered with the Federal Health Care Oversight Service. On 12 March 2020, Mayo Clinic said it had developed a test for detecting COVID-19 infection. On 13 March 2020, Roche Diagnostic was approved by the FDA to conduct tests in bulk for 3.5 hours, so one machine would do an average of 4,128 tests in 24 hours.
On 19 March 2020, the FDA issued an Emergency Authorization (EUA) to Abbott Laboratories to conduct testing of Abbott's m2000 system; the FDA has previously granted similar authorization to Halogic, LabCorp, and Thermo Fisher Scientific.
On 21 March 2020, Cepheid also received an EUA from the FDA to conduct a 45-minute lab test.
The FDA approved laboratory use of isothermal nucleic acid, which is the technology used to amplify instead of PCR.
Since this does not require much more than a large temperature cycle, the result can be predicted from a person's position in a few minutes to that of a person's position in 13 degrees north.
There are currently about 18,000 of these machines in the United States and Abbott is set to produce about 50,000 samples per day.The labs will use a single antibody that is specific to the nucleocapsid protein (N-botoxin) of the novel coronavirus and is then being developed in Taiwan, with the hope of obtaining more results in 15 to 20 minutes than the flu samples.
In March 2020, the previously available data was reviewed for "early chest X-rays of then low-cost laboratories, where CT [computer imaging] results could show a greater range of symptoms".
A common form of CT is multi-lobed lenses with a connection, structure and shape.
Reproductive immunity, the madness and the contraction of the disease.
A comparative study of PCR and CT in Wuhan, the epicenter of the pandemic at the time, showed that CT is far more sensitive than PCR, although less precise, with many of the imaging patterns overlapping with other forms of lung infection and pain progression.
As of March 2020, the US Centers for Disease Control and Prevention has recommended that "CT should not be used for laboratory testing or primary testing of COVID-19". In March 2020, the CDC recommended that primary testing should be PCR.
Part of the immune response to infection is the formation of IgM and IgG antibodies.
It can be used to detect infection in individuals as early as 7 days or when the disease has developed, to test immunity, and then to follow up with the general public.The test can be done in a central laboratory (CLT) or in a care laboratory (PoCT).
The high-input multi-system of many clinical laboratories can then be brought together but its availability depends on the output of each system.
A CLT of a single sample for a blood infection is usually used, although a solid sample can be used for follow-up of the response to a fever.
PoCT is obtained by a drop of blood through a skin piercing.
Unlike the PCR method, the pre-exposure test does not require a physical gathering.On March 26, 2020, the FDA appointed 29 companies to notify the agency as needed and then distribute the antibody samples.
As of April 7, 2020, only one laboratory has been approved by the FDA for emergency use capability regulation.At the end of March 2020, Euroimmune Health Laboratories and Epitope Laboratories approved their laboratory mouthpiece for Europe, which can monitor IgG and IgA antibodies to the virus from blood samples.
The capacity of the lab is a few hundred samples in a few hours which is much faster than the standard PCR monitoring method for virus RNA.
Antibodies are usually monitored 14 days after the first infection.In early April, the UK launched a non-antibody oral vaccine for sale and use.
Hong Kong has launched a programme whereby suspected patients can stay at home, "emergency department will give sample of patient", spit on, send and the results are announced shortly after.The British NHS has announced a lab trial of suspected patients at home which will eliminate the risk of infecting other patients if they leave the hospital or the ambulance is not used.With a vaccine carriage carrying a ton of COVID-19 suspects, healthcare professionals take samples and then use a precautionary watch.
Transportation-enabled facilities help South Koreans to get through emergency testing, which is much higher than in other countries.In Germany, the National Association for the Status of Health Insurance Doctors said on 2 March, they were able to do up to 12,000 tests per day, with 10.700 tests being done in ambulances a week ago.
The costs are covered by the health insurance when the doctor has ordered the test.
According to the head of the Institute Robert Koch, Germany has a total capacity to produce 160,000 tests per week.
From 19 March, the car-based lab is offered in several major cities.
As of 26 March 2020 the total number of samples taken in Germany is unknown, as only the source is reported.
The first data collection of samples at that time took place in week 12/2020 with a total of 483,295 samples tested including week 12/2020 and 33,491 samples (6.9%) samples detected from SARS-CoV-2.In Israel, researchers at Technion and Rambam Hospital developed and tested a method of testing samples from 64 patients in parallel, then combined the samples and only further testing would be done if results were available.Wuhan 2000 square meter emergency monitoring facility known as "H-Yanuo" (Chinese: XXXX, or "World Health Organization" in English) was opened on February 5, 2020 with a capacity of more than 10,000 samples per day.
The construction, supervised by BGI Founder Wang Jian and taking shape over 5 days, found that more than 47% of the cost equivalent to the removal of quarantine would be doubled if these samples did not comply.
Wuhan labs were immediately followed by Huo-Yan labs in Shenzhen, Tainjin in Beijing, and Shanghai, and a total of 12 cities in Jayna.
On 4 March 2020, the total daily capacity was 50,000 samples per day. Open source, complex designs then developed using Origami Assays were released which can then scan up to 1122 COVID-19 patient samples using only 93 shares. This balancing design can be administered with small samples without the need for robotic hands.
March, scarcity and insufficient quantity of chemical compounds became the neck of many nations in the EU and Britain and the United States.
This has led some authors to monitor the sample preparation process including heating the sample to 98 C (208 C) for 5 minutes to remove the RNA genomes from the additional samples.On 31 March, Immigration announced that it is conducting additional tests on the human population of Coronavirus which is more than any other country, and is then monitoring the lab-level weight to reach a larger population.
This was a combination of vehicle capability with the acquisition of mini-laboratories by Group 42 and BGI (which is in their "Huo-Yan" emergency monitoring lab in China).
Built in 14 days, the lab has the capacity to produce ten thousand RT-PCR samples per day and is the first of its kind in the world to operate outside of Jaina.
A combination of different laboratories to target different parts of the coronavirus virus data was conducted in China, France, Germany, Hong Kong, Japan and the United States.
The World Health Organization has adopted a German formula for the production of pneumonia to be sent to low-income countries that do not have the resources to consume it.
The German data was released on 17 January 2020; the system developed by the US Centers for Disease Control and Prevention did not appear until 28 January, which delayed the availability of samples in the US. Both China and the US had problems with the reliability of laboratory samples prior to the pandemic, and these countries and Australia did not have enough samples for the demand and the samples recommended by medical experts.
However, experts say that South Korea's extensive access to labs has helped to slow the spread of the novel coronavirus.
The power of laboratories, mostly private labs, has been built up for years by the South Korean government.
On March 16, the World Health Organization called for the consolidation of laboratory programs as the best way to reduce the spread of the COVID-19 pandemic.The high demand for laboratories caused by the high spread of the disease has resulted in hundreds of thousands of laboratories being stuck in private labs in the United States, and the scarcity of sample materials and chemicals.
March 2020 Jane reported problems with the reliability of her lab's samples.
In the United States, the laboratory lung developed by the CDC was "weaker"; the government later eliminated the predecessor of private labs. Spain purchased laboratory lung from the Jain company Shenzhen Bioesy Biotechnology Co Ltd. which was found to have incorrect results.
The company explained that the wrong result came from the sample not being taken or the wrong use of the lungs.
The Ministry of Health said that it will withdraw the false-result samples and replace the laboratory samples produced by Shenzhen Bioeasy. 80% of the laboratory samples purchased by the Czech Republic from Jayna produced false-results. Islovakia purchased 1.2 million samples from Jayna which produced false-results.
Prime Minister Matovic said these were being dumped into the Danube.Turkey's Health Minister Kara said the laboratory lungs they bought from Jayna were "very defective" and therefore "not used".Britain had purchased 3.5 million laboratory lungs from Jayna but announced in early April 2020 that they could not be used.
The laboratory, which followed quarantine and detection of SARS-CoV-2 positive traces, was close to being detected.
Researchers in the Italian city of Vo, where the first COVID-19 death was reported in Italy, conducted a second round of population-wide samples of about 3,400 people, which took ten days.
Until half of the people were found to have no symptoms, and all of the people found to have had them were quarantined.
By limiting the placenta, this eliminates the pain completely.
With a strong focus on "go-to-places", travel restrictions, laboratory testing and quarantine, the coronavirus pandemic in Singapore in 2020 has been seen to spread much less than in other developed countries, but without significantly tightening the closure of restaurants and shops.
Many events were cancelled, and Singapore first told people to stay home on 28 March, but schools reopened after the holiday on 23 March.
Several other countries are controlling the pandemic with strong efforts of outbreaks, travel restrictions from the point of origin, testing and quarantine but with a stay-at-home order that is not as strict as in Ayslan and South Korea.
The study's statistics suggest that these countries had done too many tests, so the number of adults who died was lower than the number who died, which may have led to them being able to better diagnose when there were few or no symptoms.
WHO recommends that countries that do not have the capacity for national labs and tests and therefore have limited COVID-19 experience send the first samples from the first 10 COVID-19 negative patients to one of the 16 WHO labs for testing verification.
Of the 16 labs, 7 are in Asia, 5 are in Europe, 2 are in Africa, 1 is in North America and 1 is in Australia.
In the following table, the section "Received % of samples" is then marked by the country's laboratory code.
The only country in the world that has a high percentage of people who are hospitalized, the country's labs have tested all of its population, whether they have symptoms or not, except for the fact that they are identical.
Handwashing (or handwashing), also known as hand sanitizing, is the practice of cleaning one's hands to remove dirt, grease, insects, and other impurities.
Handwashing (or handwashing), also known as hand sanitizing, is the practice of cleaning one's hands to remove dirt, grease, insects, or other unwanted substances.
Washing hands regularly with soap during these "critical times" of the day prevents the spread of many diseases, such as diarrhea and cholera, which are then spread through the saliva.
People can also contract respiratory diseases such as influenza or typhoid fever, for example, if they do not wash their hands and then touch their eyes, nose or mouth (e.g. through their stool).
It is important to wash your hands with soap five times a day: before and after cleaning, after washing the baby or changing the diaper, before feeding, before eating and before preparing food or touching raw meat, fish or chicken.
If you don't have soap and water, you can wash your hands with ash. The World Health Organization recommends handwashing:
Before, during and after preparing food.
Before and after treating a sick person.
After changing the towel or washing the baby's towel.
After you blow your nose, cough or sneeze.
After touching animals, feeding animals, or animal waste.
Health hand hygiene refers to hygiene practices related to health systems.
Hand washing before taking medicines or medical care prevents or reduces the spread of diseases.
The main health purpose of handwashing is to clean hands of infections (bacteria, viruses, or other pests that can cause pain) and chemicals that can cause damage or disease.
This is especially important for the food and health professionals, but it is also important for the general public.
Handwashing has many health benefits, including reducing the spread of flu, coronavirus, and other diseases; it eliminates diarrheal infections; and it prevents respiratory infections.
It reduces the mortality rate of children born at home.
A 2013 study shows that advances in handwashing can lead to advances in the developmental stage of children then under five years of age.
In developing countries, the infant mortality rate associated with respiratory problems and diarrheal diseases can be reduced simply by changing habits, such as washing hands with soap.
This simple step can reduce the mortality rate from these diseases by up to 50%.
Awareness-raising campaigns for handwashing can reduce diarrhea by up to a third, which is equivalent to clean water in low-income areas.
48% reduction in diarrhea is associated with hand washing with soap. Hand washing with soap may be the most important and inexpensive remedy for diarrhea and acute respiratory infections (ARI), which is something that can be done directly at home, in schools, and in the community as a whole.
Lung disease, a very serious disease, is the number one cause of death among children under five, killing about 1.8 million children annually.
Diarrhea and lung disease combined cause about 3.5 million child deaths each year.
According to UNICEF, washing hands with soap before eating and after washing can save more lives than any vaccine or treatment, and eliminates half of all deaths from diarrhea and respiratory diseases every three months.
Handwashing is usually replaced by other hygiene awareness programs, such as water, sanitation, and hygiene (WASH) programs.
Handwashing also protects people from skin infections that are spread through contact.
A minor side effect of regular hand washing is that regular hand washing can cause dry skin.
A 2012 study in Denmark found that too much hand washing can cause itching, skin conditions such as eczema or itching and acne, which are common among health care workers.
Excessive hand washing is known as a symptom of obsessive-compulsive disorder (OCD).
There are five times a day when it is important to wash hands with soap to reduce the risk of mouth pain: after using the towel (sweating, stool), after washing the baby (instead of a towel), before feeding the baby, before eating and before/after preparing food or processing meat, fish, or poultry.
Other times when proper handwashing is necessary are when preventing the spread of disease, including before and after treating a wound or wound; after sneezing, coughing, or removing a rash; after touching animal feces or processing animals; and after touching waste.
In many countries, very few people wash their hands with soap.
A study in 2015 found that 54 countries found that on average, 38.7% of households practice handwashing with soap.A 2014 study showed that Saudi Arabia had the highest proportion of 97%; the United States near the middle with 77%; and China with the lowest rate of 23%.Several behavioral-transformative approaches are currently in place to increase the adoption of handwashing habits in critical times.Group-based activities of school children at set times of the day are equipping countries to promote handwashing habits for children.
The "Cloud Health Care Program" implemented by the Philippine Department of Education is an example of a model of action to improve children's health and education.
With the payment twice a year, in addition to the pleasure of soap, brushing and flossing, it is a national program.
It is also well implemented in Indonesia.
To get rid of insects, soap or water is used.
The biggest step for soap and soap is to reduce the barriers to solutions and raise their targets.
Water alone is not enough to cleanse the skin as the fats and proteins, which are part of the natural sand, are not soluble in water.
The cleaning is, however, aided by a reasonable water flow.
Solid soap, since it can be reused, can contain bacteria from previous use.
A few studies on the transition of bacteria from contaminated soap have shown that it is difficult for bacteria to follow the water.
The CDC advises "Low-resistance soap to the hands so that the dishes come out better".
Bactericidal soaps are heavily advertised so that the health community can benefit from knowing about them.
To date, there is no evidence that the use of pesticides or recommended pesticides for the selection of natural antibodies is effective.
However, antibacterial soap contains a common antibacterial agent such as triclosan, which in turn contains an anti-insect agent.
So, even if antibiotic-resistant strains are not selected for antibiotic soap, they may not be as effective as they are marketed.
In addition to surface-cleaning and skin-protecting, modern designs may include acetic (acetic acid, ascorbic acid, lactic acid) as a pH-control device, active benzoic acid and additional skin-cooling agents (aloe vera, vitamins, menthol, herbal extracts).A comparative assessment by the University of Oregon Department of Public Health shows that pure soap is as effective as the consumer-recommended soap that contains triclosan to prevent and remove bacteria from the hands.
Hot water that you can carry with your hands is not hot water that kills bacteria.
Bacteria multiply when the body temperature reaches 37°C.
But, warm soapy water is more effective than cold soapy water in washing the organic oil, which then traps the sand and bacteria.
Contrary to popular belief, scientists have shown that using warm water does not reduce the number of insects on hands.
Hand sanitizer or hand disinfectant is a hand sanitizer that does not use water.
In the late 1990s and early 21st century, alcohol-free hand sanitizers (also known as alcohol-free hand sanitizers, hand sanitizers, or hand sanitizers) became popular.
Most are isopropyl alcohol or ethanol-derived alcohols that are then mixed with carbomer (acrylic polymer) and gel-like, or humectant such as glycerin that is liquid, or bubble-like so that they can be easily used and reduce the drying effect of alcohol.
Adding a dilute hydrogen peroxide device increases the effectiveness of the pest control. Hand sanitizer with a minimum alcohol content of 60 to 95% is sufficient to kill the germs.
Hand sanitizer wipes kill bacteria, bacteria that drugs do not kill (MRSA and VRE), tuberculosis, and some viruses (including HIV, herpes, RVS, rhinovirus, vaccininai, influenza, and gonorrhea) and viruses.
The hand sanitizer with 70% alcohol content kills 99.97% (3.5 times reduction, 35 times reduction) of bacteria on the hands after 30 seconds of application and 99.99% to 99.999% (4 to 5 times reduction) of bacteria on the hands after 1 minute of application. Hand sanitizer is better at eliminating bacteria and does not eliminate viruses.
Alcoholic hand sanitizers are usually free of Norovirus (or Norwalk) viruses, which are the most common cause of gestroentertis. Hand sanitizers or good alcohol should be used to rub hands while they are wet or to properly sanitize both hands.
The front and back of the hands and between and at the end of both fingers are rubbed for an average of 30 seconds until the liquid, bubble or gel is dry.
The US Centers for Disease Control and Prevention recommends hand washing with hand sanitizer, especially when hands are very wet.
The widespread use of these products is due to their ease of use and effective killing of insects; however, they should not be used as an alternative to decent hand sanitizers without soap and water.
Regular use of alcohol-based hand sanitizers can cause dry skin with moisturizers and/or formula emollients.
The drying effect of alcohol can be reduced by removing glycerin and/or adding other emollients to the mixture.
In medical tests, alcohol hand sanitizer with emollients causes less skin irritation and dryness than soap or insecticide soap.
Symptoms of contact dermatitis, urticaria or alcoholism or the accompanying hand rub may occur.
The lowest reduction in the risk of dematitis is then achieved by the use of soap and water.
Despite their effectiveness, they don't wash their hands with anything other than water, they just disinfect.
That's why hand sanitizers are less effective than soap and water at preventing the spread of insects, as insects will get on your hands.
A cough-free hand sanitizer is highly dependent on its composition and formulation, and has always been very useful when used with cough drops.
Recently, the emergence of benzalkonium chloride has been observed to have a sustained and active association of the insecticide after slaughter, unlike alcohol, which is then observed to be less severe when used regularly, as it is more likely to cause skin irritation.
Many people in low-income communities cannot afford soap and use it instead for parties or holidays.
Sand and sand dissolve in water, but are less effective than soap.
One concern is that sand or gravel is contaminated with pests, which can increase the spread of the disease instead of reducing it.
Like soap, it is also a cleanser, as it reacts with water to form an alkaline mixture.
WHO recommends that the person who uses the toilet or toilet can replace the soap when soap is not available.
The correct handwashing techniques recommended by the U.S. Centers for Disease Control and Prevention to prevent disease transmission include the following:
Wet your hands in warm or cold running water.
Running water is recommended as standing water may be contaminated, and the temperature of the water does not make a difference.
The skin of the hands when rubbed thoroughly with soap, including the back of the hands, the top of the fingers, and the bottom of the nails.
Soap disinfects the skin, and studies show that people wash their hands better when they use soap than when they use only water.
You rub it for at least 20 seconds.
Rubbing creates a scratch, which then helps the germs to pass through the skin, and then the additional rubbing releases more germs from the skin.
Lowering the flow of water.
In addition to standing, you can also hold your hands back.
Towel drying or air drying.
Wet or slightly damp hands can easily get dirty. The most common areas to get dirty are the thumb, wrist, the area between the fingers, and the under nails.
Artificial nails and paint nails can hide insects underneath.
Moisturizing is often recommended to keep hands from drying out; dry skin can cause skin damage and increase the risk of infection transmission.
Various inexpensive ways can be devised to make it easier to wash hands when tap water and/or soap are not available, such as draining water from a tap or well-drained areas and/or using a tap if you are in developing countries. In water scarcity situations (such as schools or rural areas in developing countries), there are ways to save water, such as "minimal space for a toilet" and other inexpensive options.
A plastic hanger is a simple technology that uses plastic hanging from a rope, then tilted so that a small amount of water is available for hand washing and soap.
Proper hand drying is an important part of the hygiene process, but there is some controversy over the effectiveness of hand drying in public places.
Many studies show that towels are much cleaner than the traditional hand dryers in many toilets.
In 2008, a study was conducted by the University of Westminster, London, sponsored by the paper towel industry at the European Tissue Symposium, to compare the hygiene standards provided by paper towels, air-conditioning dryers and modern air-air dryers.
After washing hands and drying them in warm air, the number of bacteria found increased by 194% on the fingers and 254% on the palms.
Air drying in airplanes increased the total number of finger bacteria by 42% and the number of pathogens by 15%.
After washing and drying hands with towel, bacteria are reduced to 76% on fingers and toxins to 77%. Scientists have also developed laboratory tests to detect if there is a potential for cross-transmission between other handwashing areas and the washing environment that results from the drying process.
The air dryer, which then emits air at 180 m/s (650 km/h; 400 mph), was able to spray the insect on hands and contaminate the area and people using the laundry area up to 2 meters apart.
Using a warm air dryer spreads the insects within 0.25 meters of the dryer.
Toilets did not have any large-scale spread of insects. In 2005, a study by TUV Produkt and Umwelt evaluated different methods of hand drying.
The following changes in the number of bacteria were observed after hand drying:
There are many different manufacturers of hand dryers, and paper dryers have been compared to paper dryers.
Hand washing with hand sanitizer is another option when traveling without soap and water.
The alcohol content of a hand sanitizer is 60%.
Health care was made mandatory after Hungarian physician Ignaz Semmelweis discovered its usefulness (1846) in preventing illness in the hospital environment.
There are electronic devices that remind hospital staff to wash their hands when they forget.
One study found that infection rates decreased with their use.
Wash your hands for at least 15 seconds with plenty of soap and water or gel to wipe and wipe any part of your hands.
The hands should be rubbed together with a rubbing.
If there is debris under the nail, a brush can be used to remove it.
Since the germs will remain in the water on the hands, it is important to wash them well and then dry them with a clean towel.
After drying, the tobacco can be used to lock the water (and to open the exit door if necessary).
You should be careful not to move your hands back from the area.
The reason for hand washing in healthcare is to remove the parasite's parasites ("germs") and to prevent transmission.
The New England Journal of Medicine reports that insulation is not generally allowed in health facilities, with many doctors and health care providers forgetting to wash their hands regularly before touching patients, thus transmitting pests.
A study shows that proper handwashing and other simple procedures reduce the amount of blood infection that passes through the urine by 66 percent. The World Health Organization has released a paper on the standard of handwashing and hand-washing in the healthcare sector.
The institution's hand hygiene guidelines are available on the website for public comment.
A relevant criticism was made by Whitby et al.
It is possible to measure and verify hand hygiene on the market, if necessary to demonstrate compliance with the requirements.
The World Health Organization has a "Five Times" for hand washing:
after contact with blood/body fluid
before you start a polluting job, and
After the patient is served. Chemical disinfectants ("medicinal soap" or "laxative") are also used to kill insects when washing hands.
Such a killing procedure may be required before surgery or in the acute killing area. The "place" of the killing should be rubbed, if necessary, the tube should be opened and closed without touching, a little chlorheidin or iodine should be washed, a clean towel to dry the hands after washing, and a clean brush should be used and other cleaning materials should be used to clean the under nails.
All cosmetics should be removed.
This procedure requires a massage of the hands and hands from the wrist to the elbow, usually for 2-6 minutes.
No long stretches of massage (10 minutes) are required.
When using water, water should be prevented from falling back into the hands.
After hand washing, hands should be cleaned with a cleaner cloth and surgical cloth should be worn.
To reduce the spread of germs, it is advisable to wash your hands or use hand sanitizer before and after treating a sick person.
To control staphylococcal infections in hospitals, the greatest benefit of handwashing is found to be from a pre-washing rate of 20%, and it is slightly reduced when the regular washing rate is more than 35%.
Washing hands with regular soap is three times more effective at eliminating foodborne bacterial infections than disinfectant soap. Compared with handwashing with alcohol and handwashing with disinfectant soap for a short time of up to 30 seconds each, it was found that handwashing with alcohol reduced bacteria by 26% per cent compared to disinfectant soap.
But soap and water are more effective than alcohol to wash hands in reducing the H1N1 influenza A virus and Clostridium that falls on hands. Hand hygiene measures in the health care system may include teaching hand washing staff, increasing access to alcohol to wash hands, and writing and speaking reminders to staff.
Further research is needed to determine which are best suited to different healthcare systems.
In developing countries, hand washing with soap is known to be the cheapest, most essential ingredient for good health, and even good nutrition.
But, with water, soap and sanitation facilities in short supply in people's homes, schools and workplaces, it is difficult to ignore the global trend of happiness.
For example, in many rural areas of Africa, there are few private entertainment facilities or public toilets, although it is the cheapest option to build entertainment facilities.
But, unhappiness is a behavior inherited from lack of soap and water.
Promoting happiness with soap can influence the decision-making process, create awareness about the benefits of happiness and bring about long-term behavioural change in the society.
To achieve this effectively, monitoring and evaluation are necessary.
An assessment of 70 studies found that community-based approaches are effective in increasing happiness in LMICs, while community-based campaigns are less effective.One example of school-based happiness awareness is UNICEF's "Three-Score Method" which encourages schools to take simple, cost-effective steps to ensure that students enjoy soap, as well as other hygiene requirements.
When the minimum score is reached, the school will eliminate the top three stars.
Creating recreational areas can be part of a joy awareness campaign to reduce childhood illness and mortality.
International Day of Happiness is another example of creating awareness to change behavior.Due to the 2019-20 coronavirus pandemic, UNICEF is running a campaign to address happiness.
Several studies have been conducted on the low-cost approach to happiness in developing countries in connection with the DALYs application.
However, one of the recommended practices for promoting handwashing with soap is far more valuable and effective than other water and sanitation activities.
The importance of the hand sanitizer for human health  especially for people in vulnerable situations such as new mothers or wounded soldiers in hospitals  was first recognized in the mid-19th century by two leaders in hand hygiene: Hungarian-born physician Ignaz Semmelweis who worked in Vienna, Austria and Florence Nightingale, who in English is "the founder of modern medical assistantship".
At that time, most people believed that infection caused a smell known as miasmas.
In the 1980s, an outbreak of foodborne infections and infectious health care led the U.S. Centers for Disease Control and Prevention to actively launch a hand hygiene awareness campaign as an important way to prevent the spread of infections.
The 2009 swine flu pandemic and 2020 COVID-19 pandemic increased awareness in many countries of the importance of soap consumption to prevent disease.
For example, papers on "the right technique for happiness" were posted near happiness on the intersection and at the entrances of office buildings and airports in Germany.
The term "hands-on" comes from the refusal of a person to take responsibility for promoting or sharing something.
It comes from the phrase in the Bible in Matthew where Pontius Pilate washed his hands of the death sentence of Jesus Christ, but it has become a very common word in some British communities.
Shakespeare Macbeth, Lady Macbeth begins to wash her hands forcibly in an effort to cleanse herself of the filth of fantasy, representing her guilty conscience for the crimes she has committed and which she led her husband to commit.
It has also been found that people, after they have a reminder or have committed a conscious act, often wash their hands more often than before, and they try to value their hobbies more than before.
In addition, those who are allowed to wash their hands after such a review are less likely to engage in other "cleaning" actions, such as voluntary.
Religions define chastity and cleanliness in an exemplary way. The symbol of happiness, using soapless water to cheer, is found in many religions, including the Baha'i faith, Hinduism, tevilah and netilah yadayim in Judaism, Lavabo in Christianity and Wudhu in Islam. Religions also write about happiness, especially certain acts performed.
Hinduism, Judaism, and Islam all require that you be happy when you're born.
And, Hinduism, Buddhism, Sikhism, Judaism and Islam all mandate happiness before and after food.
COVID-19 workplace risk assessment is a programme to implement workplace safety and health practices to control harm in the context of the coronavirus disease 2019 (COVID-19).
The correct way to manage workplace risks depends on the workplace and the workplace, the risk assessment of the source, the extent of the disease in the community, and the risk situations of individual workers who are vulnerable to contracting COVID-19.
According to the U.S. Occupational Safety and Health Administration (OSHA), reducing the risk of trafficking while at work reduces the risk of transmission between the public and the workplace, which requires basic measures to prevent the spread of infection, including hand washing, encouraging employees to stay home if they are sick, have respiratory illnesses, and maintain regular hygiene and disinfection at the workplace.
Particularly at risk at work are people who need to deal with or approach unknown or suspected COVID-19 people, but may have received a community infection during a trip abroad.
These include the public sector, such as schools, crowded workplaces, and crowded shops.
Risk prevention in this group, as well as basic infection prevention measures, including respirators that use high-quality air purifiers, protecting against the actions of others, and having personal protective equipment available in case of contact with someone with COVID-19.
OSHA monitors health care and elderly workers who have contact with unknown persons or people suspected of COVID-19 are considered high risk, which increases the risk if the employee has a general procedure, or collects or processes samples of a known or suspected person with COVID-19.
Control of the damage to these workers, including mechanical control of the negative pressure air conditioner, and appropriate personal protective equipment at work.
The COVID-19 outbreak can have a negative impact on the workplace.
Employees may not be able to attend work because of illness, because they need to take care of someone else, or because they are afraid of a disaster.
The business model may change, such as the goods needed and the way to obtain them (e.g. by buying the wrong watch or by bringing it to the house or by buying it in a car).
Finally, products from areas with high COVID-19 prevalence may be disrupted.The Prepare for and Response to Infectious Diseases Plan can be used to guide you on precautions to guide us.
Risk response plans for various workplaces and occupations, including workplaces, home and community hazards, and personal work hazards such as old age or long-term health problems.
They also discuss the necessities of responding to these threats, and the plan to avoid if an outbreak occurs.
Prevention and response plans may require or change the recommendations.
Effective responses to the epidemic include reducing the transmission of the disease among workers, protecting people at highest risk of adverse health effects, running a business, and reducing the bad hours of other businesses.
The severity of the disease in the community in which the business is located affects the response.
In addition to harm control, there is a wide use of occupational safety and health in the effective management of group hazards.
While the effects of COVID-19 cannot be mitigated, the most effective way to control it is through surveillance, followed by administrative surveillance, and finally personal protective equipment.
Control involves protecting workers from the risk of workplace harm without compromising the behaviour of workers, and can be the most cost-effective solution.
Administrative control is a change in the system or regulation that requires the employee or employer to take action.
Personal protective equipment (PPE) is considered less effective than the design and implementation of controls, but it can prevent certain infections.
Each type of PPE should be selected based on the risk to the worker, be well-adapted and appropriate (e.g. for breathing), be worn regularly and appropriately, be regularly checked, repaired, replaced, properly disposed, cleaned, stored or discarded to prevent infection.
According to the U.S. Occupational Safety and Health Administration (OSHA), low-risk jobs are the ones that are most likely to affect the working class.
Basic prevention measures recommended in all workplaces include washing hands regularly and thoroughly, encouraging workers to stay home if they are sick, holding their mouth and nose if they cough and sneeze, providing a cleanser and garbage disposal, preparing them to work from another place or arranging work schedules if necessary, calling workers to use tools and equipment together, and regularly cleaning and disinfecting the workplace.
Immediate removal and isolation of potential infection carriers is an important step to protect employees, customers, visitors, and other people at the workplace.
The U.S. Centers for Disease Control and Prevention (CDC) recommends that employees with severe respiratory symptoms stay at home until the nausea, nausea, and other symptoms have disappeared for at least 24 hours without using medications that reduce or alter the nausea, and have a flexible sick leave policy, which allows employees to stay at home and care for any sick family member, and that employees are aware of these rules.
According to OSHA, low-risk jobs include those where people are in frequent contact or interaction with customers less than six feet (1.8 m) away from people who are unknown or suspected to be COVID-19 patients, but who may have SARS-CoV-2 as it is a contagious disease in the business area, as the person has traveled to another area where COVID-19 is suspected to be spreading.
These include workers who have been to public places such as schools, high-security workplaces, and crowded areas of shops. Making controls for high-risk groups include creating high-quality air purifiers, increasing the amount of air purified, creating interfaces such as plastic detectors that hold the building insides, and making a window for the person in his or her vehicle to be closed. Information for the management of this multi-faceted workplace includes encouraging sick workers to stay at home, changing the glasses in the emergency room, organizing this workplace, providing access to safe and sanitary facilities in the emergency room, including COVID-19-related safety and health services, providing staff with safety and security equipment, and providing training on how to use personal protective equipment, including COVID-19-related safety and emergency equipment, and providing staff with the necessary tools to prevent and prevent COVID-19 hazards, including emergency equipment, safety equipment, and safety equipment.
Workers in this risk group do not often use respirators.
If a person becomes ill on board an aircraft, the proper control measures for the staff and other passengers include removing the person from the crew and keeping them at a distance of 6 feet, assigning one person to the severely ill person, and giving the sick person a mask or requiring the sick person to wear a mouth and nose covering and remove a clinker when coughing or sneezing.
Airline staff wear one-time protective goggles when they are attending to a sick passenger or when they are in contact with fluid or areas where germs may be deposited, and additional personal protective equipment if the sick passenger has fever, frequent coughing, or difficulty breathing.
The gloves and other disposable items should be put in a chemical waste bag, and contaminated areas should be cleaned and disinfected. On commercial ships, including cruise ships and other passenger ships, measures to prevent the risk include delaying the travel of sick persons, wearing a seatbelt, and providing immediate medical care if a person has a scar or other illness while on board.
In schools and child care centers, the CDC recommends brief lockdowns for cleaning or disinfection if an infected person comes to the school, regardless of whether or not they have spread the infection to the community.
In the event of a moderate or severe outbreak, social distancing is implemented, such as stopping educational trips, gatherings, and other mass gatherings such as group classes or art classes or dining in restaurants, increasing the distance between tables, adjusting arrival and departure times, limiting unnecessary visits, and using a separate health office elsewhere for children with symptoms such as influenza.
When there is a critical infection in the local community, in addition to the social distancing, extending school closures is considered.For police officers who perform daytime duties, the CDC considers their health risks to be low.
Police officers who come into contact with people who have been confirmed or suspected of having COVID-19 are advised to follow the same guidelines as emergency medical technicians, including personal protective equipment.
If they do occur during the handling, the employee must clean and disinfect the work belt and equipment before reuse with household cleaning spray or towel, and follow the standard workplace procedure of dirtying and disposing of used PPE including dirty clothes in their washing machine.
OSHA considers that certain health care and occupational mortality are too high or high risk.
High-risk jobs include providing health care, support, laboratory, and medical transportation personnel who have been infected or suspected of being infected with COVID-19.
This is especially dangerous if the staff is doing work, or working on collecting or testing samples, of a suspected or known COVID-19 patient.
The general procedure includes the formulation, the shape of the cough, bronchoscopies, some dental treatment and laboratory tests, or taking solid samples.
High-risk jobs include those who work preparing the bodies of people known or suspected to have COVID-19 at the time of death; these are especially risky if they are performing autopsy. Additional technical controls for the risk group include the confinement room for known or suspected COVID-19 patients, including general work performed at that time.
Special negative pressure can be applied to health care facilities and cemeteries.
The sample must be submitted to the Biosafety Level 3 test.
The World Health Organization (WHO) recommends that patients be isolated and protected depending on whether they are suspected of having COVID-19. As well as PPE, OSHA recommends respiratory isolation for people who work within 6 feet of a known, suspected, or SARS-CoV-2 patient, and for people who are doing general treatment.
In the United States, NIOSH-approved N95 respiratory masks with filtered breathing are used for effective, written breathing in monitoring programs including adhesion testing, biopsy, and clinical testing.
Other forms of respiration can provide greater protection and improved comfort for workers.WHO does not recommend full face covering, as COVID-19 is a respiratory disease and does not transmit through bodily fluids.
WHO recommends that only surgical personnel wear masks at the entrance to the laboratory.
People who are taking respiratory samples, caring for, or infecting COVID-19 patients without general treatment, WHO recommends wearing surgical masks, face masks, or face pads, wearing a strap and a golf club.
If a treatment is being given that may cause an infection, the surgical mask will be replaced with N95 or FFP2 masks.
As access to PPE is symptomatically low, WHO recommends reducing the need for PPE which is to mediate hearing and vision in people, such as a clean window, which allows all people involved in direct care to access the room with COVID-19 patients, to use only the essential PPE for specific tasks, to continue using the same masks without separating the different patients who are receiving treatment, to insert and combine PPE, and to encourage people to use masks for patients who are sick.
On March 4, 2020, I declared a State of Emergency in California due to the COVID-19 threat.
FOLLOW: All the staff of the Wikimedia Foundation
THEME LINE: [Covid-19] Stress reduction and preparation for the future
Date/time of the call: March 14, 2020, 00:24 UTC
CC0: No number is given
We've been in a tough spot this month.
The COVID-19 pandemic has demonstrated the need for global human solidarity and responsibility for one another.
We cannot stop the spread of the disease, but we know the reliable way to respond in the workplace and build a global community that is a function of this organization.
This reflects the dedication and interest we've seen in all of our staff in e-mail, chat and chat which greatly confirms the incredible humanity we've been fortunate to work with.
We're not all proud of working together.
Last week, someone posted a thank you for our work.
It reminded me how useful it is for the world to have access to Wikipedia right now, and the powerful sign that it is a source of vital information that it is online and accessible to all.
Your work is made possible by whether the website is still in existence or whether our employees receive a salary or social security.
The world needs the information Wikipedia provides, and it needs it more and more.
Right now, it's not just what we do, but how we do it, that has a huge impact on the world.
Because this work and your contribution is so important, we're going to make significant improvements to the way we work together, starting this week.
We need to organize our work and our schedule.
As previously reported by Robyn, Group-C met last night to discuss the format and schedule for the coming days and months.
In the conversation, we looked at what we thought was the appropriate response to what we were facing and the best way to keep the organization going at this time.
We want to remove the media from our space and support our work in the long run.
If you need to get back to it, that's normal.
All our employees, contractors and contractors:
We're going to be working four hours a day, or 20 hours a week until further notice.
We do not provide any leave - if you can work during normal hours, which can be used for work.
But, globally, it's unpredictable right now, and whether you need to take care of a family member, go grocery shopping, or see a doctor, your safety is your priority.
We're not tracking your time.
If you are sick, do not work.
And we said, "We are not going to do this.
You do not need to apply for sick leave or PTO - just tell your manager and help your team to organize their schedule so that they can set a time for important work.
(If you are being advised of COVID-19, please tell Bryan at T&C Ops. T&C can help support you and ensure that your condition is properly addressed and managed.
The hourly wage will be paid in full.
We've said it before, and we've committed to complying with our contractual obligations and our employee hours.
Everyone will be paid the normal hourly wage under normal conditions.
This includes if you are ill and unable to work.
If you want to work, we will help you.
Many people use work as a way to reduce noise pollution around the world.
It's incredibly rewarding, especially at a time like this.
I repeat, this is self-care.
We only ask that you contact your manager, so that we can find out what to expect and then arrange the work.
Some jobs are considered essential.
There are things we have to keep doing.
SRE, HR Ops, Trust & Security, and Team Finance (and other activities) are essential tasks that require additional support.
We're going to start a cross-departmental process so that we can get to the immediate goals and then focus on supporting our essential tasks.
There's a lot more we can do, and we're just going to focus on the projects that are essential.
Cutting back now won't do any good.
We don't plan to "enter the workforce twice" after the disease is over.
You are not obliged to work overtime so that you can complete the work in the same time, which is not possible at this time.
We've accepted that things have changed, and we're going to do it in a timely and targeted manner.
What happened to APP?
In order to adjust the new department and the expected working hours of the day, we plan to adjust the time to be provided in the Annual Plan 2020-2021.
We are proposing to extend the 2019-2020 plan so that time can be given to the budget to allow employees to prioritize essential jobs, self-care, and family care during the receptions of people who need or want to work part time over the next few weeks.
This time extension significantly reduces the workload of the time plan and the pressure on the whole institution.
We will be briefing our plan to the Commission next week and will update the agency and teams on the next steps as soon as we have confirmation.
Thank you to the APP team for taking the lead on this.
Office conditions, delivery and cleaning.
Last week, we learned that one of the SF staff may have been infected with COVID-19.
But, by the way, we hired a team to disinfect the entire San Francisco office.
Use of the hospital's disinfectant to disinfect the contact areas, as well as the reception area and the elevators on the floors.
The building has a security system, so that tenants can benefit from security support.
We are confident that the office will be ready for us when we need to return.
Our DC office is located in WeWork, which has shared its COVID-19 system with us and all DC staff.
Last week, our DC office was moved to fully house-operated according to guidelines shared with San Francisco.
As some of our NYC staffers know, we've also been discussing how to rent a space in Brooklyn.
The conversation is going on, but it's late.
Some of our employees are working elsewhere for the first time.
Our long-term home-based workers know that we can arrange this, and we want to give you some advice:
You can reduce the time of the meeting to one or at most two hours.
If you need a longer platform, you can arrange to have it ready within a few days.
At the meeting, you must clearly set an agenda and send a report to be read in advance.
You make live video, and you use tools like Google Docs and Zoom to make that easier and more interactive.
You will lead the facilitation of each meeting, someone will follow the discussion of any questions and then the list of speakers, and someone will help you take notes (or to combine the taken notes).
If you need a suitable solution, send an e-mail to the technical support department.
You use your good copies.
Participate in the Slack #remoties discussion on division of labour
The Labour Department Working Group is looking at webinar guidelines for increasing support for basic division of labour.
Last week we urged the community to suspend Wikimedia fundraising events, such as editing, until WHO announces that the pandemic is over.
We told him that we understood that our application was cancelled and that there were other restrictions that could be imposed on the grant that he approved for the activities and that no one deserved to be punished for delay or modification of these grants.
Next week we will follow further guidelines for Wikimedia and other communities and community-level meetings.
The overall structure of the global community seems to be saddened by the disruption, but we believe in transparency and the ability to focus on their communities, Wikimedia and so on.
So CRT is working on a Meta-Wiki page to provide a community space to track influencers and track our interactions.
Monitoring of COVID-19 related issues
We will send out an invitation for the special staff meeting next Thursday, 14:00 UTC/07:00 PT.
We'll use that time to provide additional information, answer questions, and spend more time connecting with others.
We are with them and we will help them in any way we can.
At this time, information is being forwarded to the Wiki Office through this email, and other important information related to COVID-19.
CRT will work on putting this page and all the information in one place.
We also work to stay in touch with workers in countries where this is a time of great impact.
If you have any questions about travel, events, live broadcasts of work for adults, or online chat, or anything else you need, please do not hesitate to contact CRT.
We're here to help and work with you as needed.
If you have a confidential or sensitive matter, please send an e-mail to Bryan Judan - Public Works Manager of the Department of Labour and Employment.
None of these changes should be seen as a burden on our work or obligations.
But, there is the identity of the moment, where the tasks and responsibilities are likely to be adapted as they were before.
There are steps we consider essential to support each other so that we can continue to work, and our movement can provide the support they need, and the world of services they depend on.
Our planned work will be there when the time comes.
At this point, it's time to support each other and set the stage for the critical work in the weeks and months ahead.
We all need you to make that happen, and we all want you to take care of yourselves and your families so that we can help you when the need arises.
Now, please -- wash your hands and don't touch your face!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, and Tony S), and the rest of the Leadership Team (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, and Toby N).
The SARS-CoV-2 virus caused by COVID-19 (coronavirus disease 2019), which is an infectious respiratory disease that was first detected in December 2019, in Wigan, Hubei, Jayna.
ACE2 inhibits the activity of angiotensin-converting enzyme (ACE) by reducing the amount of angiotensin-II and increasing Ang (1-7), making it an effective target for cardiovascular disease. ACE2 is also the entry point for some coronavirus cells.
The non-human copy of the enzyme is often referred to as hACE2.
Angiostensin-substituted enzyme 2 is a zinc-containing metalloenzyme found on the surface of endothelial and other cells.
The ACE2 protein contains an N-terminal peptide M2 site and a C-terminal amino acid rental site.
ACE2 is a type I single-chain protein, which has an enzymatically active region and then reaches the cell surface of the lungs and other tissues.
The ACE2 extracellular region is marked by a cell region that receives an enzyme called sheddase, which carries a soluble protein to the bloodstream and destroys any urine that is removed.
ACE2 is present in most cells: ACE2 attacks the cell wall, typically the lung type II alveolar cells, enterocytes in the small intestine, various endothelial and vascular cells, and most muscle cells.
Alternatively spliced ACE2mRNAs are also found in the cerebral cortex, striatum, hypothalamus, and brain cells.
The first function of ACE2 is to balance ACE.
ACE cleaves angiotensin I from the muscle membrane and angiotensin II from the muscle membrane.
ACE2 is a carboxyl-terminal amino acid derivative of phenylalanine angiotensin II (Asp-Arg-Val-Tyr-lle-His-Pro-Phe) and is hydrolysed by the vasodilator angiotensin (1-7), (H-Asp-Arg-Val-Tyr-lle-His-Pro-OH).
ACE2 also reacts with a number of other peptides including [des-arg9] - bradykinin, apelin, neurotensin, dynorphin A and ghrelin.
ACE2 also regulates the binding of neutral amino acid derived from SLC6A19 which is then reported in Hartnup syndrome.
The inhibitory protein, ACE2, is the major cell entry point for some coronaviruses, including HCoV-NL63; SARS-CoV (the virus that causes SARS); and SARS-CoV-2 (the virus that causes COVID-19).
In particular, the combination of the enhanced S1 and SARS-CoV2 enzyme proteins in the ACE2 enzymatic region on the cell surface from endocytosis and transmission of the virus and the enzyme to endosomes within the cell.
This process requires the activation of the serina-like protein TMPRSS2, which is currently being studied as a natural protein. This may lead to the hypothesis that it lowers ACE2 levels within the cell, which may help fight disease.
However, many professional societies and regulatory organizations have recommended that the continuing use of ACE and ARB treatment should be maintained.
A continuous assessment and meta-analysis published on July 11, 2012, found that "ACE respirator use was associated with a significant 34% reduction in the risk of pulmonary disease compared to controlled use".
Also, "The risk of lung disease may also be reduced in patients treated with ACE respirators who are therefore at higher risk for a disease, especially in people with respiratory and cardiac disease.
Use of ACE in respiratory tract associated with pulmonary disease reduces mortality, although nitroglycerin is much less effective in comparison to overall risk of pulmonary disease".
The human-to-human combination of ACE2 (rhACE2) is a novel treatment for severe lung injury, and to advance the elimination of hemodynamics and oxygenation in pigs with severe respiratory symptoms with lipopolysaccharide.
The half-life of rhACE2 in humans is about 10 hours, based on an additional 30 minutes of action with an effective duration of 24 hours.
Several studies indicate that rhACE2 is an effective drug for people who cannot take the respiratory medication renin-angiotesin (RAS respiratory medication) or have increased angiotensin II circulation.Injection of rhACE2 has been evaluated in a clinical trial for the treatment of acute respiratory illness.
b'Bat SARS-like coronavirus WIV1 (Bat SL_CoV-WIV1), also known as SARS-like coronavirus WIV1, is a severe respiratory illness coronavirus (SARSr-CoV) that was isolated from a bat washed with a javelin (Rhinolophus sinicus).
Various governments have developed or recommended it, and government officials provide support in some local and regional areas.
Several systems have been developed to monitor the app.
Privacy concerns arose, particularly in systems based on tracking the location of the app user.
A less common method is to use a Bluetooth dial to record the usage of other connected phones.
On April 10, 2020, Google and Apple jointly announced that they would be implementing a way to power the Bluetooth app directly on their Android and iOS operating systems.
In Jaina, the government of Jaina, in partnership with Alipay, has developed an app that allows citizens to check if a person has been close to someone with COVID-19.
It is used in more than 200 cities and in Singapore, an app called TraceTogether is used.
The app was developed by the local IT community, released as open source and is being handed over to the government.In North Macedonia, "StopKorona!" was developed, a Bulutuut-powered tracking app that reaches out to people with the disease and thus provides a quick response from healthcare authorities.
The app was developed by the Ministry of Communications and Technology and the Ministry of Health.
On 14 April 2020, the app is awaiting approval from the Google Play Store and Apple App Store.
On 12 April, the government announced that a positive trend is emerging with the proximity tracking app, which will be launched within a week.A similar app ("StopCovid") is also planned in Ireland and France.
Australia and New Zealand are both considering implementing Singapore-based TraceTogether app and BlueTrace system.Russia is developing an environmental app to track COVID-19 patients in Moscow, which is designed to ensure that they do not leave the house.
Ross Anderson, professor of ambiguous engineering at Cambridge University, has put together a list of potential problems with the app-based system, including lying about who owns it and the fact that it will fail if the app is used by only a few people.
In response to concerns about the spread of the coronavirus being fake or harmful, Apple has imposed a limitation on which entities can add coronavirus-related apps to the App Store, which is limited to "officers" or larger entities.
Google and Amazon have also made similar restrictions.
Intelligence activists expressed concern about the difficulties that mass tracking using the coronavirus-like app could cause, especially if it is designed to track construction workers to deal with the coronavirus pandemic and is distributed when the risk is exceeded.
Amnesty International and more than 100 other organizations issued a statement calling for a limit on such surveillance.
The agency has set eight criteria for public projects:
the supervision is "legal, necessary and fair";
The phrase "removing surveillance" was a flash in the pan.
The use of information is restricted to COVID-19 purposes only.
the security and confidentiality of the information could be maintained to show that the protection was based on evidence;
digital surveillance can prevent discrimination and harassment;
Any information that is shared with others must be provided for by law.
there must be a protection against harassment and the right of citizens to respond to harassment;
The effective participation of all "stakeholders" will be needed, including public health experts and vaccinated groups. The German Chaos Computer Club (CCC) and Reporters Without Borders (RSF) have also developed a watchlist.
The Google/Apple recommended plan is designed to address the problem of continuous monitoring by removing the tracking of devices and operating systems when it is not necessary.
Some countries use local networks to track apps, which eliminates the need to download apps and the ability to track traffic.
In Israel, the Internet surveillance system was adopted.
Network solutions found in the same places have future privacy problems.
However, all systems with a central server need to access location information; many encrypted systems have been developed that use a central server to communicate with each other (see section below).
In South Korea, there is a system for monitoring conversions without an app.
Instead of using a separate app, the system collects tracking information from various locations including mobile device tracking information and card transaction information and adds this information to the created text messages of people who may be infected.
Along with the use of the alert information, the government also makes the location information available to everyone, sometimes allowing it as it is difficult to change the privacy law after the MERS pandemic hit the country.
This information is available in a number of applications and websites, and in some countries, including Germany, there are encryption and public access systems.
As of April 6, 2020, no details have been released.
Encryption monitoring is a broad concept, which was achieved through a large data study that has been ongoing since 2013. On 7 April 2020, a team of dozens of experts were working on encryption-protecting solutions, such as using Bluetooth Low Energy (BLE) to locate the area where other people's phones are located.
However, PEPP-PT combines efforts in a single-site and widespread format, not just one format.The single-site system includes Protected and Sanitized Area Monitoring (DP-PPT/DP-3T), Access to Information Networking (TCN), Sensitive Encryption and Mobile Communication Monitoring (PACT) and others.
In these systems, personal data is not passed through the device, and all processing takes place on the device.
The Privacy Team at MIT Media Lab has developed SafePaths, a platform for using privacy-protection technologies to collect location-based data to track the spread of COVID-19.
Based on the study found in the white paper "Rogue Apps Gone: Protecting Personal Privacy from Cybercrime" released in March 2020. Another similar effort is SafeTrace platform by Enigma MPC, a technology developer that was originally developed at MIT Media Lab.
SafeTrace uses a network technology that enables users to share sensitive location and health information with other users and authorities, without compromising data privacy.
On 5 April 2020, the global TCN Partnership, established by similar collaboration groups and highly interdependent systems, aims to reduce bottlenecks, facilitate global interconnection of tracking and warning apps, an important means of achieving widespread implementation.
On 9 April 2020, the Singapore government announced that it had launched the BlueTrace system using the official government app.
On April 10, 2020, Google and Apple, the leading Android and iOS mobile operating companies, announced a proximity tracking software, which is said to protect encryption, which summarizes the combination of low-energy technology of Bulut and encryption protection.
They also revealed what the technology of the system is.
According to Apple and Google, the system is designed to be three-step:
The toolkit that enables the government to create a coronavirus tracking app that officially protects privacy.
In response to the ongoing monitoring problem, Google and Apple are planning to first distribute the system and update the system, and then remove it when the threat disappears in the same way.
The development of a vaccine or a treatment for the 2019-20 coronavirus disease (COVID-19) is still underway.
This is one line of scientific research that is currently being used to develop a safe and effective treatment for COVID-19.
Other studies are in the pipeline including the development of a vaccine and blood cell vaccination for COVID-19. SARS-CoV-2 has about 66 protein drugs, each of which has multiple n ligand sites.
The combined evaluation of these sites provides a plausible prediction for the development of an effective protein for the killer virus COVID-19.
Among the most important targeting proteins of SARS-CoV-2 are papain-like protease, RNA-dependent RNA polymersare, helicase, S protein, and ADP ribophosphatase.
Hussein A, et al studied several compounds which were then used and evaluated to form a mixture similar to the approved advanced drugs to speed up the composition of the anti-SARS-CoV-2 drug in the pre-clinical study to be developed in the trial study format.
Chloroquine is an antimalarial drug that has also been used in some direct immune diseases.
On 18 March, WHO announced that chloroquine and its derivative hydroxychloroquine will be among the four drugs that will be part of the clinical trials of the United Nations.
New York Governor Andrew Cuomo announced that trials of chloroquine and hydroxychloroquine in New York State will begin on March 24.On March 28, the FDA approved the use of hydroxychloroquie sulfate and chloroquine phosphate as part of the Emergency Use Authorization (EUA) process.
The drug has not been approved by the FDA for clinical trials and has only been approved under the EUA as an experimental treatment for emergency use in patients who are hospitalized but not for clinical trial treatment.
The CDC said that "the use, quantity, or duration of hydroxychloroquine for prophylaxis or treatment of SARS-CoV-2 infection" is not yet known.
Doctors said they would use the drug as they had no "alternative" treatment.
A Turkish research team conducted a small study in Istanbul using chloroquine in combination with zinc, vitamin A, vitamin C and vitamin D.
Large studies are underway at Duke University and Oxford University.
The NYU Langone School of Medicine is conducting a safety and efficacy trial of the preventive use of hydroxychloroquine.
Clinical trials conducted by Jayna in Wuhan and Shenzhen reportedly found favipiravir to be "clearly effective".
35 patients in Shenzhen were missing from the 4-day unit, while the illness duration was 11 days 45 patients were not given the medicine.
In a study of 240 patients with lung disease, half were given favipiravir and the other half were given umifenovir.
The Italian Medicines Agency has told the public that there is evidence that the vaccine is still undergoing trials and is still in the preliminary stage.
On 2 April, Germany announced that it would purchase medicines from its Japanese stockpile, which it will use to deliver the drugs to university hospitals, and the drugs will be used to treat COVID-19 patients.
According to the South China Morning Post, Shinzo Abe responded to the Trump administration's purchase of the drug, which may not have helped the virus that had initially multiplied.
It may not be safe for pregnant women or those trying to conceive.
One study on lopinavir/ritonavir (Kaletra), which combines the antiviral drug lopinavir with ritonavir, "did not show any benefit".
The drug is designed for people living with HIV so that it does not alter the proteinase mix.
A team of researchers from the University of Colorado is trying to modify drugs to find genes that combine with the protease of SARS-CoV-2.There is criticism from the scientific community about the direction of resources to reuse what was specifically designed for HIV/AIDS.
WHO has included lopinavir/ritonavir in the international cohesion trial.
Remdesivir was developed and developed by Gilead Sciences to treat Ebola virus and Marburg virus.Gilead Sciences later developed Remdesivir which had in vitro pharmacological activity against several phyllo-, pneumo-, paramyxo-, and corona-viruses.
One problem is that the treatment is designed to resist the mutation and can lead to a number of diseases and infections.
Some studies on remdesivir show that it has a high inhibitory resistance.There are several clinical trials underway, including two in the Cleveland University Hospitals; one in people with mild to severe pain.
There is an ongoing clinical trial of vitamin C intake for hospitalized and severely ill COVID-19 patients; two placebo-controlled (June, Canada) and one uncontrolled (Italy).
The state of New York began testing the antibiotic azithromycin on March 24, 2020.
The Japan National Center for Health and Global Medicine (NCGM) is planning a clinical trial of Teijin Alvesco (ciclesonide), an absorbable corticosteroid in the urine, to treat patients before they develop the novel coronavirus disease.
A phase II trial of angiotensin-converting enzyme 2 is underway with 200 patients from people with chronic disease and is being placed in hospitals in Denmark, Germany, and Austria to determine the effectiveness of treatment.
Researchers at the Montreal Heart Institute in Canada are currently studying the role that colchicine can play in reducing inflammation and dyspnea in patients with mild COVID-19 symptoms.
The study, named COLCORONA, included 6000 adults aged 40 and over who were diagnosed with COVID-19 and thus had moderate illness requiring hospitalization.
Pregnant women, breastfeeding women or those who do not have a good birth control pill are not eligible.
Several anticoagulants are being tested in Italy.
The lightweight molecules of heparin are widely used in the treatment of patients, which has led the Italian Medicines Agency to issue guidelines on how to use them.
A multi-clinical study involving 300 patients using sodium enoxaparin as a prophylactic and therapeutic drug was announced in Italy on April 14.
As SARS-CoV-2 is a virus, many scientists are focusing on reusing previously approved anti-virus drugs that were developed before the pandemic outbreak of MERS, SARS and West Nile virus.
Ribavirin: Ribavirin is recommended for the treatment of COVID-19 according to the guidelines of the 7th edition of January.
Umifenovir: umifenovir is recommended for the treatment of COVID-19 according to the guidelines of the 7th edition of Jan.
Some antibiotics have been identified as being unlikely to be used again in the treatment of COVID-19.
Tocilizumab (Anti-IL-6 receptor): It is not approved.
Also the Italian and Chinese tests.
It is not yet clear whether pregnancy may involve diabetes, heart disease, hypercoagulability or coagulation, which poses an increased risk to pregnant women as it is intended for non-pregnant women.
Although no vaccine has been fully tested, several trials are underway to develop a vaccine.
In late February 2020, the World Health Organization (WHO) said it did not expect the SARS-CoV-2 vaccine, a deadly virus, to be available in the next 18 months.
Five vaccines were selected for Phase I of the April safety study.
COVID-19 was diagnosed in December 2019.
A massive pandemic swept the world in 2020, leading to a large amount of funding and governmental studies to find a vaccine.
Many organizations are using insecticides to make SARS-CoV-2 vaccines.
As reported in April, the CEPI program is developing the vaccine together and then moving forward with speed, production capacity, mass production, and international availability.
In April, CEPI scientists said that 10 technology platforms are undergoing studies to develop an effective COVID-19 vaccine during early 2020.
Major topics targeted to create Phase I safety include:
nucleic acids (DNA and RNA) (Phase I development and production of vaccine selection: Moderna, mRNA-1273)
the viral variant (Phase I testing and vaccine development: CanSino Biologics, adenovirus type 5 factor)
According to CEPI scientists in April, 115 vaccine mixtures have been developed from the initial vaccine development, and 78 ongoing projects have been confirmed (79 according to the Milken Institute), 37 others have been reported, but little information is available (which is said to be planned or drafted).
The planned Phase I-II trial of safety and immunogenicity samples, usually randomized, placebo-controlled, multi-site, was clinically clear, and marginally effective.
Phase III trials usually involve more participants, including the control group, and the efficacy of the vaccine trial, along with the negative effects of drug abuse.
Of the 79 vaccines currently in development (confirmed in early April 2020), 74 have not yet been evaluated in humans (the study is still in "pre-trial" phase).
As of 24 January 2020, in Australia, the University of Queensland announced the development of a potential molecular vaccine that will modify the protein code of the virus to provide immunity.
As of 24 January 2020, Canada, the International Vaccine Center (VIDO-InterVac) of the University of Saskatchewan announced the start of the vaccine work, which is intended to begin non-human trials in 2021.
The projects for the production of the vaccine were announced by the Centre for Disease Control and Prevention on 26 January 2020, and by the University of Hong Kong on 28 January.
As of 29 January 2020, Janssen Pharmaceutical Company, headed by Hanneke Schuitemaker, announced that it had begun to develop a vaccine.
Janssen is developing a vaccine based on oral biotechnology, Vaxart.
On March 18, 2020, Emergent BioSolutions announced that it is co-producing the Vaxart vaccine.
On 8 February 2020, Romania's OncoGen lab released a report that it had developed a similar vaccine to be used in the treatment of cancer with a neoantigen vaccine.
On 25 March, the agency's chief research officer announced that they had concluded the development of the vaccine and would therefore begin the trial.
On 27 February 2020, Generex's subsidiary, NuGenerex Ummo-Ancology, announced that it was launching a vaccine project developed from the COVID-19 vaccine li-Key peptide.
They want to develop a selective vaccine that can then be tested on humans "in 90 days".
On 5 March 2020, Washington University in St. Louis announced the project to develop the vaccine.
On 5 March 2020, the U.S. Army Research and Development Department at Fort Detrick and the Army Walter Reed Research Institute at Silver Springs, both in western Maryland, announced that they were working on a vaccine.
As of 10 March 2020, Emergent Biosolution announced that it is partnering with Novavax Inc.
the development and manufacture of vaccines.
The people also announced that they are planning a pre-clinical trial and Phase I clinical trial by July 2020.
On 12 March 2020, the Indian Health Ministry announced that they are working with 11 people in isolation, accelerating the development of the vaccine to take at least a cycle of one and a half to two years.
On 12 March 2020, Medicago, a biotechnology company based in Quebec City, Quebec, announced that it was developing a coronavirus-like product with funding in part from the Canadian Agency for Health Research.
Selective laboratory vaccine, human-free trial planned for July or August 2020.
Earlier this week, The Guardian reported that US President Donald Trump had given CureVac "a lot of money to evaluate the Covid-19 vaccine on their own", despite opposition from the German government.
On 17 March 2020, the US pharmaceutical company Pfizer announced that it is partnering with the German company BioNTech to collaborate on an mRNA-vaccine.
The mRNA vaccine was selected as BNT162, which is currently undergoing clinical trials and is expected to begin clinical trials in April 2020.
Italy 17 March 2020, Takis Biotech, an Italian biotech company announced that they will receive the results of the clinical trial before April 2020, and the vaccine they choose will begin human trials in the autumn.
On 19 March 2020, the Coalition for Prepare for Pandemic Program (CEPI) announced a US$4.9 million investment in the COVID-19 vaccine study by the co-operative Istitut Pasteur, Themis Bioscience (Fuyeena, Astaria), University of Pittsburgh, which makes the total CEPI funding for the COVID-19 vaccine to be made US$29 million.
Other CEPI partners that are funding the development of COVID-19 vaccines are Moderna, Curevac, Inovio, Novavax, the University of Hong Kong, the University of Oxford, and the University of Queensland.
On 20 March 2020, Russian health officials announced that scientists had begun animal testing of selected vaccines.
Researchers at Imperial College London announced on 20 March 2020 that they will develop a self-developed COVID-19 RNA vaccine.
They remembered the vaccine within 14 days of their diagnosis of the Jane flu.
In late March, the Government of Canada announced that it would invest C$275 million in 96 research projects to combat COVID-19, including several cross-border vaccines being run by Canadian companies and universities, such as the Medicago and University of Saskatchewan programs.
To date, the Government of Canada has announced C$192 million specifically developed for COVID-19 vaccines, and plans to establish a national "vaccine stockpile" of several new vaccines that can be used for other coronavirus pandemics when it arrives.
On 2 April 2020, researchers at the University of Pittsburgh Department of Medicine reported testing PittCoVacc, a COVID-19 vaccine on mice, stating that "MNA provides the SARS-CoV-2 S1 vaccine and then a specific antigen that the antibody responds to [the mouse] which then starts at 2 weeks after injection".
Canada On 16 April 2020, the University of Waterloo Department of Medicine announced that it has developed a DNA vaccine that can then be taken from the nose.
Using bacteriophages, DNA is designed to replace non-human bacteria with a harmless, anti-virus that can activate the immune system to produce antibodies designed for the SARS-CoV-2 virus.
In March 2020, the US government, industry, and three universities joined forces to acquire a unique IB computer, whose data is stored on the resources of Hewlett Packard Enterprise, Amazon, Microsoft, and Google.
Some of the monuments have a single function, also called an indeterminate function.
That means it can do more than prevent pain.
Additional randomized testing in Austria is being sought to control enrollment of 4,170 healthcare workers.
It is possible that the vaccine was developed to be unsafe or ineffective.
Preliminary studies evaluating the efficacy of vaccines using specific COVID-19 in animals, such as mice injected with ACE2, other animal laboratories, and non-free, show that the level 3 safety of pandemic measures in working with live viruses, and international collaboration in ensuring systemic safety standards, is important.
SARS and MERS vaccines were tested in non-free forms.
As of 2020, there is no vaccine or drug that protects against SARS that has been proven safe and effective against humans.
According to the study reports issued in 2005 and 2006, identification and development of novel vaccines and drugs to treat SARS were a priority for governments and health agencies around the world.
When MERS emerged, it was seen that existing research on SARS could provide an effective blueprint for vaccination and treatment of MERS-CoV infection.
As of March 2020, there is a (DNA) MERS vaccine that has completed Phase I of the human-drone trial, and three others are underway, all of which are viral vaccines, two adenoviral viruses (ChAdOx1-MERS, BVRS-GamVac), and one MVA virus (MVA-MERS-S).
A poster was posted on social media that stated that the virus that causes COVID-19 is known and a vaccine has been developed.
Companies have posted on various social media platforms the company's first series of vaccines and vaccines against other coronavirus diseases such as SARS coronavirus.
b'Coronavirus is a group of related viruses that is transmitted by reptiles and birds.
Common symptoms include fever, cough, and shortness of breath.
Other symptoms include fatigue, muscle pain, diarrhea, sore throat, bad breath, and stomach pain.
The time between the onset of symptoms is usually about five days, but can range from two to fourteen days.
Although it usually causes mild pain, it can also cause viral pneumonia and the cessation of many cells.
As of 17 April 2020, more than 2.24 million cases have been reported in 210 countries and territories, resulting in more than 153,000 deaths.
More than 568,000 people have recovered from the virus, which is first transmitted to humans through close contact, and even through saliva droplets that are transmitted when a person coughs, sneezes or speaks.
Although these spots are caused by respiration, they usually occur on the ground or in areas of contact where they would be detected at a distance.
Most people can get it by touching a surface and then touching their eyes, nose, or mouth.
The virus can survive for up to 72 hours.
It is most prevalent in the first three days after symptoms appear, although it is possible to transmit before symptoms appear.A common way to diagnose it is by the rapid transcription of polymerase response (rRT-PCR) in the tissue sample.
The use of masks is recommended for people suspected of having the virus and caregivers.
The recommendations for the use of masks for the general public vary, with some authorities warning against their use, some recommending their use, and others making it mandatory.
Currently, there is no specific vaccine or specific medication for the treatment of COVID-19.
Long-term infection was reported mostly in all six WHO regions.
These infections are viruses that either cause or cause flu-like symptoms such as fever, fatigue, and shortness of breath.
Symptoms include difficulty breathing, persistent or pressurized chest pain, dizziness, difficulty walking, and blue faces or legs; it is recommended to seek immediate medical attention if these symptoms are present.
In less common cases, symptoms of upper respiratory tract such as dizziness, bloated nose or blocked throat may be seen.
Stomach symptoms such as bruising, itching, and diarrhea were observed in a variety of cases.
In some cases, pain in the chest and a heart attack were first detected.
In some places, the pain can be pneumonia, stem cell failure, and death.
This is called the asymptomatic period.
The period without symptoms of COVID-19 is usually short and can be five to six days, with many being two to 14 days.
97.5% of people who develop symptoms develop symptoms within 11.5 days of infection.Reports show that not all people with the infection have symptoms.
The role of these symptoms in the spread is not yet known, but preliminary evidence suggests that they may contribute to the spread of the disease.
The number of people who develop symptoms among those infected is not known at this time and the study is ongoing, and the Korean Center for Disease Control and Prevention (KCDC) said that 20% of all confirmed cases develop symptoms while in hospital.
The National Health Board of Jain started adding symptomatic cases to the daily cases starting from 1 April; of 166 people infected that day, 130 (78%) had symptoms at the time of testing.
Some mosquitoes and ticks can carry a large number of viruses.
A large number of votes will result in more points than the number of votes.
A study in Singapore found that a cough that is not placed in the mouth can fly up to 4.5 meters (15 feet).
Although the virus is not fungible in the air, the National Institute of Science said that bioerosol transmission is possible and that the RNA virus has been found in air collectors on patios outside public rooms.
Some medical procedures such as respiratory and cardiac resuscitation (CPR) can cause respiratory extraction which can lead to respiratory air being filtered.
Although there is concern that the virus may be transmitted through feces, this risk is considered low. The virus is most likely to spread to people with symptoms; although it is possible to spread to people without symptoms, the risk is low.
The European Union Centres for Disease Control and Prevention (ECDC) said that although it is not clear how easily the disease can be transmitted, it usually infects two to three people per person.The virus can survive on a surface for hours to days.
In particular, the virus can survive on cardboard for one day, and on plastic (polypropylene, 304) and metal (AISI, 304) for three days, and on 99% copper for four hours.
This, however, varies depending on the humidity and temperature.
Soap and soap also have an effect if used correctly; soap destroys the viral fat that protects the surface, and also removes the skin and areas on it.
Another solution is benzalkonium chloride and chlorhexidine gluconate (germis dile), which is less effective.A study in Hong Kong, samples of feces taken with medication for two days after hospitalization.
In five to six patients, the first sample showed high viral load, and the sixth patient showed high viral load on the second day of testing.
The severe coronavirus respiratory disease 2 (SARS-CoV-2) is a highly contagious novel coronavirus respiratory disease. The first three people who were isolated had a combination of lung disease and severe respiratory disease in Wuhan.
All novel SARS-CoV-2 forms of the coronavirus in the wild.
Outside the human body, the virus is killed by household soap, which penetrates the protective layer. SARS-CoV-2 is closely related to SARS-CoV.
The lungs are the most common cell affected by COVID-19 as the virus can enter the angiotensin-enzyme cell and convert it to enzyme 2 (ACE2), which is more common in the type II alveolar cell of the lungs.
The virus uses a high-level glycoprotein called a peplomer to bind to ACE2 and all receptor cells.
Severe heart failure is seen in 12% of those admitted to hospital in Wuhan, Jayna, and is more common in severe cases.
Heart attacks are common, which cause a reactive inflammation and disruption of the immune system during the course of the attack, but severe myocardial injury can also be associated with ACE2 receptors in the heart.
ACE2 receptors are highly expressed in the heart and can cause heart failure.
An increase in thrombosis (31%) and venous thromboembolis (25%) was observed in ICU patients with COVID-19 and may be related to their poor health.Active tests performed on people who died from COVID-19 were found to have alveolar damage (DAD), and in which lymphocytes contained a cognitive filter burn in the lungs.
Although SARS-COV-2 has an ACE2-specific epithelial cell tropism in respiratory monitoring, patients with COVID-19 have more severe symptoms of the inflammatory system.
In particular, the disease of T-cell-perforating GM-CSF has been seen to be associated with the presence of IL-6 inflammation and exacerbation of lung pain in COVID-19 patients.
Lymphocytic inflammation was also detected in autopsies.
WHO has published several laboratory tests for the disease.
The official method of testing is then to replace the polymerase response script (rRT-PCR).
The test is performed only on a sample of the nasal swab taken from the nasal brush; however, a sample of the nasal swab or a swab can also be used.
The results are usually obtained within a few hours to two days.
Blood can also be used, but blood samples will need to be taken every two weeks and the results will be somewhat mediocre.
Scientists have isolated the coronavirus cells and distributed them as a sample so that international laboratories can voluntarily perform a laboratory response (PCR) to detect the virus infection.
On 4 April 2020, an antibody test (which detects active infection and whether a person has had it before) was developed, but it has not yet been widely used.
A laboratory test of the Jains has shown 60 to 70 percent accuracy.
The US FDA approved the first-line laboratory on 21 March 2020 for use at the end of the month.The laboratory guidelines were released by the Zhongnan University Hospital of Wihan as its recommended diagnostic method based on the clinical trial model of the pandemic risk.
Several double-sided lower glass tibolae with periphral, asymmetrical posterior opacities are most common.
In subpleural masses, severe formation (differential lobular septal mass) and the same ear can be a painful process.
There is little information available about the prevalence and severity of COVID-19.
The most commonly diagnosed autopsy disorders are:
Mascroscopy: pleurisy, pericarditis, pulmonary fusion and edema of the lungs
Four highly aggressive strains of the virus were detected:
Some lung diseases: pulmonary edema, pneumocyte edema, a wide range of inflammatory diseases, inflammation of the intestine with lymphocytic and multinucleated processes from cell formation.
acute pulmonary disease: alveolar damage (DAD) from alveolar entry is excluded.
DAD causes acute respiratory distress syndrome (ARDS) and hypoxemia.
heat lung disease: they work by removing the alveolar cartilage and the small intestine.
Blood: closed-cell division (DIC); leukoerythroblastic response
Measures to reduce the risk of infection include staying at home, avoiding public places, washing hands often with soap and water and rubbing for at least 20 seconds, maintaining respiratory hygiene and avoiding touching eyes, nose, or mouth without rubbing.
The CDC recommends that mouth and nose be removed from clinics when coughing or sneezing and recommends that the mouth and nose be removed from clinics if there are no clinics.
The right to be happy after coughing or sneezing.
CDC recommends the use of clean face masks when outdoors, to reduce the transmission of personal toxins.Distancing is intended to reduce the movement of people through school and workplaces, limit movement and stop mass gatherings.
The guidelines for distance include that people should stay 6 feet (1.8 meters) apart.
There is no known cure for COVID-19. And the vaccine is not expected to be available until early 2021, a key part of managing COVID-19 is to slow the spread, which is known as "reducing the flow".
The CDC recommends frequent soaking with soap and water for at least 20 seconds, especially when the teeth are out or the hands are thick and visible, before cooking and after the lump is removed, crushed or inhaled.
It is also recommended to use hand sanitizer containing at least 60% alcohol, but only when soap and water are not available.Where hand sanitizer is not sold, WHO offers a step-by-step method.
In this reaction, the antimicrobial activity is produced by ethanol or isopropanol.
Hydrogen peroxide is used to eliminate bacterial resistance in alcohol; it is "not an active ingredient".
Glycerol is added to the humectant.
People are treated with supervised care, which includes fluid therapy, oxygen support, and support for other cells affected by the virus.
The CDC recommends that people suspected of having the virus wear masks.
Extracoronal Oxygenation (ECMO) is used as a response to respiratory distress, but its efficacy is still being studied.
Personal hygiene and healthy lifestyle and nutrition are said to boost immunity.
Supportive treatment may be helpful for people with mild symptoms during the early stages of the disease.The WHO and the National Health Commission of Jamaica have called for recommendations on how to protect people hospitalized with COVID-19.
Internists and pulmonologists have combined the recommended American treatments from various organizations into a free resource, IBCC.
As of April 2020, there is no specific treatment for COVID-19.
Some health professionals recommend that acetaminophen be preferred to ibubarafin first.
Care should be taken to reduce the risk of transmission of the virus, especially in the health care system when conducting treatment that involves inhalation, such as intubation or hand-breathing.
For healthcare professionals caring for people with COVID-19, the CDC recommends that people be admitted to the Common Infection Assessment Room (CIIR) in addition to the usual precautions, social contact and airway precautions.The CDC said guidelines for using personal protective equipment (PPE) during the pandemic.
Recommended equipment is: PPE, respirator or mask, eye protection, and gloves. When available, respirator (instead of mask) is preferred.
N95 masks are approved for this function but the FDA has issued an Emergency Use Approval (EUA) for use as masks.
They are designed to protect against airborne diseases such as malaria but they are harmful to all living things but cannot guarantee any use.
When masks are not available, the CDC recommends wearing a mask, or, if otherwise, making a mask at home.
COVID-19 is usually not very severe or does not change its shape, but in some cases it does.
The respiratory support forms for COVID-19 are associated with respiratory failure which is well studied in hospitalized patients, with evidence suggesting that either a nasal tube or two levels of airway pressure can be avoided.
Whether these two are beneficial for patients is not known.
Some doctors prefer to stay at home with respiratory therapy when available, as this method limits the spread of respiratory therapy compared to nasal therapy.
Many developing countries do not have enough hospital beds for their population, which limits the capacity of the health system to deal with if there is a sudden increase in the number of people with severe COVID-19 who need hospital treatment.
One study in Jayna found that 5% of people in the intensive care unit, 2.3% needed a respiratory support machine, and 1.4% died.
And, an average of 30% of people hospitalized with COVID-19 are eventually referred to the ICU department.
The respiratory system is impaired as the respiratory syndrome (ARDS) increases as COVID-19 increases and oxygen intake becomes more difficult.
Pressure-controlled breathing machines and high-level PEEP were needed to maximize oxygen supply to reduce the respiratory risk associated with lung and preumothorax injury.
The PEEP is not high enough for the old respirators.
A study suggests that treatment will begin in January 2020, and the antiviral drugs will be tested in clinical trials.
Remdesivir seems to be the most useful.
Although new drugs may take until 2021 to develop, several of these drugs have been tested and approved for alternative uses or initially in advanced stages.
Viral medicines can be tested on people with chronic diseases.
WHO said that people with similar responsibilities are participating in future efficacy and safety trials of the treatment.FDA has granted temporary approval for convalescent plasma as an experimental treatment when a person's condition is severe or requires immediate treatment.
No clinical trials have been conducted to show the effectiveness of the drug in treating pain.
In February 2020, Jayne developed an app to work with epidemics.
Users are asked to enter their name and ID number.
The app is able to monitor the 'in-crowd' using surveillance information and potential exposure risks.
Each user can also view the status of three other users.
If a potential threat is detected, the app not only advises lockdown, but also notifies local authorities.It edits a wealth of information including cell phones, facial recognition, mobile tracking and technology is being used to track infected people and people close to them in South Korea, Taiwan and Singapore.
In March 2020, the Israeli government allowed a mental health agency to monitor mobile phones suspected of being infected with coronavirus.
Measures have been taken to implement quarantine and protect those close to infected people.
Also in March 2020, Deutsche Telekom shared information about the location of the phone with the German federal government agency, Robert Koch Institute, to then track and prevent the spread of the virus.
Russia has developed facial recognition technology to track people who have violated their quarantine orders.
Italy's local health commissioner Giulio Gallera told the telephone company that "40% of people are moving around as they please".
Germany conducted a 48-hour computer-based study over the two days of the holiday with more than 42,000 participants.
Also, the President of Estonia, Kersti Kaljulaid, has made an international call for solutions to the coronavirus outbreak.
People may flock to the area during quarantine, travel restrictions, the unhealthy effects of treatment or because they are afraid to carry it.
BBC quotes Rory O'Connor as saying, "The increasing isolation, loneliness, media, noise and financial lockdowns are a destructive wind for people's mental health and well-being".
It may reduce the symptoms of mild or no symptoms, which are similar to other respiratory diseases such as influenza.
Mild illnesses usually go away in two weeks, while severe or severe illnesses can take up to six weeks to heal.
Pregnant women may be at higher risk of contracting COVID-19 as data from similar viruses, such as SARS and MERS, has been found, but data on COVID-19 is still scarce. In some people, COVID-19 can affect the cause that causes lung disease.
In severe cases, COVID-19 can be a severe respiratory syndrome (ARDS) that causes respiratory distress, blood-toxicity, or cell death.
COVID-19-related problems of blood poisoning, abnormal clots and damage to the heart, kidneys, and liver.
Abnormal renal function is usually seen in 6% of COVID-19 hospitalized patients, while abnormal renal function is seen in 4% of this group.
An average of 20-30% of people diagnosed with COVID-19 have high levels of liver enzymes (transaminases).
The same report said the time between the onset of symptoms and death is ten days, with five days in the hospital.
However, the transfer of patients to ICU takes seven days from the time of hospitalization to the time of death.
In a study of earlier cases, the time from mild symptoms to death is 14 days, which is a maximum of 41 days.
According to a study by the National Health Commission (NHC) in Jaina, men have a mortality rate of 2.8% and women have a mortality rate of 1.7%.
Histopathological laboratory of lung sample examined by alveolar swabs of removed fubromyxiod from the lungs.
The virus mutation was found to be a cause of pain.
The pulmonary imaging was seen in severe acute respiratory syndrome (ARDS).
In 11.8% of deaths reported by the National Health Commission of Jayna, heart damage was seen to cause increased troponin or heart failure.
According to data from March in the United States, 89% of those hospitalized had a pre-existing illness. Available medical resources and local economic practices may have an impact on mortality.
The cost of accommodation varies according to the circumstances and the environment, but also because there is a strict structure.
The number of minor cases of death has been greatly reduced.
But, since the death was caused by a delay, it would mean that the death toll would be reduced.
Smokers are 1.4 times more likely to develop multiple COVID-19 infections and an average of 2.4 times more likely to suffer from advanced care or die than non-smokers.
Hong Kong Hospital Administration found a 20% to 30% decrease in lung capacity in people who recovered from the disease, and a scan of the lungs showed cell damage.
This can also lead to negative effects on well-being.
As of March 2020, it is not known whether other diseases and long-term immunity to disease caused by infection.
It may not have been harmful, based on other coronavirus behaviours, but cases recovered from COVID-19 were followed by coronavirus samples later reported.
These cases are considered to be more likely to develop into a recurrent infection.
The virus is considered to be a natural animal-derived, transmitted infection.
The official origin is unknown, but in December 2019 the outbreak was completely contagious.
A study of the first 41 confirmed cases of COVID-19, published in January 2020, in The Lancet, reported that the earliest date of onset of symptoms was 1 December 2019.
An official report by WHO said the symptoms began on 8 December 2019.
Several measurements have been made that are known to be fatal.
These numbers vary by region and time period and can affect the size of the lab, the quality of health care systems, treatment options, the time to when it started and income patterns such as age, gender and general health.
In late 2019, WHO classified the disease under ICD-10 code U07.1 for deaths based on laboratory-confirmed SARS-CoV-2 infection and U07.2 for deaths in clinical or laboratory epidemiological laboratory from COVID-19 infection confirmed by laboratory-confirmed SARS-CoV-2 infection.The death toll of cases is reflected in the number of deaths divided by the number of cases received in a given period of time.
Based on statistics from Hopkins University, the mortality rate of the plague cases is 6.9% (153,822/2,240,191) as of 17 April 2020.
Other measures include the mortality limit (CFR), which indicates the number of persons who died from disease, and the disease factor (IFR), which indicates the percentage of persons (tested or not) who died from disease.
These statistics may not be timely and do not follow a specific sample of cases that have recovered.
Although not all people have antibodies, the presence of antibodies can provide information about how many people have contracted the disease.
In the most populous area of Italy, Castiglione d'Adda, a small village of about 4600 inhabitants, 80 (1.7%) died.
In Galgelt, the disease spread at a carnival event, and spread to young people, resulting in relatively few deaths, not all of the COVID-19 deaths being attributed to the disease.
Also, the German healthcare system is not well-functioning.
In the Netherlands, up to 3% had antibodies, according to the blood donor.
69 (0.004% of the population) were confirmed to have died from COVID-19.
The effects of the disease and the mortality rate are significant and do not differ between men and women.
Mortality is higher in men in both China and Italy.
The risk is higher in men in their 50s, and the difference between men and women is only 90.
And, the mortality rate was reported to be 2.8 percent for men and 1.7 percent for women.
The exact cause of gender differences is unknown, but gender and behaviour may be a factor.
Gender-based immune disparities, low smoking among women and the fact that men develop erectile dysfunction less often than women have contributed to more male deaths.
In Europe, 57% of the infected men and 72% of those who died from COVID-19 were men.
As of April 2020, the US government has not tracked gender-related deaths from COVID-19.
A study shows that viral diseases such as Ebola, HIV, influenza and SARS affect men and women differently.
A high proportion of healthcare workers, especially healthcare assistants, are women, and they are at high risk of carrying the virus.
The World Health Organization announced on 11 February 2020 that the official name of the disease is "COVID-19".
WHO Director General Tedros Adhanom Ghebreyesus said that CO stands for corona, VI stands for virus, D stands for disease and 19 stands for when the pandemic was first detected: 31 December 2019.
The name was chosen to avoid a cardinal environment for a disease (such as the genus Jaina), a species of animal or a group of people, in line with international recommendations for the purpose of naming to eliminate discrimination.The virus that causes COVID-19 is called the acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
WHO also uses "COVID-19 virus" and "virus that causes COVID-19" when issuing its reports.
Both the disease and the virus are called "coronavirus".
During the first pandemic in Wuhan, China, the virus and disease were known as "coronavirus" and "Wuhan coronavirus".
In January 2020, WHO recommended that 2019-nCov and 2019 nCoV acute respiratory syndrome be a temporary name for the virus and the disease in accordance with the 2015 guidelines not to be used as a substitute when naming disease and the virus.
The official designation of COVID-19 and SARS-CoV-2 was made on 11 February 2020.
As there was a limit on the sales volume, some digital industries have published healthcare products such as pulse-carrying tissue samples and components of respirators.
For example, when an Italian hospital had an urgent need for respirator models, and the necessary supplies were not available in time, a local startup company designed and produced 100 taps overnight.
After the first outbreak of COVID-19, much was being overlooked, misinformation and false information about the origin, extent, prevention, treatment and other aspects of the disease was urgently needed online.
Without humans, we seem to be less powerful than some other animals.
The virus was not detected in pigs, poultry, and chickens.
There is no approved medicine or vaccine for treatment.
International studies of COVID-19 vaccines and medicines are underway by governmental and governmental agencies, academic groups and study departments.
In March, the World Health Organization launched a "TEST" to evaluate the effectiveness of a prescription for a virus that was then claimed to be potentially lethal.
Maybe a vaccine, but various agencies are working on getting vaccinated.
Previous SARS-CoV functions have been exploited as both SARS-CoV and SARS-CoV-2 are used as ACE2 receptors that enter non-human cells.
There are three stages of vaccination being studied.
First, the researchers' goal is to develop a vaccine for all viruses.
The use of this type of virus, either inactive or dead, is intended to stimulate the body's immune response to novel COVID-19 infections.
The second step, the development of vaccines, is to determine the sensitivity of the immune system to certain viruses.
In the case of SARS-CoV-2, such studies focus on the increase of S-helper protein in the ACE2 receptor enzyme.
The third vaccine is nucleation (DNA or RNA vaccine, the new technique for making vaccines).
A trial vaccine developed with a single dose will be tested for safety and efficacy.On 16 March 2020, the first clinical trial of the vaccine began in four volunteers in Seattle.
The vaccine contains a harmless, mutated version of the virus that causes the disease.There is an increased antibody that suggests there is a challenge to developing a vaccine for SARS-COV-2, but it is controversial.
There are more than 300 clinical trials in progress as of April 2020.
Several tests have been evaluated and approved for malate, including studies of hydroxychloroquine or chloroquine.
The reuse of antiviral drugs was the focus of the Jani study, which underwent nine phase III trials of remdesivir in several countries, according to a report released in late April.
Widespread criticism of the development of the health facility's COVID-19 vaccine and drugs developed, April 2020. Several early antiviral drugs were evaluated for treatment of COVID-19, including remdesivir, chloroquine and hyroxychloroquine, lopinavir/ritonavir and lopinavir/ritonavir plus interferon beta.
Evidence is being observed for the decline in remdesivir, as of March 2020.
Improvements in health were observed in patients with compassionate use of remdesivir.
Phase III clinical trials were conducted in the United States, Japan, and Italy.Chloroquine, which was previously used in malaria treatment, was studied in Japan in February 2020, with preliminary results released.
But, there is a need for peer researchers to look at it.
The Korean and Japanese Health Administration recommends the use of chloroquine.
But, the Wuhan Institute for Viruses, although it recommends a daily limit of one gram, says that the normal dose is twice as high as the risk of harmful effects.
On 28 March 2020, the FDA issued an emergency use authorization for hydroxychloroquine and chloroquine approved by doctors treating people with COVID-19. The 7th edition of the guidelines also includes interferon, ribavirin or umifenovir for use against COVID-19.
Preliminary data indicate that the nasal dose of ribavirin is being taken for SARS-CoV-2 in vitro.
Nitrozoxanide was recommended for future use in vivo studies after a small respiratory strain of SARS-CoV-2 was detected.Studies on the serine-transferase-transferase-promoting protein 2 (TMPRSS2) were essential for the entry of SARS-CoV-2 into ACE2 receptor interaction.
Studies on chloroquine and hydroxchloroquine with or without azithromycin have been too limited to warrant a medical community offering this treatment without a study. Oseltamivir does not limit in vitro administration of SARS-CoV-2 and its role in the treatment of COVID-19 is unknown.
Cyclosporine cyclones can be a problem in the late stages of severe COVID-19.
There is evidence that hydroxychloroquine may have anti-cytokine activity.Tocilizumab is also included in the treatment guidelines of the National Health Board of China after the study is completed.
If the current phase 2 is not a national laboratory dumping of body parts in Italy after detection of the fetal tissue of people with chronic pain.
The combination of serum ferritin from blood tests with cytocin storm detection represents an uncontrolled substance, a process that is thought to cause death in some people.
The interleukin-6 receptor antagonist was approved by the FDA based on a clinical study of the causative agent of the cytokine-producing steroid that causes inflammation, CAR T cells, in patients in 2017.
So far, there is no evidence of a toxic control for the treatment of CRS infection.
The transmission of clean and dense antibodies developed in the immune system of people recovering from COVID-19 to people in need is being investigated in a non-vaccination and ongoing immunization mode.
This application was treated with SARS and the result was incomplete.
The virus immunity of the desired form of sleeping antibody therapy activity can be transmitted to SARS-CoV-2.
Other methods, however, such as antibody-dependent cell cytotoxicity and/or phagocytosis, are possible.
Other types of anti-fungal therapy, for example, using monoclonal antibodies, are being developed.
Convalescent serum, which contains a liquid component of blood taken from a patient that contains a specific antibody to the virus, can increase the rate of formation.
Coronavirus, a group of closely related diseases
Li Wenlian, a doctor at Wuhan Central Hospital, who later contracted and died of COVID-19 after reporting the virus outbreak.
Li Wenlian, a doctor at Wuhan Central Hospital, who later contracted and died of COVID-19 after reporting the virus outbreak.
